Evolution of whole cells and organisms by recursive sequence recombination

ABSTRACT

The invention provides methods employing iterative cycles of recombination and selection/screening for evolution of whole cells and organisms toward acquisition of desired properties. Examples of such properties include enhanced recombinogenicity, genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites.

CROSS-REFERENCE TO RELATED APPLICATION

Pursuant to 37 C.F.R 1.71(e), Applicants note that a portion of thisdisclosure contains material which is subject to copyright protection.The copyright owner has no objection to the facsimile reproduction byanyone of the patent document or patent disclosure, as it appears in thePatent and Trademark Office patent file or records, but otherwisereserves all copyright rights whatsoever.

This application claims priority to U.S. Ser. No. 60/035,054, filed Jan.17, 1997, which is incorporated by reference in its entirety for allpurposes. This application also claims priority to PCT/US/98/00852 filedJan. 16, 1998, designating the U.S., which is also incorporated byreference in its entirety for all purposes.

TECHNICAL FIELD

The invention applies the technical field of molecular genetics toevolve the genomes of cells and organisms to acquire new and improvedproperties.

BACKGROUND

Cells have a number of well-established uses in molecular biology. Forexample, cells are commonly used as hosts for manipulating DNA inprocesses such as transformation and recombination. Cells are also usedfor expression of recombinant proteins encoded by DNA transformed intothe cells. Some types of cells are also used as progenitors forgeneration of transgenic animals and plants. Although all of theseprocesses are now routine, in general, the genomes of the cells used inthese processes have evolved little from the genomes of natural cells,and particularly not toward acquisition of new or improved propertiesfor use in the above processes.

The traditional approach to artificial or forced molecular evolutionfocuses on optimization of individual genes having discrete andselectable phenotypes. The strategy is to clone a gene, identify adiscrete function for the gene and an assay by which it can be selected,mutate selected positions in the gene (e.g., by error-prone PCR orcassette mutagenesis) and select variants of the gene for improvement inthe known function of the gene. A variant having improved function canthen be expressed in a desired cell type. This approach has a number oflimitations. First, it is only applicable to genes that have beenisolated and functionally characterized. Second, the approach is usuallyonly applicable to genes that have a discrete function. In other words,multiple genes that cooperatively confer a single phenotype cannotusually be optimized in this manner—and many genes have cooperativefunctions. Finally, this approach can only explore a very limited numberof the total number of permutations even for a single gene. For example,varying even ten positions in a protein with every possible amino acidwould generate 20¹⁰ variants, which is more than can be accommodated byexisting methods of transfection and screening.

In view of these limitations, traditional approaches are inadequate forimproving cellular genomes in many useful properties. For example, toimprove a cell's capacity to express a recombinant protein might requiremodification in any or all of a substantial number of genes, known andunknown, having roles in transcription, translation, posttranslationalmodification, secretion or proteolytic degradation, among others.Attempting individually to optimize even all the known genes having suchfunctions would be a virtually impossible task, let alone optimizinghitherto unknown genes which may contribute to expression in manners notyet understood.

For example, one area where traditional methods are used extensively isin the fermentation industry. The primary goal of current strainimprovement programs (SIPs) in fermentation is typically an increase inproduct titre. State-of-the-art mutagenesis and screening is practicedby large fermentation companies, such as those in the pharmaceutical andchemical industries. Parent strains are mutated and individualfermentations of 5,000-40,000 mutants are screened by high-throughputmethods for increases in product titre. For a well developed strain, anincrease in yield of 10% per year (i.e., one new parent strain per year)is achieved using these methods. In general, cells are screened fortitre increases significantly above that of the parent, with thedetection sensitivity of most screens being ˜5% increase due tovariation in growth conditions. Only those that “breed true” duringscale up make it to production and become the single parent of the nextround of random mutagenesis.

Employing optimal mutation conditions one mutant out of 5,000-40,000typically has a titre increase of 10%. However, a much higher percentagehas slightly lower titre increases, 4-6%. These are generally notpursued, since experience has demonstrated that a higher producer can beisolated and that a significant percent of the lower producers actuallyare no better than the parent strain. The key to finding high producersusing current strategies is to screen very large numbers of mutants perround of mutagenesis and to have a stable and sensitive assay. For thesereasons, R&D to advance this field are in the automation and thescreening capacity of the SIPs. Unfortunately, this strategy isinherently limited by the value of single mutations to strainimprovement and the growth rate of the target organisms.

The present invention overcomes the problems noted above, providing,inter alia, novel methods for evolving the genome of whole cells andorganisms.

SUMMARY OF THE INVENTION

In one aspect, the invention provides methods of evolving a cell toacquire a desired function. Such methods entail, e.g., introducing alibrary of DNA fragments into a plurality of cells, whereby at least oneof the fragments undergoes recombination with a segment in the genome oran episome of the cells to produce modified cells. The modified cellsare then screened for modified cells that have evolved towardacquisition of the desired function. DNA from the modified cells thathave evolved toward the desired function is then recombined with afurther library of DNA fragments, at least one of which undergoesrecombination with a segment in the genome or the episome of themodified cells to produce further modified cells. The further modifiedcells are then screened for further modified cells that have furtherevolved toward acquisition of the desired function. Steps ofrecombination and screening/selection are repeated as required until thefurther modified cells have acquired the desired function.

In some methods, the library or further library of DNA fragments iscoated with recA protein to stimulate recombination with the segment ofthe genome. In some methods, the library of fragments is denatured toproduce single-stranded DNA, the single-stranded DNA are annealed toproduce duplexes some of which contain mismatches at points of variationin the fragments, and duplexes containing mismatches are selected byaffinity chromatography to immobilized MutS.

In some methods, the desired function is secretion of a protein, and theplurality of cells further comprises a construct encoding the protein.The protein is inactive unless secreted and further modified cells areselected for protein function. Optionally, the protein is toxic to theplurality of cells unless secreted. In this case, the modified orfurther modified cells which evolve toward acquisition of the desiredfunction are screened by propagating the cells and recovering survivingcells.

In some methods, the desired function is enhanced recombination. In suchmethods, the library of fragments sometimes comprises a cluster of genescollectively conferring recombination capacity. Screening can beachieved using cells carrying a gene encoding a marker whose expressionis prevented by a mutation removable by recombination. The cells arescreened by their expression of the marker resulting from removal of themutation by recombination.

In some methods, the plurality of cells are plant cells and the desiredproperty is improved resistance to a chemical or microbe. The modifiedor further modified cells (or whole plants) are exposed to the chemicalor microbe and modified or further modified cells having evolved towardthe acquisition of the desired function are selected by their capacityto survive the exposure.

In some methods, the plurality of cells are embryonic cells of ananimal, and the method further comprises propagating the transformedcells to transgenic animals.

The invention further provides methods for performing in vivorecombination. At least first and second segments from at least one geneare introduced into a cell, the segments differing from each other in atleast two nucleotides, whereby the segments recombine to produce alibrary of chimeric genes. A chimeric gene is selected from the libraryhaving acquired a desired function.

The invention further provides methods of predicting efficacy of a drugin treating a viral infection. Such method entail recombining a nucleicacid segment from a virus, whose infection is inhibited by a drug, withat least a second nucleic acid segment from the virus, the secondnucleic acid segment differing from the nucleic acid segment in at leasttwo nucleotides, to produce a library of recombinant nucleic acidsegments. Host cells are then contacted with a collection of viruseshaving genomes including the recombinant nucleic acid segments in amedia containing the drug, and progeny viruses resulting from infectionof the host cells are collected.

A recombinant DNA segment from a first progeny virus recombines with atleast a recombinant DNA segment from a second progeny virus to produce afurther library of recombinant nucleic acid segments. Host cells arecontacted with a collection of viruses having genomes including thefurther library or recombinant nucleic acid segments, in mediacontaining the drug, and further progeny viruses are produced by thehost cells. The recombination and selection steps are repeated, asnecessary, until a further progeny virus has acquired a desired degreeof resistance to the drug, whereby the degree of resistance acquired andthe number of repetitions needed to acquire it provide a measure of theefficacy of the drug in treating the virus. Viruses are optionallyadapted to grow on particular cell lines.

The invention further provides methods of predicting efficacy of a drugin treating an infection by a pathogenic microorganism. These methodsentail delivering a library of DNA fragments into a plurality ofmicroorganism cells, at least some of which undergo recombination withsegments in the genome of the cells to produce modified microorganismcells. Modified microorganisms are propagated in a media containing thedrug, and surviving microorganisms are recovered. DNA from survivingmicroorganisms is recombined with a further library of DNA fragments atleast some of which undergo recombination with cognate segments in theDNA from the surviving microorganisms to produce further modifiedmicroorganisms cells. Further modified microorganisms are propagated inmedia containing the drug, and further surviving microorganisms arecollected. The recombination and selection steps are repeated as needed,until a further surviving microorganism has acquired a desired degree ofresistance to the drug. The degree of resistance acquired and the numberof repetitions needed to acquire it provide a measure of the efficacy ofthe drug in killing the pathogenic microorganism.

The invention further provides methods of evolving a cell to acquire adesired function. These methods entail providing a populating ofdifferent cells. The cells are cultured under conditions whereby DNA isexchanged between cells, forming cells with hybrid genomes. The cellsare then screened or selected for cells that have evolved towardacquisition of a desired property. The DNA exchange andscreening/selecting steps are repeated, as needed, with thescreened/selected cells from one cycle forming the population ofdifferent cells in the next cycle, until a cell has acquired the desiredproperty.

Mechanisms of DNA exchange include conjugation, phage-mediatedtransduction, protoplast fusion, and sexual recombination of the cells.Optionally, a library of DNA fragments can be transformed orelectroporated into the cells.

As noted, some methods of evolving a cell to acquire a desired propertyare effected by protoplast-mediated exchange of DNA between cells. Suchmethods entail forming protoplasts of a population of different cells.The protoplasts are then fused to form hybrid protoplasts, in whichgenomes from the protoplasts recombine to form hybrid genomes. Thehybrid protoplasts are incubated under conditions promoting regenerationof cells. The next step is to select or screen to isolate regeneratedcells that have evolved toward acquisition of the desired property. DNAexchange and selection/screening steps are repeated, as needed, withregenerated cells in one cycle being used to form protoplasts in thenext cycle until the regenerated cells have acquired the desiredproperty. Industrial microorganisms are a preferred class of organismsfor conducting the above methods. Some methods further comprise a stepof selecting or screening for fused protoplasts free from unfusedprotoplasts of parental cells. Some methods further comprise a step ofselecting or screening for fused protoplasts with hybrid genomes freefrom cells with parental genomes. In some methods, protoplasts areprovided by treating individual cells, mycelia or spores with an enzymethat degrades cell walls. In some methods, the strain is a mutant thatis lacking capacity for intact cell wall synthesis, and protoplasts formspontaneously. In some methods, protoplasts are formed by treatinggrowing cells with an inhibitor of cell wall formation to generateprotoplasts.

In some methods, the desired property is expression and/or secretion ofa protein or secondary metabolite, such as an industrial enzyme, atherapeutic protein, a primary metabolite such as lactic acid orethanol, or a secondary metabolite such as erythromycin cyclosporin A ortaxol. In other methods it is the ability of the cell to convertcompounds provided to the cell to different compounds. In yet othermethods, the desired property is capacity for meiosis. In some methods,the desired property is compatibility to form a heterokaryon withanother strain.

The invention further provides methods of evolving a cell towardacquisition of a desired property. These methods entail providing apopulation of different cells. DNA is isolated from a firstsubpopulation of the different cells and encapsulated in liposomes.Protoplasts are formed from a second subpopulation of the differentcells. Liposomes are fused with the protoplasts, whereby DNA from theliposomes is taken up by the protoplasts and recombines with the genomesof the protoplasts. The protoplasts are incubated under regeneratingconditions. Regenerating or regenerated cells are then selected orscreened for evolution toward the desired property.

The invention further provides methods of evolving a cell towardacquisition of a desired property using artificial chromosomes. Suchmethods entail introducing a DNA fragment library cloned into anartificial chromosome into a population of cells. The cells are thencultured under conditions whereby sexual recombination occurs betweenthe cells, and DNA fragments cloned into the artificial chromosomehomologously recombines with corresponding segments of endogenouschromosomes of the populations of cells, and endogenous chromosomesrecombine with each other. Cells that have evolved toward acquisition ofthe desired property are then selected or screened. The method is thenrepeated with cells that have evolved toward the desired property in onecycle forming the population of different cells in the next cycle.

The invention further provides methods of evolving a DNA segment clonedinto an artificial chromosome for acquisition of a desired property.These methods entail providing a library of variants of the segment,each variant cloned into separate copies of an artificial chromosome.The copies of the artificial chromosome are introduced into a populationof cells. The cells are cultured under conditions whereby sexualrecombination occurs between cells and homologous recombination occursbetween copies of the artificial chromosome bearing the variants.Variants are then screened or selected for evolution toward acquisitionof the desired property.

The invention further provides hyperrecombinogenic recA proteins.Examples of such proteins are from clones 2, 4, 5, 6 and 13 shown inFIG. 13.

BRIEF DESCRIPTION OF THE DRAWING

FIG. 1, panels A-D: Scheme for in vitro shuffling of genes.

FIG. 2: Scheme for enriching for mismatched sequences using MutS.

FIG. 3: Alternative scheme for enriching for mismatched sequences usingMutS.

FIG. 4: Scheme for evolving growth hormone genes to produce larger fish.

FIG. 5: Scheme for shuffling prokaryotes by protoplast fusion.

FIG. 6: Scheme for introducing a sexual cycle into fungi previouslyincapable of sexual reproduction.

FIG. 7: General scheme for shuffling of fungi by protoplast fusion.

FIG. 8: Shuffling fungi by protoplast fusion with protoplasts generatedby use of inhibitors of enzymes responsible for cell wall formation.

FIG. 9: Shuffling fungi by protoplast fusion using fungal strainsdeficient in cell-wall synthesis that spontaneously form protoplasts.

FIG. 10: YAC-mediated whole genome shuffling of Saccharomyces cerevisiaeand related organisms.

FIG. 11: YAC-mediated shuffling of large DNA fragments.

FIGS. 12: (A, B, C and D) DNA sequences of a wildtype recA protein andfive hyperrecombinogenic variants thereof.

FIG. 13: Amino acid sequences of a wildtype recA protein and fivehyperrecombinogenic variants thereof.

FIG. 14: illustration of combinatoriality.

FIG. 15: Repeated pairwise recombination to access multi-mutant progeny.

FIG. 16: graph of fitness versus sequence space for three differentmutation strategies.

FIG. 17: graphs of asexual sequential mutagenesis and sexual recursiverecombination.

FIG. 18: Schematic for non-homologous recombination.

FIG. 19: Schematic for split and pool strategy.

FIG. 20, panel A: schematic for selectable/counterselectable markerstrategy.

FIG. 20, panel B: schematic for selectable/counterselectable markerstrategy for Rec A.

FIG. 21: plant regeneration strategy for regenerating salt-tolerantplants.

FIG. 22: Whole genome shuffling of parsed (subcloned) genomes.

FIG. 23: Schematic for blind cloning of gene homologs.

FIG. 24: High throughput family shuffling.

FIG. 25: Schematic and graph of poolwise recombination.

FIG. 26: Schematic of protoplast fusion.

FIG. 27: Schematic assay for poolwise recombination.

FIG. 28: Schematic of halo assay and integrated system.

DEFINITIONS

The term cognate refers to a gene sequence that is evolutionarily andfunctionally related between species. For example, in the human genome,the human CD4 gene is the cognate gene to the mouse CD4 gene, since thesequences and structures of these two genes indicate that they arehomologous and that both genes encode a protein which functions insignaling T-cell activation through MHC class II-restricted antigenrecognition.

Screening is, in general, a two-step process in which one firstdetermines which cells do and do not express a screening marker orphenotype (or a selected level of marker or phenotype), and thenphysically separates the cells having the desired property. Selection isa form of screening in which identification and physical separation areachieved simultaneously by expression of a selection marker, which, insome genetic circumstances, allows cells expressing the marker tosurvive while other cells die (or vice versa). Screening markers includeluciferase, β-galactosidase, and green fluorescent protein. Selectionmarkers include drug and toxin resistance genes.

An exogenous DNA segment is one foreign (or heterologous) to the cell orhomologous to the cell but in a position within the host cell nucleicacid in which the element is not ordinarily found. Exogenous DNAsegments can be expressed to yield exogenous polypeptides.

The term gene is used broadly to refer to any segment of DNA associatedwith a biological function. Thus, genes include coding sequences and/orthe regulatory sequences required for their expression. Genes alsoinclude nonexpressed DNA segments that, for example, form recognitionsequences for other proteins.

The terms “identical” or percent “identity,” in the context of two ormore nucleic acids or polypeptide sequences, refer to two or moresequences or subsequences that are the same or have a specifiedpercentage of amino acid residues or nucleotides that are the same, whencompared and aligned for maximum correspondence, as measured using oneof the following sequence comparison algorithms or by visual inspection.

The phrase “substantially identical,” in the context of two nucleicacids or polypeptides, refers to two or more sequences or subsequencesthat have at least 60%, preferably 80%, most preferably 90-95%nucleotide or amino acid residue identity, when compared and aligned formaximum correspondence, as measured using one of the following sequencecomparison algorithms or by visual inspection. Preferably, thesubstantial identity exists over a region of the sequences that is atleast about 50 residues in length, more preferably over a region of atleast about 100 residues, and most preferably the sequences aresubstantially identical over at least about 150 residues. In a mostpreferred embodiment, the sequences are substantially identical over theentire length of the coding regions.

For sequence comparison, typically one sequence acts as a referencesequence, to which test sequences are compared. When using a sequencecomparison algorithm, test and reference sequences are input into acomputer, subsequence coordinates are designated, if necessary, andsequence algorithm program parameters are designated. The sequencecomparison algorithm then calculates the percent sequence identity forthe test sequence(s) relative to the reference sequence, based on thedesignated program parameters.

Optimal alignment of sequences for comparison can be conducted, e.g., bythe local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482(1981), by the homology alignment algorithm of Needleman & Wunsch, J.Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson& Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerizedimplementations of algorithms GAP, BESTFIT, FASTA, and TFASTA in theWisconsin Genetics Software Package Release 7.0, Genetics ComputerGroup, 575 Science Dr., Madison, Wis.

Another example of a useful alignment algorithm is PILEUP. PILEUPcreates a multiple sequence alignment from a group of related sequencesusing progressive, pairwise alignments to show relationship and percentsequence identity. It also plots a tree or dendogram showing theclustering relationships used to create the alignment. PILEUP uses asimplification of the progressive alignment method of Feng & Doolittle,J. Mol. Evol. 35:351-360 (1987). The method used is similar to themethod described by Higgins & Sharp, CABIOS 5:151-153 (1989). Theprogram can align up to 300 sequences, each of a maximum length of 5,000nucleotides or amino acids. The multiple alignment procedure begins withthe pairwise alignment of the two most similar sequences, producing acluster of two aligned sequences. This cluster is then aligned to thenext most related sequence or cluster of aligned sequences. Two clustersof sequences are aligned by a simple extension of the pairwise alignmentof two individual sequences. The final alignment is achieved by a seriesof progressive, pairwise alignments. The program is run by designatingspecific sequences and their amino acid or nucleotide coordinates forregions of sequence comparison and by designating the programparameters. For example, a reference sequence can be compared to othertest sequences to determine the percent sequence identity relationshipusing the following parameters: default gap weight (3.00), default gaplength weight (0.10), and weighted end gaps.

Another example of algorithm that is suitable for determining percentsequence identity and sequence similarity is the BLAST algorithm, whichis described in Altschul et al., J. Mol. Biol. 215:403-410 (1990).Software for performing BLAST analyses is publicly available through theNational Center for Biotechnology Information(http://www.ncbi.nlm.nih.gov/). This algorithm involves firstidentifying high scoring sequence pairs (HSPs) by identifying shortwords of length W in the query sequence, which either match or satisfysome positive-valued threshold score T when aligned with a word of thesame length in a database sequence. T is referred to as the neighborhoodword score threshold (Altschul et al, supra). These initial neighborhoodword hits act as seeds for initiating searches to find longer HSPscontaining them. The word hits are then extended in both directionsalong each sequence for as far as the cumulative alignment score can beincreased. Cumulative scores are calculated using, for nucleotidesequences, the parameters M (reward score for a pair of matchingresidues; always >0) and N (penalty score for mismatching residues;always <0). For amino acid sequences, a scoring matrix is used tocalculate the cumulative score. Extension of the word hits in eachdirection are halted when: the cumulative alignment score falls off bythe quantity X from its maximum achieved value; the cumulative scoregoes to zero or below, due to the accumulation of one or morenegative-scoring residue alignments; or the end of either sequence isreached. The BLAST algorithm parameters W, T, and X determine thesensitivity and speed of the alignment. The BLASTN program (fornucleotide sequences) uses as defaults a wordlength (W) of 11, anexpectation (E) of 10, M=5, N=−4, and a comparison of both strands. Foramino acid sequences, the BLASTP program uses as defaults a wordlength(W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (seeHenikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)).

In addition to calculating percent sequence identity, the BLASTalgorithm also performs a statistical analysis of the similarity betweentwo sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA90:5873-5787 (1993)). One measure of similarity provided by the BLASTalgorithm is the smallest sum probability (P(N)), which provides anindication of the probability by which a match between two nucleotide oramino acid sequences would occur by chance. For example, a nucleic acidis considered similar to a reference sequence if the smallest sumprobability in a comparison of the test nucleic acid to the referencenucleic acid is less than about 0.1, more preferably less than about0.01, and most preferably less than about 0.001.

A further indication that two nucleic acid sequences or polypeptides aresubstantially identical is that the polypeptide encoded by the firstnucleic acid is immunologically cross reactive with the polypeptideencoded by the second nucleic acid, as described below. Thus, apolypeptide is typically substantially identical to a secondpolypeptide, for example, where the two peptides differ only byconservative substitutions. Another indication that two nucleic acidsequences are substantially identical is that the two moleculeshybridize to each other under stringent conditions.

The term “naturally-occurring” is used to describe an object that can befound in nature. For example, a polypeptide or polynucleotide sequencethat is present in an organism (including viruses) that can be isolatedfrom a source in nature and which has not been intentionally modified byman in the laboratory is naturally-occurring. Generally, the termnaturally-occurring refers to an object as present in a non-pathological(undiseased) individual, such as would be typical for the species.

Asexual recombination is recombination occurring without the fusion ofgametes to form a zygote.

A “mismatch repair deficient strain” can include any mutants in anyorganism impaired in the functions of mismatch repair. These includemutant gene products of mutS, mutT, mutH, mutL, ovrD, dcm, vsr, umuC,umuD, sbcB, recJ, etc. The impairment is achieved by genetic mutation,allelic replacement, selective inhibition by an added reagent such as asmall compound or an expressed antisense RNA, or other techniques.Impairment can be of the genes noted, or of homologous genes in anyorganism.

Detailed Description

I. General

A. The Basic Approach

The invention provides methods for artificially evolving cells toacquire a new or improved property by recursive sequence recombination.Briefly, recursive sequence recombination entails successive cycles ofrecombination to generate molecular diversity and screening/selection totake advantage of that molecular diversity. That is, a family of nucleicacid molecules is created showing substantial sequence and/or structuralidentity but differing as to the presence of mutations. These sequencesare then recombined in any of the described formats so as to optimizethe diversity of mutant combinations represented in the resultingrecombined library. Each recombination cycle is followed by at least onecycle of screening or selection for molecules having a desiredcharacteristic. The molecule(s) selected in one round form the startingmaterials for generating diversity in the next round.

The cells to be evolved can be bacteria, archaebacteria, or eukaryoticcells and can constitute a homogeneous cell line or mixed culture.Suitable cells for evolution include the bacterial and eukaryotic celllines commonly used in genetic engineering, protein expression, or theindustrial production or conversion of proteins, enzymes, primarymetabolites, secondary metabolites, fine, specialty or commoditychemicals. Suitable mammalian cells include those from, e.g., mouse,rat, hamster, primate, and human, both cell lines and primary cultures.Such cells include stem cells, including embryonic stem cells andhemopoietic stem cells, zygotes, fibroblasts, lymphocytes, Chinesehamster ovary (CHO), mouse fibroblasts (NIH3T3), kidney, liver, muscle,and skin cells. Other eukaryotic cells of interest include plant cells,such as maize, rice, wheat, cotton, soybean, sugarcane, tobacco, andarabidopsis; fish, algae, fungi (penicillium, aspergillus, podospora,neurospora, saccharomyces), insect (e.g., baculo lepidoptera), yeast(picchia and saccharomyces, Schizosaccharomyces pombe). Also of interestare many bacterial cell types, both gram-negative and gram-positive,such as Bacillus subtilis, B. licehniformis, B. cereus, Escherichiacoli, Streptomyces, Pseudomonas, Salmonella, Actinomycetes and Erwinia.The complete genome sequences of E. coli and Bacillus subtilis aredescribed by Blattner et al., Science 277, 1454-1462 (1997); Kunst etal., Nature 390, 249-256 (1997)).

Evolution commences by generating a population of variant cells.Typically, the cells in the population are of the same type butrepresent variants of a progenitor cell. In some instances, thevariation is natural as when different cells are obtained from differentindividuals within a species, from different species or from differentgenera. In other instances, variation is induced by mutagenesis of aprogenitor cell. Mutagenesis can be effected by subjecting the cell tomutagenic agents, or if the cell is a mutator cell (e.g., has mutationsin genes involved in DNA replication, recombination and/or repair whichfavor introduction of mutations) simply by propagating the mutatorcells. Mutator cells can be generated from successive selections forsimple phenotypic changes (e.g., acquisition of rifampicin-resistance,then nalidixic acid resistance then lac− to lac+ (see Mao et al., J.Bacteriol. 179, 417-422 (1997)), or mutator cells can be generated byexposure to specific inhibitors of cellular factors that result in themutator phenotype. These could be inhibitors of mutS, mutL, mutD, recD,mutY, mutM, dam, uvrD and the like.

More generally, mutations are induced in cell populations using anyavailable mutation technique. Common mechanisms for inducing mutationsinclude, but are not limited to the use of strains comprising mutationssuch as those involved in mismatch repair e.g. mutations in mutS, mutT,mutL and mutH; exposure to U.V. light; Chemical mutagenesis, e.g. use ofinhibitors of MMR, DNA damage inducible genes, or SOS inducers;overproduction/underproduction/mutation of any component of thehomologous recombination complex/pathway, eg. RecA, ssb, etc.;overproduction/underproduction/mutation of genes involved in DNAsynthesis/homeostasis; overproduction/underproduction/mutation ofrecombination-stimulating genes from bacteria, phage (eg. Lambda Redfunction), or other organisms; addition of chi sites into/flanking thedonor DNA fragments; coating the DNA fragments with RecA/ssb and thelike.

In other instances, variation is the result of transferring a library ofDNA fragments into the cells (e.g., by conjugation, protoplast fusion,transformation, transduction or natural competence). At least one, andusually many of the fragments in the library, show some, but notcomplete, sequence or structural identity with a cognate or allelic genewithin the cells sufficient to allow homologous recombination to occur.For example, in one embodiment, homologous integration of a plasmidcarrying a shuffled gene or metabolic pathway leads to insertion of theplasmid-borne sequences adjacent to the genomic copy. Optionally, acounter-selectable marker strategy is used to select for recombinants inwhich recombination occurred between the homologous sequences, leadingto elimination of the counter-selectable marker. This strategy isillustrated in FIG. 20A. A variety of selectable and counter selectablemarkers are amply illustrated in the art. For a list of useful markers,see, Berg and Berg (1996), Transposable element tools for microbialgenetics. Escherichia coli and Salmonella Neidhardt. Washington, D.C.,ASM Press. 2:2588-2612; La Rossa, ibid., 2527-2587.

The library of fragments can derive from one or more sources. One sourceof fragments is a genomic library of fragments from a different species,cell type, organism or individual from the cells being transfected. Inthis situation, many of the fragments in the library have a cognate orallelic gene in the cells being transformed but differ from that genedue to the presence of naturally occurring species variation,polymorphisms, mutations, and the presence of multiple copies of somehomologous genes in the genome. Alternatively, the library can bederived from DNA from the same cell type as is being transformed afterthat DNA has been subject to induced mutation, by conventional methods,such as radiation, error-prone PCR, growth in a mutator organism orcassette mutagenesis. Alternatively, the library can derive from agenomic library of fragments generated from the pooled genomic DNA of apopulation of cells having the desired characteristics. Alternatively,the library can derive from a genomic library of fragments generatedfrom the pooled-genomic DNA of a population of cells having desiredcharacteristics.

In any of these situations, the genomic library can be a completegenomic library or subgenomic library deriving, for example, from aselected chromosome, or part of a chromosome or an episomal elementwithin a cell. As well as, or instead of these sources of DNA fragments,the library can contain fragments representing natural or selectedvariants of selected genes of known function (i.e., focused libraries).

The number of fragments in a library can vary from a single fragment toabout 10¹⁰, with libraries having from 10³ to 10⁸ fragments beingcommon. The fragments should be sufficiently long that they can undergohomologous recombination and sufficiently short that they can beintroduced into a cell, and if necessary, manipulated beforeintroduction. Fragment sizes can range from about 10 b to about 20 mb.Fragments can be double- or single-stranded.

The fragments can be introduced into cells as whole genomes or ascomponents of viruses, plasmids, YACS, HACs or BACs or can be introducedas they are, in which case all or most of the fragments lack an originof replication. Use of viral fragments with single-stranded genomesoffer the advantage of delivering fragments in single stranded form,which promotes recombination. The fragments can also be joined to aselective marker before introduction. Inclusion of fragments in a vectorhaving an origin of replication affords a longer period of time afterintroduction into the cell in which fragments can undergo recombinationwith a cognate gene before being degraded or selected against and lostfrom the cell, thereby increasing the proportion of cells withrecombinant genomes. Optionally, the vector is a suicide vector capableof a longer existence than an isolated DNA fragment but not capable ofpermanent retention in the cell line. Such a vector can transientlyexpress a marker for a sufficient time to screen for or select a cellbearing the vector (e.g., because cells transduced by the vector are thetarget cell type to be screened in subsequent selection assays), but isthen degraded or otherwise rendered incapable of expressing the marker.The use of such vectors can be advantageous in performing optionalsubsequent rounds of recombination to be discussed below. For example,some suicide vectors express a long-lived toxin which is neutralized bya short-lived molecule expressed from the same vector. Expression of thetoxin alone will not allow vector to be established. Jense & Gerdes,Mol. Microbiol., 17, 205-210 (1995); Bernard et al., Gene 162, 159-160.Alternatively, a vector can be rendered suicidal by incorporation of adefective origin of replication (e.g. a temperature-sensitive origin ofreplication) or by omission of an origin of replication. Vectors canalso be rendered suicidal by inclusion of negative selection markers,such as ura3 in yeast or sacB in many bacteria. These genes become toxiconly in the presence of specific compounds. Such vectors can be selectedto have a wide range of stabilities. A list of conditional replicationdefects for vectors which can be used, e.g., to render the vectorreplication defective is found, e.g., in Berg and Berg (1996),“Transposable element tools for microbial genetics” Escherichia coli andSalmonella Neidhardt. Washington, D.C., ASM Press. 2: 2588-2612.Similarly, a list of counterselectable markers, generally applicable tovector selection is also found in Berg and Berg, id. See also, LaRossa(1996) “Mutant selections linking physiology, inhibitors, and genotypes”Escherichia coli and Salmonella F. C. Neidhardt. Washington, D.C., ASMPress. 2: 2527-2587.

After introduction into cells, the fragments can recombine with DNApresent in the genome, or episomes of the cells by homologous,nonhomologous or site-specific recombination. For present purposes,homologous recombination makes the most significant contribution toevolution of the cells because this form of recombination amplifies theexisting diversity between the DNA of the cells being transfected andthe DNA fragments. For example, if a DNA fragment being transfecteddiffers from a cognate or allelic gene at two positions, there are fourpossible recombination products, and each of these recombinationproducts can be formed in different cells in the transformed population.Thus, homologous recombination of the fragment doubles the initialdiversity in this gene. When many fragments recombine with correspondingcognate or allelic genes, the diversity of recombination products withrespect to starting products increases exponentially with the number ofmutations. Recombination results in modified cells having modifiedgenomes and/or episomes.

The variant cells, whether the result of natural variation, mutagenesis,or recombination are screened or selected to identify a subset of cellsthat have evolved toward acquisition of a new or improved property. Thenature of the screen, of course, depends on the property and severalexamples will be discussed below. Optionally, the screening is repeatedbefore performing subsequent cycles of recombination. Stringency can beincreased in repeated cycles of screening.

The subpopulation of cells surviving screening are optionally subjectedto a further round of recombination. In some instances, the furtherround of recombination is effected by propagating the cells underconditions allowing exchange of DNA between cells. For example,protoplasts can be formed from the cells, allowed to fuse, andregenerated. Cells with recombinant genomes are propagated from thefused protoplasts. Alternatively, exchange of DNA can be promoted bypropagation of cells or protoplasts in an electric field. For cellshaving a conjugative transfer apparatus, exchange of DNA can be promotedsimply by propagating the cells.

In other methods, the further round of recombination is performed by asplit and pool approach. That is, the surviving cells are divided intotwo pools. DNA is isolated from one pool, and if necessary amplified,and then transformed into the other pool. Accordingly, DNA fragmentsfrom the first pool constitute a further library of fragments andrecombine with cognate fragments in the second pool resulting in furtherdiversity. An example of this strategy is illustrated in FIG. 19. Asshown, a pool of mutant bacteria with improvements in a desiredphenotype is obtained and split. Genes are obtained from one half, e.g.,by PCR or by cloning of random genomic fragments. These are thenshuffled, or simply cloned into an allele replacement vector (e.g., onecarrying selectable and counter-selectable markers). The gene pool isthen transformed into the other half of the original mutant pool andrecombinants are selected and screened for further improvements inphenotype. These best variants are used as the starting point for thennext cycle.

In other methods, some or all of the cells surviving screening aretransfected with a fresh library of DNA fragments, which can be the sameor different from the library used in the first round of recombination.In this situation, the genes in the fresh library undergo recombinationwith cognate genes in the surviving cells. If genes are introduced ascomponents of a vector, compatibility of this vector with any vectorused in a previous round of transfection should be considered. If thevector used in a previous round was a suicide vector, there is noproblem of incompatibility. If, however, the vector used in a previousround was not a suicide vector, a vector having a differentincompatibility origin should be used in the subsequent round. In all ofthese formats, further recombination generates additional diversity inthe DNA component of the cells resulting in further modified cells.

The further modified cells are subjected to another round ofscreening/selection according to the same principles as the first round.Screening/selection identifies a subpopulation of further modified cellsthat have further evolved toward acquisition of the property. Thissubpopulation of cells can be subjected to further rounds ofrecombination and screening according to the same principles, optionallywith the stringency of screening being increased at each round.Eventually, cells are identified that have acquired the desiredproperty.

B. Variations

1. Coating Fragments with recA Protein

The frequency of homologous recombination between library fragments andcognate endogenous genes can be increased by coating the fragments witha recombinogenic protein before introduction into cells. See Pati etal., Molecular Biology of Cancer 1, 1 (1996); Sena & Zarling, NatureGenetics 3, 365 (1996); Revet et al., J. Mol. Biol. 232, 779-791 (1993);Kowalczkowski & Zarling in Gene Targeting (CRC 1995), Ch. 7. Therecombinogenic protein promotes homologous pairing and/or strandexchange. The best characterized recA protein is from E. coli and isavailable from Pharmacia (Piscataway, N.J.). In addition to thewild-type protein, a number of mutant recA-like proteins have beenidentified (e.g., recA803). Further, many organisms have recA-likerecombinases with strand-transfer activities (e.g., Ogawa et al., ColdSpring Harbor Symposium on Quantitative Biology 18, 567-576 (1993);Johnson & Symington, Mol. Cell. Biol. 15, 4843-4850 (1995); Fugisawa etal., Nucl. Acids Res. 13, 7473 (1985); Hsieh et al., Cell 44, 885(1986); Hsieh et al., J. Biol. Chem. 264, 5089 (1989); Fishel et al.,Proc. Natl. Acad. Sci. USA 85, 3683 (1988); Cassuto et al., Mol. Gen.Genet. 208, 10 (1987); Ganea et al., Mol. Cell Biol. 7, 3124 (1987);Moore et al., J. Biol. Chem. 19, 11108 (1990); Keene et al., Nucl. AcidsRes. 12, 3057 (1984); Kimiec, Cold Spring Harbor Symp. 48, 675 (1984);Kimeic, Cell 44, 545 (1986); Kolodner et al., Proc. Natl. Acad. Sci. USA84, 5560 (1987); Sugino et al., Proc. Natl. Acad. Sci. USA 85, 3683(1985); Halbrook et al., J. Biol. Chem. 264, 21403 (1989); Eisen et al.,Proc. Natl. Acad. Sci. USA 85, 7481 (1988); McCarthy et al., Proc. Natl.Acad. Sci. USA 85, 5854 (1988); Lowenhaupt et al., J. Biol. Chem. 264,20568 (1989). Examples of such recombinase proteins include recA,recA803, uvsX, (Roca, A. I., Crit. Rev. Biochem. Molec. Biol. 25, 415(1990)), sep1 (Kolodner et al., Proc. Natl. Acad. Sci. (U.S.A.) 84, 5560(1987); Tishkoff et al., Molec. Cell. Biol. 11, 2593), RuvC (Dunderdaleet al., Nature 354, 506 (1991)), DST2, KEM1, XRN1 (Dykstra et al.,Molec. Cell. Biol. 11, 2583 (1991)), STPα/DST1 (Clark et al., Molec.Cell. Biol. 11, 2576 (1991)), HPP-1 (Moore et al., Proc. Natl. Acad.Sci. (U.S.A.) 88, 9067 (1991)), other eukaryotic recombinases (Bishop etal., Cell 69, 439 (1992); Shinohara et al., Cell 69, 457.

RecA protein forms a nucleoprotein filament when it coats asingle-stranded DNA. In this nucleoprotein filament, one monomer of recAprotein is bound to about 3 nucleotides. This property of recA to coatsingle-stranded DNA is essentially sequence independent, althoughparticular sequences favor initial loading of recA onto a polynucleotide(e.g., nucleation sequences). The nucleoprotein filament(s) can beformed on essentially any DNA to be shuffled and can form complexes withboth single-stranded and double-stranded DNA in procaryotic andeukaryotic cells.

Before contacting with recA or other recombinase, fragments are oftendenatured, e.g., by heat-treatment. RecA protein is then added at aconcentration of about 1-10 μM. After incubation, the recA-coatedsingle-stranded DNA is introduced into recipient cells by conventionalmethods, such as chemical transformation or electroporation. Thefragments undergo homologous recombination with cognate endogenousgenes. Because of the increased frequency of recombination due torecombinase coating, the fragments need not be introduced as componentsof vectors.

Fragments are sometimes coated with other nucleic acid binding proteinsthat promote recombination, protect nucleic acids from degradation, ortarget nucleic acids to the nucleus. Examples of such proteins includesAgrobacterium virE2 (Durrenberger et al., Proc. Natl. Acad. Sci. USA 86,9154-9158 (1989)). Alternatively, the recipient strains are deficient inRecD activity. Single stranded ends can also be generated by 3′-5′exonuclease activity or restriction enzymes producing 5′ overhangs.

2. MutS Selection

The E. coli mismatch repair protein MutS can be used in affinitychromatography to enrich for fragments of double-stranded DNA containingat least one base of mismatch. The MutS protein recognizes the bubbleformed by the individual strands about the point of the mismatch. See,e.g., Hsu & Chang, WO9320233. The strategy of affinity enriching forpartially mismatched duplexes can be incorporated into the presentmethods to increase the diversity between an incoming library offragments and corresponding cognate or allelic genes in recipient cells.

FIG. 2 shows one scheme in which MutS is used to increase diversity. TheDNA substrates for enrichment are substantially similar to each otherbut differ at a few sites. For example, the DNA substrates can representcomplete or partial genomes (e.g., a chromosome library) from differentindividuals with the differences being due to polymorphisms. Thesubstrates can also represent induced mutants of a wildtype sequence.The DNA substrates are pooled, restriction digested, and denatured toproduce fragments of single-stranded DNA. The single-stranded DNA isthen allowed to reanneal. Some single-stranded fragments reanneal with aperfectly matched complementary strand to generate perfectly matchedduplexes. Other single-stranded fragments anneal to generate mismatchedduplexes. The mismatched duplexes are enriched from perfectly matchedduplexes by MutS chromatography (e.g., with MutS immobilized to beads).The mismatched duplexes recovered by chromatography are introduced intorecipient cells for recombination with cognate endogenous genes asdescribed above. MutS affinity chromatography increases the proportionof fragments differing from each other and the cognate endogenous gene.Thus, recombination between the incoming fragments and endogenous genesresults in greater diversity.

FIG. 3 shows a second strategy for MutS enrichment. In this strategy,the substrates for MutS enrichment represent variants of a relativelyshort segment, for example, a gene or cluster of genes, in which most ofthe different variants differ at no more than a single nucleotide. Thegoal of MutS enrichment is to produce substrates for recombination thatcontain more variations than sequences occurring in nature. This isachieved by fragmenting the substrates at random to produce overlappingfragments. The fragments are denatured and reannealed as in the firststrategy. Reannealing generates some mismatched duplexes which can beseparated from perfectly matched duplexes by MutS affinitychromatography. As before, MutS chromatography enriches for duplexesbearing at least a single mismatch. The mismatched duplexes are thenreassembled into longer fragments. This is accomplished by cycles ofdenaturation, reannealing, and chain extension of partially annealedduplexes (see Section V). After several such cycles, fragments of thesame length as the original substrates are achieved, except that thesefragments differ from each other at multiple sites. These fragments arethen introduced into cells where they undergo recombination with cognateendogenous genes.

3. Positive Selection For Allelic Exchange

The invention further provides methods of enriching for cells bearingmodified genes relative to the starting cells. This can be achieved byintroducing a DNA fragment library (e.g., a single specific segment or awhole or partial genomic library) in a suicide vector (i.e., lacking afunctional replication origin in the recipient cell type) containingboth positive and negative selection markers. Optionally, multiplefragment libraries from different sources (e.g., B. subtilis, B.licheniformis and B. cereus) can be cloned into different vectorsbearing different selection markers. Suitable positive selection markersinclude neo^(R), kanamycin^(R), hyg, hisD, gpt, ble, tet^(R), hprt SacBand ura3. Suitable negative selection markers include hsv-tk, hprt, gpt,and cytosine deaminase. A variety of examples of conditional replicationvectors, mutations affecting vector replication, limited host rangevectors, and counterselectable markers are found in Berg and Berg,supra, and LaRossa, ibid. and the references therein.

In one example, a plasmid with R6K and f1 origins of replication, apositively selectable marker (beta-lactamase), and a counterselectablemarker (B. subtilis sacB) was used. M13 transduction of plasmidscontaining cloned genes were efficiently recombined into the chromosomalcopy of that gene in a rep mutant E. coli strain.

Another strategy for applying negative selection is to include awildtype rpsL gene (encoding ribosomal protein S12) in a vector for usein cells having a mutant rpsL gene conferring streptomycin resistance.The mutant form of rpsL is recessive in cells having wildtype rpsL.Thus, selection for Sm resistance selects against cells having awildtype copy of rpsL. See Skorupski & Taylor, Gene 169, 47-52 (1996).Alternatively, vectors bearing only a positive selection marker can beused with one round of selection for cells expressing the marker, and asubsequent round of screening for cells that have lost the marker (e.g.,screening for drug sensitivity). The screen for cells that have lost thepositive selection marker is equivalent to screening against expressionof a negative selection marker. For example, Bacillus can be transformedwith a vector bearing a CAT gene and a sequence to be integrated. SeeHarwood & Cutting, Molecular Biological Methods for Bacillus, at pp.31-33. Selection for chloramphenicol resistance isolates cells that havetaken up vector. After a suitable period to allow recombination,selection for CAT sensititivity isolates cells which have lost the CATgene. About 50% of such cells will have undergone recombination with thesequence to be integrated.

Suicide vectors bearing a positive selection marker and optionally, anegative selection marker and a DNA fragment can integrate into hostchromosomal DNA by a single crossover at a site in chromosomal DNAhomologous to the fragment. Recombination generates an integrated vectorflanked by direct repeats of the homologous sequence. In some cells,subsequent recombination between the repeats results in excision of thevector and either acquisition of a desired mutation from the vector bythe genome or restoration of the genome to wildtype.

In the present methods, after transfer of the gene library cloned in asuitable vector, positive selection is applied for expression of thepositive selection marker. Because nonintegrated copies of the suicidevector are rapidly eliminated from cells, this selection enriches forcells that have integrated the vector into the host chromosome. Thecells surviving positive selection can then be propagated and subjectedto negative selection, or screened for loss of the positive selectionmarker. Negative selection selects against cells expressing the negativeselection marker. Thus, cells that have retained the integrated vectorexpress the negative marker and are selectively eliminated. The cellssurviving both rounds of selection are those that initially integratedand then eliminated the vector. These cells are enriched for cellshaving genes modified by homologous recombination with the vector.

4. Individualized Optimization of Genes

In general, the above methods do not require knowledge of the number ofgenes to be optimized, their map location or their function. However, insome instances, where this information is available for one or moregene, it can be exploited. For example, if the property to be acquiredby evolution is enhanced recombination of cells, one gene likely to beimportant is recA, even though many other genes, known and unknown, maymake additional contributions. In this situation, the recA gene can beevolved, at least in part, separately from other candidate genes. TherecA gene can be evolved by any of the methods of recursiverecombination described in Section V. Briefly, this approach entailsobtaining diverse forms of a recA gene, allowing the forms to recombine,selecting recombinants having improved properties, and subjecting therecombinants to further cycles of recombination and selection. At anypoint in the individualized improvement of recA, the diverse forms ofrecA can be pooled with fragments encoding other genes in a library tobe used in the general methods described herein. In this way, thelibrary is seeded to contain a higher proportion of variants in a geneknown to be important to the property sought to be acquired than wouldotherwise be the case.

In one example (illustrated in FIG. 20B), a plasmid is constructedcarrying a non-functional (mutated) version of a chromosomal gene suchas URA3, where the wild-type gene confers sensitivity to a drug (in thiscase 5-fluoroorotic acid). The plasmid also carries a selectable marker(resistance to another drug such as kanamycin), and a library of recAvariants. Transformation of the plasmid into the cell results inexpression of the recA variants, some of which will catalyze homologousrecombination at an increased rate. Those cells in which homologousrecombination occurred are resistant to the selectable drug on theplasmid, and to 5-fluoroorotic acid because of the disruption of thechromosomal copy of this gene. The recA variants which give the highestrates of homologous recombination are the most highly represented in apool of homologous recombinants. The mutant recA genes can be isolatedfrom this pool by PCR, re-shuffled, cloned back into the plasmid and theprocess repeated. Other sequences can be inserted in place of recA toevolve other components of the homologous recombination system.

5. Harvesting DNA Substrates for Shuffling

In some shuffling methods, DNA substrates are isolated from naturalsources and are not easily manipulated by DNA modifying or polymerizingenzymes due to recalcitrant impurities, which poison enzymaticreactions. Such difficulties can be avoided by processing DNA substratesthrough a harvesting strain. The harvesting strain is typically a celltype with natural competence and a capacity for homologous recombinationbetween sequences with substantial diversity (e.g., sequences exhibitingonly 75% sequence identity). The harvesting strain bears a vectorencoding a negative selection marker flanked by two segmentsrespectively complementary to two segments flanking a gene or otherregion of interest in the DNA from a target organism. The harvestingstrain is contacted with fragments of DNA from the target organism.Fragments are taken up by natural competence, or other methods describedherein, and a fragment of interest from the target organism recombineswith the vector of the harvesting strain causing loss of the negativeselection marker. Selection against the negative marker allows isolationof cells that have taken up the fragment of interest. Shuffling can becarried out in the harvester strain or vector can be isolated from theharvester strain for in vitro shuffling or transfer to a different celltype for in vivo shuffling. Alternatively, the vector can be transferredto a different cell type by conjugation, protoplast fusion orelectrofusion. An example of a suitable harvester strain isAcinetobacter calcoaceticus mutS. Young et al., 97th ASM MeetingAbstracts. This strain is naturally competent and takes up DNA in anonsequence-specific manner. Also, because of the mutS mutation, thisstrain is capable of homologous recombinatin of sequences showing only75% sequence identity.

III. Applications

A. Recombinogenicity

One goal of whole cell evolution is to generate cells having improvedcapacity for recombination. Such cells are useful for a variety ofpurposes in molecular genetics including the in vivo formats ofrecursive sequence recombination described in Section V. Almost thirtygenes (e.g., recA, recB, reC, recD, recE, recF, recG, recO, recQ, recR,recT, ruvA, ruvB, ruvC, sbcB, ssb, topA, gyrA and B, lig, polA, uvrD, E,recL, mutD, mutH, mutL, mutT, mutU, helD) and DNA sites (e.g., chi,recN, sbcC) involved in genetic recombination have been identified in E.coli, and cognate forms of several of these genes have been found inother organisms (e.g., rad51, rad55-rad57, Dmc1 in yeast (seeKowalczykowski et al., Microbiol. Rev. 58, 401-465 (1994); Kowalczkowski& Zarling, supra) and human homologs of Rad51 and Dmc1 have beenidentified (see Sandler et al., Nucl. Acids Res. 24, 2125-2132 (1996)).At least some of the E. coli genes, including recA are functional inmammalian cells, and can be targeted to the nucleus as a fusion withSV40 large T antigen nuclear targeting sequence (Reiss et al., Proc.Natl. Acad. Sci. USA, 93, 3094-3098 (1996)). Further, mutations inmismatch repair genes, such as mutL, mutS, mutH, mutT relax homologyrequirements and allow recombination between more diverged sequences(Rayssiguier et al., Nature 342, 396-401 (1989)). The extent ofrecombination between divergent strains can be enhanced by impairingmismatch repair genes and stimulating SOS genes. Such can be achieved byuse of appropriate mutant strains and/or growth under conditions ofmetabolic stress, which have been found to stimulate SOS and inhibitmismatch repair genes. Vulic et al., Proc. Natl. Acad. Sci. USA 94(1997). In addition, this can be achieved by impairing the products ofmismatch repair genes by exposure to selective inhibitors.

Starting substrates for recombination are selected according to thegeneral principles described above. That is, the substrates can be wholegenomes or fractions thereof containing recombination genes or sites.Large libraries of essentially random fragments can be seeded withcollections of fragments constituting variants of one or more knownrecombination genes, such as recA. Alternatively, libraries can beformed by mixing variant forms of the various known recombination genesand sites.

The library of fragments is introduced into the recipient cells to beimproved and recombination occurs, generating modified cells. Therecipient cells preferably contain a marker gene whose expression hasbeen disabled in a manner that can be corrected by recombination. Forexample, the cells can contain two copies of a marker gene bearingmutations at different sites, which copies can recombine to generate thewildtype gene. A suitable marker gene is green fluorescent protein. Avector can be constructed encoding one copy of GFP having stopcodonsnear the N-terminus, and another copy of GFP having stopcodons near theC-terminus of the protein. The distance between the stop codons at therespective ends of the molecule is 500 bp and about 25% of recombinationevents result in active GFP. Expression of GFP in a cell signals that acell is capable of homologous recombination to recombine in between thestop codons to generate a contiguous coding sequence. By screening forcells expressing GFP, one enriches for cells having the highest capacityfor recombination. The same type of screen can be used followingsubsequent rounds of recombination. However, unless the selection markerused in previous round(s) was present on a suicide vector, subsequentround(s) should employ a second disabled screening marker within asecond vector bearing a different origin of replication or a differentpositive selection marker to vectors used in the previous rounds.

B. Multigenomic Copy Number—Gene Redundancy

The majority of bacterial cells in stationary phase cultures grown inrich media contain two, four or eight genomes. In minimal medium thecells contain one or two genomes. The number of genomes per bacterialcell thus depends on the growth rate of the cell as it enters stationaryphase. This is because rapidly growing cells contain multiplereplication forks, resulting in several genomes in the cells aftertermination. The number of genomes is strain dependent, although allstrains tested have more than one chromosome in stationary phase. Thenumber of genomes in stationary phase cells decreases with time. Thisappears to be due to fragmentation and degradation of entirechromosomes, similar to apoptosis in mammalian cells. This fragmentationof genomes in cells containing multiple genome copies results in massiverecombination and mutagenesis. Useful mutants may find ways to useenergy sources that will allow them to continue growing. Multigenome orgene-redundant cells are much more resistant to mutagenesis and can beimproved for a selected trait faster.

Some cell types, such as Deinococcus radians (Daly and Minton J.Bacteriol. 177, 5495-5505 (1995)) exhibit polyploidy throughout the cellcycle. This cell type is highly radiation resistant due to the presenceof many copies of the genome. High frequency recombination between thegenomes allows rapid removal of mutations induced by a variety of DNAdamaging agents.

A goal of the present methods is to evolve other cell types to haveincreased genome copy number akin to that of Deinoccocus radians.Preferably, the increased copy number is maintained through all or mostof its cell cycle in all or most growth conditions. The presence ofmultiple genome copies in such cells results in a higher frequency ofhomologous recombination in these cells, both between copies of a genein different genomes within the cell, and between a genome within thecell and a transfected fragment. The increased frequency ofrecombination allows the cells to be evolved more quickly to acquireother useful characteristics.

Starting substrates for recombination can be a diverse library of genesonly a few of which are relevant to genomic copy number, a focusedlibrary formed from variants of gene(s) known or suspected to have arole in genomic copy number or a combination of the two. As a generalrule one would expect increased copy number would be achieved byevolution of genes involved in replication and cell septation such thatcell septation is inhibited without impairing replication. Genesinvolved in replication include tus, xerC, xerD, dif, gyrA, gyrB, parE,parC, dif, TerA, TerB, TerC, TerD, TerE, TerF, and genes influencingchromosome partitioning and gene copy number include minD, mukA (tolC),mukB, mukC, mukD, spoOJ, spoIIIE (Wake & Errington, Annu. Rev. Genet.29, 41-67 (1995)). A useful source of substrates is the genome of a celltype such as Deinoccocus radians known to have the desired phenotype ofmultigenomic copy number. As well as, or instead of, the abovesubstrates, fragments encoding protein or antisense RNA inhibitors togenes known to be involved in cell septation can also be used.

In nature, the existence of multiple genomic copies in a cell type wouldusually not be advantageous due to the greater nutritional requirementsneeded to maintain this copy number. However, artificial conditions canbe devised to select for high copy number. Modified cells havingrecombinant genomes are grown in rich media (in which conditions,multicopy number should not be a disadvantage) and exposed to a mutagen,such as ultraviolet or gamma irradiation or a chemical mutagen, e.g.,mitomycin, nitrous acid, photoactivated psoralens, alone or incombination, which induces DNA breaks amenable to repair byrecombination. These conditions select for cells having multicopy numberdue to the greater efficiency with which mutations can be excised.Modified cells surviving exposure to mutagen are enriched for cells withmultiple genome copies. If desired, selected cells can be individuallyanalyzed for genome copy number (e.g., by quantitative hybridizationwith appropriate controls). Some or all of the collection of cellssurviving selection provide the substrates for the next round ofrecombination. In addition, individual cells can be sorted using a cellsorter for those cells containing more DNA, e.g., using DNA specificfluorescent compounds or sorting for increased size using lightdispersion. Eventually cells are evolved that have at least 2, 4, 6, 8or 10 copies of the genome throughout the cell cycle.

C. Secretion

The protein (or metabolite) secretion pathways of bacterial andeukaryotic cells can be evolved to export desired molecules moreefficiently, such as for the manufacturing of protein pharmaceuticals,small molecule drugs or specialty chemicals. Improvements in efficiencyare particularly desirable for proteins requiring multisubunit assembly(such as antibodies) or extensive posttranslational modification beforesecretion.

The efficiency of secretion may depend on a number of genetic sequencesincluding a signal peptide coding sequence, sequences encodingprotein(s) that cleave or otherwise recognize the coding sequence, andthe coding sequence of the protein being secreted. The latter may affectfolding of the protein and the ease with which it can integrate into andtraverse membranes. The bacterial secretion pathway in E. coli includethe SecA, SecB, SecE, SecD and SecF genes. In Bacillus subtilis, themajor genes are secA, secD, secE, secF, secY, ffh, ftsY together withfive signal peptidase genes (sipS, sipT, sipU, sipV and sipW) (Kunst etal, supra). For proteins requiring posttranslational modification,evolution of genes effecting such modification may contribute toimproved secretion. Likewise genes with expression products having arole in assembly of multisubunit proteins (e.g., chaperonins) may alsocontribute to improved secretion.

Selection of substrates for recombination follows the general principlesdiscussed above. In this case, the focused libraries referred to abovecomprise variants of the known secretion genes. For evolution ofprocaryotic cells to express eukaryotic proteins, the initial substratesfor recombination are often obtained at least in part from eukaryoticsources. Incoming fragments can undergo recombination both withchromosomal DNA in recipient cells and with the screening markerconstruct present in such cells (see below). The latter form ofrecombination is important for evolution of the signal coding sequenceincorporated in the screening marker construct. Improved secretion canbe screened by the inclusion of marker construct in the cells beingevolved. The marker construct encodes a marker gene, operably linked toexpression sequences, and usually operably linked to a signal peptidecoding sequence. The marker gene is sometimes expressed as a fusionprotein with a recombinant protein of interest. This approach is usefulwhen one wants to evolve the recombinant protein coding sequencetogether with secretion genes.

In one variation, the marker gene encodes a product that is toxic to thecell containing the construct unless the product is secreted. Suitabletoxin proteins include diphtheria toxin and ricin toxin. Propagation ofmodified cells bearing such a construct selects for cells that haveevolved to improve secretion of the toxin. Alternatively, the markergene can encode a ligand to a known receptor, and cells bearing theligand can be detected by FACS using labelled receptor. Optionally, sucha ligand can be operably linked to a phospholipid anchoring sequencethat binds the ligand to the cell membrane surface following secretion.(See commonly owned, copending Ser. No. 08/309,345). In a furthervariation, secreted marker protein can be maintained in proximity withthe cell secreting it by distributing individual cells into agar drops.This is done, e.g., by droplet formation of a cell suspension. Secretedprotein is confined within the agar matrix and can be detected by e.g.,FACS. In another variation, a protein of interest is expressed as afusion protein together with b-lactamase or alkaline phosphatase. Theseenzymes metabolize commercially available chromogenic substrates (e.g.,X-gal), but do so only after secretion into the periplasm. Appearance ofcolored substrate in a colony of cells therefore indicates capacity tosecrete the fusion protein and the intensity of color is related to theefficiency of secretion.

The cells identified by these screening and selection methods have thecapacity to secrete increased amounts of protein. This capacity may beattributable to increased secretion and increased expression, or fromincreased secretion alone.

D. Expression

Cells can also be evolved to acquire increased expression of arecombinant protein. The level of expression is, of course, highlydependent on the construct from which the recombinant protein isexpressed and the regulatory sequences, such as the promoter,enhancer(s) and transcription termination site contained therein.Expression can also be affected by a large number of host genes havingroles in transcription, posttranslational modification and translation.In addition, host genes involved in synthesis of ribonucleotide andamino acid monomers for transcription and translation may have indirecteffects on efficiency of expression. Selection of substrates forrecombination follows the general principles discussed above. In thiscase, focused libraries comprise variants of genes known to have rolesin expression. For evolution of procaryotic cells to express eukaryoticproteins, the initial substrates for recombination are often obtained,at least in part, from eukaryotic sources; that is eukaryotic genesencoding proteins such as chaperonins involved in secretion and/assemblyof proteins. Incoming fragments can undergo recombination both withchromosomal DNA in recipient cells and with the screening markerconstruct present in such cells (see below).

Screening for improved expression can be effected by including areporter construct in the cells being evolved. The reporter constructexpresses (and usually secretes) a reporter protein, such as GFP, whichis easily detected and nontoxic. The reporter protein can be expressedalone or together with a protein of interest as a fusion protein. If thereporter gene is secreted, the screening effectively selects for cellshaving either improved secretion or improved expression, or both.

E. Plant Cells

A further application of recursive sequence recombination is theevolution of plant cells, and transgenic plants derived from the same,to acquire resistance to pathogenic diseases (fungi, viruses andbacteria), insects, chemicals (such as salt, selenium, pollutants,pesticides, herbicides, or the like), including, e.g., atrazine orglyphosate, or to modify chemical composition, yield or the like. Thesubstrates for recombination can again be whole genomic libraries,fractions thereof or focused libraries containing variants of gene(s)known or suspected to confer resistance to one of the above agents.Frequently, library fragments are obtained from a different species tothe plant being evolved.

The DNA fragments are introduced into plant tissues, cultured plantcells or plant protoplasts by standard methods including electroporation(From et al., Proc. Natl. Acad. Sci. USA 82, 5824 (1985), infection byviral vectors such as cauliflower mosaic virus (CaMV) (Hohn et al.,Molecular Biology of Plant Tumors, (Academic Press, New York, 1982) pp.549-560; Howell, U.S. Pat. No. 4,407,956), high velocity ballisticpenetration by small particles with the nucleic acid either within thematrix of small beads or particles, or on the surface (Klein et al.,Nature 327, 70-73 (1987)), use of pollen as vector (WO 85/01856), or useof Agrobacterium tumefaciens or A. rhizogenes carrying a T-DNA plasmidin which DNA fragments are cloned. The T-DNA plasmid is transmitted toplant cells upon infection by Agrobacterium tumefaciens, and a portionis stably integrated into the plant genome (Horsch et al., Science 233,496-498 (1984); Fraley et al., Proc. Natl. Acad. Sci. USA 80, 4803(1983)).

Diversity can also be generated by genetic exchange between plantprotoplasts according to the same principles described below for fungalprotoplasts. Procedures for formation and fusion of plant protoplastsare described by Takahashi et al., U.S. Pat. No. 4,677,066; Akagi etal., U.S. Pat. No. 5,360,725; Shimamoto et al., U.S. Pat. No. 5,250,433;Cheney et al., U.S. Pat. No. 5,426,040.

After a suitable period of incubation to allow recombination to occurand for expression of recombinant genes, the plant cells are contactedwith the agent to which resistance is to be acquired, and survivingplant cells are collected. Some or all of these plant cells can besubject to a further round of recombination and screening. Eventually,plant cells having the required degree of resistance are obtained.

These cells can then be cultured into transgenic plants. Plantregeneration from cultured protoplasts is described in Evans et al.,“Protoplast Isolation and Culture,” Handbook of Plant Cell Cultures 1,124-176 (MacMillan Publishing Co., New York, 1983); Davey, “RecentDevelopments in the Culture and Regeneration of Plant Protoplasts,”Protoplasts, (1983) pp. 12-29, (Birkhauser, Basal 1983); Dale,“Protoplast Culture and Plant Regeneration of Cereals and OtherRecalcitrant Crops,” Protoplasts (1983) pp. 31-41, (Birkhauser, Basel1983); Binding, “Regeneration of Plants,” Plant Protoplasts, pp. 21-73,(CRC Press, Boca Raton, 1985).

In a variation of the above method, one or more preliminary rounds ofrecombination and screening can be performed in bacterial cellsaccording to the same general strategy as described for plant cells.More rapid evolution can be achieved in bacterial cells due to theirgreater growth rate and the greater efficiency with which DNA can beintroduced into such cells. After one or more rounds ofrecombination/screening, a DNA fragment library is recovered frombacteria and transformed into the plants. The library can either be acomplete library or a focused library. A focused library can be producedby amplification from primers specific for plant sequences, particularlyplant sequences known or suspected to have a role in conferringresistance.

Example: Concatemeric Assembly of Atrazine-Catabolizing Plasmid

Pseudomonas atrazine catabolizing genes AtzA and AtzB were subclonedfrom pMD1 (deSouza et al., Appl. Environ. Microbiol. 61, 3373-3378(1995); de Souza et al., J. Bacteriol. 178, 4894-4900 (1996)) intopUC18. A 1.9 kb Aval fragment containing AtzA was end-filled andinserted into an AvaI site of pUC18. A 3.9 kb ClaI fragment containingAtzB was end-filled and cloned into the HincII site of pUC18. AtzA wasthen excised from pUC18 with EcoRI and BamHI, AzB with BamHI andHindIII, and the two inserts were co-ligated into pUC18 digested withEcoRI and HindIII. The result was a 5.8 kb insert containing AtzA andAtzB in pUC18 (total plasmid size 8.4 kb).

Recursive sequence recombination was performed as follows. The entire8.4 kb plasmid was treated with DNaseI in 50 mM Tris-Cl pH 7.5, 10 mMMnCl₂ and fragments between 500 and 2000 bp were gel purified. Thefragments were assembled in a PCR reaction using Tth-XL enzyme andbuffer from Perkin Elmer, 2.5 mM MgOAc, 400 μM dNTPs and serialdilutions of DNA fragments. The assembly reaction was performed in an MJResearch “DNA Engine” programmed with the following cycles: 1) 94° C.,20 seconds; 2) 94° C., 15 seconds; 3) 40° C., 30 seconds; 4) 72° C., 30seconds+2 seconds per cycle; 5) go to step 2, 39 more times; 6) 4° C.

We were unable to amplify the AtzA and AtzB genes from the assemblyreaction using the polymerase chain reaction, so instead we purified DNAfrom the reaction by phenol extraction and ethanol precipitation, thendigested the assembled DNA with a restriction enzyme that linearized theplasmid (KpnI: the KpnI site in pUC18 was lost during subcloning,leaving only the KpnI site in AtzA). Linearized plasmid wasgel-purified, self-ligated overnight and transformed into E. coli strainNM522. (The choice of host strain was important: very little plasmid ofpoor quality was obtained from a number of other commercially availablestrains including TG1, DH10B, DH12S.)

Serial dilutions of the transformation reaction were plated onto LBplates containing 50 μg/ml ampicillin, the remainder of thetransformation was made 25% in glycerol and frozen at −80° C. Once thetransformed cells were titered, the frozen cells were plated at adensity of between 200 and 500 on 150 mm diameter plates containing 500μg/ml atrazine and grown at 37° C.

Atrazine at 500 μg/ml forms an insoluble precipitate. The products ofthe AtzA and AtzB genes transform atrazine into a soluble product. Cellscontaining the wild type AtzA and AtzB genes in pUC18 will thus besurrounded by a clear halo where the atrazine has been degraded. Themore active the AtzA and AtzB enzymes, the more rapidly a clear halowill form and grow on atrazine-containing plates. Positives were pickedas those colonies that most rapidly formed the largest clear zones. The(approximately ) 40 best colonies were picked, pooled, grown in thepresence of 50 μg/ml ampicillin and plasmid prepared from them. Theentire process (from DNase-treatment to plating on atrazine plates) wasrepeated 4 times with 2000-4000 colonies/cycle.

A modification was made in the fourth round. Cells were plated on both500 μg/ml atrazine, and 500 μg/ml of the atrazine analogueterbutylazine, which was undegradable by the wild type AtzA and AtzBgenes. Positives were obtained that degraded both compounds. Theatrazine chlorohydrolase (product of AtzA gene) was 10-100 fold higherthan that produced by the wildtype gene.

F. Plant Genome Shuffling

Plant genome shuffling allows recursive cycles to be used for theintroduction and recombination of genes or pathways that confer improvedproperties to desired plant species. Any plant species, including weedsand wild cultivars, showing a desired trait, such as herbicideresistance, salt tolerance, pest resistance, or temperature tolerance,can be used as the source of DNA that is introduced into the crop orhorticultural host plant species.

Genomic DNA prepared from the source plant is fragmented (e.g. byDNaseI, restriction enzymes, or mechanically) and cloned into a vectorsuitable for making plant genomic libraries, such as pGA482 (An. G.,1995, Methods Mol. Biol. 44:47-58). This vector contains the A.tumefaciens left and right borders needed for gene transfer to plantcells and antibiotic markers for selection in E. coli, Agrobacterium,and plant cells. A multicloning site is provided for insertion of thegenomic fragments. A cos sequence is present for the efficient packagingof DNA into bacteriophage lambda heads for transfection of the primarylibrary into E. coli. The vector accepts DNA fragments of 25-40 kb.

The primary library can also be directly electroporated into an A.tumefaciens or A. rhizogenes strain that is used to infect and transformhost plant cells (Main, GD et al., 1995, Methods Mol. Biol. 44:405-412).Alternatively, DNA can be introduced by electroporation or PEG-mediateduptake into protoplasts of the recipient plant species (Bilang et al.(1994) Plant Mol. Biol Manual, Kluwer Academic Publishers, A1:1-16) orby particle bombardment of cells or tissues (Christou, ibid, A2:1-15).If necessary, antibiotic markers in the T-DNA region can be eliminated,as long as selection for the trait is possible, so that the final plantproducts contain no antibiotic genes.

Stably transformed whole cells acquiring the trait are selected on solidor liquid media containing the agent to which the introduced DNA confersresistance or tolerance. If the trait in question cannot be selected fordirectly, transformed cells can be selected with antibiotics and allowedto form callus or regenerated to whole plants and then screened for thedesired property.

The second and further cycles consist of isolating genomic DNA from eachtransgenic line and introducing it into one or more of the othertransgenic lines. In each round, transformed cells are selected orscreened for incremental improvement. To speed the process of usingmultiple cycles of transformation, plant regeneration can be eliminateduntil the last round. Callus tissue generated from the protoplasts ortransformed tissues can serve as a source of genomic DNA and new hostcells. After the final round, fertile plants are regenerated and theprogeny are selected for homozygosity of the inserted DNAs. Ultimately,a new plant is created that carries multiple inserts which additively orsynergistically combine to confer high levels of the desired trait.

In addition, the introduced DNA that confers the desired trait can betraced because it is flanked by known sequences in the vector. EitherPCR or plasmid rescue is used to isolate the sequences and characterizethem in more detail. Long PCR (Foord, OS and Rose, EA, 1995, PCR Primer:A Laboratory Manual, CSHL Press, pp 63-77) of the full 25-40 kb insertis achieved with the proper reagents and techniques using as primers theT-DNA border sequences. If the vector is modified to contain the E. coliorigin of replication and an antibiotic marker between the T-DNAborders, a rare cutting restriction enzyme, such as NotI or SfiI, thatcuts only at the ends of the inserted DNA is used to create fragmentscontaining the source plant DNA that are then self-ligated andtransformed into E. coli where they replicate as plasmids. The total DNAor subfragment of it that is responsible for the transferred trait canbe subjected to in vitro evolution by DNA shuffling. The shuffledlibrary is then introduced into host plant cells and screened forimprovement of the trait. In this way, single and multigene traits canbe transferred from one species to another and optimized for higherexpression or activity leading to whole organism improvement.

Example: Acquisition of Salt Tolerance

As depicted in FIG. 21, DNA from a salt tolerant plant is isolated andused to create a genomic library. Protoplasts made from the recipientspecies are electroporated with the genomic library. Cells are selectedon media with a normally inhibitory level of NaCl. Only the cells withnewly acquired salt tolerance will grow into callus tissue. The bestlines are chosen and genomic libraries are made from their pooled DNA.These libraries are electroporated into protoplasts made from the firstround transformed calli. Again, cells are selected on increased saltconcentrations. After the desired level of salt tolerance is achieved,the callus tissue can be induced to regenerate whole plants. Progeny ofthese plants are typically analyzed for homozygosity of the inserts toensure stability of the acquired trait. At the indicated steps, plantregeneration or isolation and shuffling of the introduced genes can beadded to the overall protocol.

G. Transgenic Animals

1. Transgenic Optimization

One goal of transgenesis is to produce transgenic animals, such as mice,rabbits, sheep, pigs, goats, and cattle, secreting a recombinant proteinin the milk. A transgene for this purpose typically comprises inoperable linkage a promoter and an enhancer from a milk-protein gene(e.g., α, β, or γ casein, β-lactoglobulin, acid whey protein orα-lactalbumin), a signal sequence, a recombinant protein coding sequenceand a transcription termination site. Optionally, a transgene can encodemultiple chains of a multichain protein, such as an immunoglobulin, inwhich case, the two chains are usually individually operably linked tosets of regulatory sequences. Transgenes can be optimized for expressionand secretion by recursive sequence recombination. Suitable substratesfor recombination include regulatory sequences such as promoters andenhancers from milk-protein genes from different species or individualanimals. Cycles of recombination can be performed in vitro or in vivo byany of the formats discussed in Section V. Screening is performed invivo on cultures of mammary-gland derived cells, such as HCll or MacT,transfected with transgenes and reporter constructs such as thosediscussed above. After several cycles of recombination and screening,transgenes resulting in the highest levels of expression and secretionare extracted from the mammary gland tissue culture cells and used totransfect embryonic cells, such as zygotes and embryonic stem cells,which are matured into transgenic animals.

2. Whole Animal Optimization

In this approach, libraries of incoming fragments are transformed intoembryonic cells, such as ES cells or zygotes. The fragments can bevariants of a gene known to confer a desired property, such as growthhormone. Alternatively, the fragments can be partial or complete genomiclibraries including many genes.

Fragments are usually introduced into zygotes by microinjection asdescribed by Gordon et al., Methods Enzymol. 101, 414 (1984); Hogan etal., Manipulation of the Mouse Embryo: A Laboratory Manual (C.S.H.L.N.Y., 1986) (mouse embryo); and Hammer et al., Nature 315, 680 (1985)(rabbit and porcine embryos); Gandolfi et al., J. Reprod. Fert. 81,23-28 (1987); Rexroad et al., J. Anim. Sci. 66, 947-953 (1988) (ovineembryos) and Eyestone et al., J. Reprod. Fert. 85, 715-720 (1989);Camous et al., J. Reprod. Fert. 72, 779-785 (1984); and Heyman et al.,Theriogenology 27, 5968 (1987) (bovine embryos) by reference in theirentirety for all purposes). Zygotes are then matured and introduced intorecipient female animals which gestate the embryo and give birth to atransgenic offspring.

Alternatively, transgenes can be introduced into embryonic stem cells(ES). These cells are obtained from preimplantation embryos cultured invitro. Bradley et al., Nature 309, 255-258 (1984). Transgenes can beintroduced into such cells by electroporation or microinjection.Transformed ES cells are combined with blastocysts from a nonhumananimal. The ES cells colonize the embryo and in some embryos form thegerm line of the resulting chimeric animal. See Jaenisch, Science, 240,1468-1474 (1988).

Regardless whether zygotes or ES are used, screening is performed onwhole animals for a desired property, such as increased size and/orgrowth rate. DNA is extracted from animals having evolved towardacquisition of the desired property. This DNA is then used to transfectfurther embryonic cells. These cells can also be obtained from animalsthat have acquired toward the desired property in a split and poolapproach. That is, DNA from one subset of such animals is transformedinto embryonic cells prepared from another subset of the animals.Alternatively, the DNA from animals that have evolved toward acquisitionof the desired property can be transfected into fresh embryonic cells.In either alternative, transfected cells are matured into transgenicanimals, and the animals subjected to a further round of screening forthe desired property.

FIG. 4 shows the application of this approach for evolving fish toward alarger size. Initially, a library is prepared of variants of a growthhormone gene. The variants can be natural or induced. The library iscoated with recA protein and transfected into fertilized fish eggs. Thefish eggs then mature into fish of different sizes. The growth hormonegene fragment of genomic DNA from large fish is then amplified by PCRand used in the next round of recombination. Alternatively, fish α-IFNis evolved to enhance resistance to viral infections as described below.

3. Evolution of Improved Hormones for Expression in Transgenic Animals(e.g., Fish) to Create Animals with Improved Traits

Hormones and cytokines are key regulators of size, body weight, viralresistance and many other commercially important traits. DNA shufflingis used to rapidly evolve the genes for these proteins using in vitroassays. This was demonstrated with the evolution of the human alphainterferon genes to have potent antiviral activity on murine cells.Large improvements in activity were achieved in two cycles of familyshuffling of the human IFN genes.

In general, a method of increasing resistance to virus infection incells can be performed by first introducing a shuffled librarycomprising at least one shuffled interferon gene into animal cells tocreate an initial library of animal cells or animals. The initiallibrary is then challenged with the virus. Animal cells or animals areselected from the initial library which are resistant to the virus and aplurality of transgenes from a plurality of animal cells or animalswhich are resistant to the virus are recovered. The plurality oftransgenes is recovered to produce an evolved library of animal cells oranimals which is again challenged with the virus. Cells or animals areselected from the evolved library the which are resistant to the virus.

For example, genes evolved with in vitro assays are introduced into thegermplasm of animals or plants to create improved strains. Onelimitation of this procedure is that in vitro assays are often onlycrude predictors of in vivo activity. However, with improving methodsfor the production of transgenic plants and animals, one can now marrywhole organism breeding with molecular breeding. The approach is tointroduce shuffled libraries of hormone genes into the species ofinterest. This can be done with a single gene per transgenic or withpools of genes per transgenic. Progeny are then screened for thephenotype of interest. In this case, shuffled libraries of interferongenes (alpha IFN for example) are introduced into transgenic fish. Thelibrary of transgenic fish are challenged with a virus. The mostresistant fish are identified (i.e. either survivors of a lethalchallenge; or those that are deemed most ‘healthy’ after the challenge).The IFN transgenes are recovered by PCR and shuffled in either apoolwise or a pairwise fashion. This generates an evolved library of IFNgenes. A second library of transgenic fish is created and the process isrepeated. In this way, IFN is evolved for improved antiviral activity ina whole organism assay.

This procedure is general and can be applied to any trait that isaffected by a gene or gene family of interest and which can bequantitatively measured.

Fish interferon sequence data is available for the Japanese flatfish(Paralichthys olivaceus) as mRNA sequence (Tamai et al. (1993) “Cloningand expression of flatfish (Paralichthys olivaceus) interferon cDNA.”Biochem. Biophys. Acta 1174, 182-186; see also, Tami et al. (1993)“Purification and characterization of interferon-like antiviral proteinderived from flatfish (Paralichthys olivaceus) lymphocytes immortalizedby oncogenes.” Cytotechnology 1993; 1 1 (2):121-131). This sequence canbe used to clone out IFN genes from this species. This sequence can alsobe used as a probe to clone homologous interferons from additionalspecies of fish. As well, additional sequence information can beutilized to clone out more species of fish interferons. Once a libraryof interferons has been cloned, these can be family shuffled to generatea library of variants.

A Protein sequence of flatfish interferon is:

MIRSTNSNKS DILMNCHHLIIR YDDNSAPSGGSL FRKMIMLLKL LKLITFGQLRVVELFVKSNTSKTS TVLSIDGSNLISL LDAPKDILDKPSCNSF QLDLLLASSAWTLLT ARLLNYPYPAVLLSAGVASVVLVQVP.

In one embodiment, BHK-21 (A fibroblast cell line from hamster) can betransfected with the shuffled IFN-expression plasmids. Activerecombinant IFN is produced and then purified by WGA agarose affinitychromatography (Tamai, et al. 1993 Biochim Ciophys Acta. supra). Theantiviral activity of IFN can be measured on fish cells challenged byrhabdoviurs. Tami et al. (1993) “Purification and characterization ofinterferon-like antiviral protein derived from flatfish (Paralichthysolivaceus) lymphocytes immortalized by oncogenes.” Cytotechnology 1993;1 1 (2):121-131).

H. Rapid Evolution as a Predictive Tool

Recursive sequence recombination can be used to simulate naturalevolution of pathogenic microorganisms in response to exposure to a drugunder test. Using recursive sequence recombination, evolution proceedsat a faster rate than in natural evolution. One measure of the rate ofevolution is the number of cycles of recombination and screeningrequired until the microorganism acquires a defined level of resistanceto the drug. The information from this analysis is of value in comparingthe relative merits of different drugs and in particular, in predictingtheir long term efficacy on repeated administration.

The pathogenic microorganisms used in this analysis include the bacteriathat are a common source of human infections, such as chlamydia,rickettsial bacteria, mycobacteria, staphylococci, streptocci,pneumonococci, meningococci and conococci, klebsiella, proteus,serratia, pseudomonas, legionella, diphtheria, salmonella, bacilli,cholera, tetanus, botulism, anthrax, plague, leptospirosis, and Lymesdisease bacteria. Evolution is effected by transforming an isolate ofbacteria that is sensitive to a drug under test with a library of DNAfragments. The fragments can be a mutated version of the genome of thebacteria being evolved. If the target of the drug is a known protein ornucleic acid, a focused library containing variants of the correspondinggene can be used. Alternatively, the library can come from other kindsof bacteria, especially bacteria typically found inhabiting humantissues, thereby simulating the source material available forrecombination in vivo. The library can also come from bacteria known tobe resistant to the drug. After transformation and propagation ofbacteria for an appropriate period to allow for recombination to occurand recombinant genes to be expressed, the bacteria are screened byexposing them to the drug under test and then collecting survivors.Surviving bacteria are subject to further rounds of recombination. Thesubsequent round can be effected by a split and pool approach in whichDNA from one subset of surviving bacteria is introduced into a secondsubset of bacteria. Alternatively, a fresh library of DNA fragments canbe introduced into surviving bacteria. Subsequent round(s) of selectioncan be performed at increasing concentrations of drug, therebyincreasing the stringency of selection.

A similar strategy can be used to simulate viral acquisition of drugresistance. The object is to identify drugs for which resistance can beacquired only slowly, if at all. The viruses to be evolved are thosethat cause infections in humans for which at least modestly effectivedrugs are available. Substrates for recombination can come from inducedmutants, natural variants of the same viral strain or different viruses.If the target of the drug is known (e.g., nucleotide analogs whichinhibit the reverse transcriptase gene of HIV), focused librariescontaining variants of the target gene can be produced. Recombination ofa viral genome with a library of fragments is usually performed invitro. However, in situations in which the library of fragmentsconstitutes variants of viral genomes or fragments that can beencompassed in such genomes, recombination can also be performed invivo, e.g., by transfecting cells with multiple substrate copies (seeSection V). For screening, recombinant viral genomes are introduced intohost cells susceptible to infection by the virus and the cells areexposed to a drug effective against the virus (initially at lowconcentration). The cells can be spun to remove any noninfected virus.After a period of infection, progeny viruses can be collected from theculture medium, the progeny viruses being enriched for viruses that haveacquired at least partial resistance to the drug. Alternatively, virallyinfected cells can be plated in a soft agar lawn and resistant virusesisolated from plaques. Plaque size provides some indication of thedegree of viral resistance.

Progeny viruses surviving screening are subject to additional rounds ofrecombination and screening at increased stringency until apredetermined level of drug resistance has been acquired. Thepredetermined level of drug resistance may reflect the maximum dosage ofa drug practical to administer to a patient without intolerable sideeffects. The analysis is particularly valuable for investigatingacquisition of resistance to various combination of drugs, such as thegrowing list of approved anti-HIV drugs (e.g., AZT, ddI, ddC, d4T, TIBO82150, nevaripine, 3TC, crixivan and ritonavir).

I. Fermentation

The fermentation of microorganisms for the production of naturalproducts is the oldest and most sophisticated application ofbiocatalysis. Industrial microorganisms effect the multistep conversionof renewable feedstocks to high value chemical products in a singlereactor and in so doing catalyze a multi-billion dollar industry.Fermentation products range from fine and commodity chemicals such asethanol, lactic acid, amino acids and vitamins, to high value smallmolecule pharmaceuticals, protein pharmaceuticals, and industrialenzymes. See, e.g., McCoy (1998) C&EN 13-19) for an introduction tobiocatalysis.

Success in bringing these products to market and success in competing inthe market depends on continuous improvement of the whole cellbiocatalysts. Improvements include increased yield of desired products,removal of unwanted co-metabolites, improved utilization of inexpensivecarbon and nitrogen sources, and adaptation to fermenter conditions,increased production of a primary metabolite, increased production of asecondary metabolite, increased tolerance to acidic conditions,increased tolerance to basic conditions, increased tolerance to organicsolvents, increased tolerance to high salt conditions and increasedtolerance to high or low temperatures. Shortcomings in any of theseareas can result in high manufacturing costs, inability to capture ormaintain market share, and failure of bringing promising products tomarket. For this reason, the fermentation industry invests significantfinancial and personnel resources in the improvement of productionstrains.

Current strategies for strain improvement rely on the empirical anditerative modification of fermenter conditions and genetic manipulationof the producing organism. While advances in the molecular biology ofestablished industrial organisms have been made, rational metabolicengineering is information intensive and is not broadly applicable toless characterized industrial strains. The most widely practicedstrategy for strain improvement employs random mutagenesis of theproducing strain and screening for mutants having improved properties.For mature strains, those subjected to many rounds of improvement, theseefforts routinely provide a 10% increase in product titre per year.Although effective, this classic strategy is slow, laborious, andexpensive. Technological advances in this area are aimed at automationand increasing sample screening throughput in hopes of reducing the costof strain improvement. However, the real technical barrier resides inthe intrinsic limitation of single mutations to effect significantstrain improvement. The methods herein overcome this limitation andprovide access to multiple useful mutations per cycle which can be usedto complement automation technologies and catalyze strain improvementprocesses.

The methods herein allow biocatalysts to be improved at a faster pacethan conventional methods. Whole genome shuffling can at least doublethe rate of strain improvement for microorganisms used in fermentationas compared to traditional methods. This provides for a relativedecrease in the cost of fermentation processes. New products can enterthe market sooner, producers can increase profits as well as marketshare, and consumers gain access to more products of higher quality andat lower prices. Further, increased efficiency of production processestranslates to less waste production and more frugal use of resources.Whole genome shuffling provides a means of accumulating multiple usefulmutation per cycle and thus eliminate the inherent limitation of currentstrain improvement programs (SIPs).

DNA shuffling provides recursive mutagenesis, recombination, andselection of DNA sequences. A key difference between DNAshuffling-mediated recombination and natural sexual recombination isthat DNA shuffling effects both the pairwise (two parents) and thepoolwise (multiple parents) recombination of parent molecules, asdescribed supra. Natural recombination is more conservative and islimited to pairwise recombination. In nature, pairwise recombinationprovides stability within a population by preventing large leaps insequences or genomic structure that can result from poolwiserecombination. However, for the purposes of directed evolution, poolwiserecombination is appealing since the beneficial mutations of multipleparents can be combined during a single cross to produce a superioroffspring. Poolwise recombination is analogous to the crossbreeding ofinbred strains in classic strain improvement, except that the crossesoccur between many strains at once. In essence, poolwise recombinationis a sequence of events that effects the recombination of a populationof nucleic acid sequences that results in the generation of new nucleicacids that contains genetic information from more than two of theoriginal nucleic acids.

There are a few general methods for effecting efficient recombination inprokaryotes. Bacteria have no known sexual cycle per se, but there arenatural mechanisms by which the genomes of these organisms undergorecombination. These mechanisms include natural competence,phage-mediated transduction, and cell-cell conjugation. Bacteria thatare naturally competent are capable of efficiently taking up naked DNAfrom the environment. If homologous, this DNA undergoes recombinationwith the genome of the cell, resulting in genetic exchange. Bacillussubtilis, the primary production organism of the enzyme industry, isknown for the efficiency with which it carries out this process.

In generalized transduction, a bacteriophage mediates genetic exchange.A transducing phage will often package headfulls of the host genome.These phage can infect a new host and deliver a fragment of the formerhost genome which is frequently integrated via homologous recombination.Cells can also transfer DNA between themselves by conjugation. Cellscontaining the appropriate mating factors transfer episomes as well asentire chromosomes to an appropriate acceptor cell where it canrecombine with the acceptor genome. Conjugation resembles sexualrecombination for microbes and can be intraspecific, interspecific, andintergeneric. For example, an efficient means of transformingStreptomyces sp., a genera responsible for producing many commercialantibiotics, is by the conjugal transfer of plasmids from Echerichiacoli.

For many industrial microorganisms, knowledge of competence, transducingphage, or fertility factors is lacking. Protoplast fusion has beendeveloped as a versatile and general alternative to these naturalmethods of recombination. Protoplasts are prepared by removing the cellwall by treating cells with lytic enzymes in the presence of osmoticstabilizers. In the presence of a fusogenic agent, such as polyethyleneglycol (PEG), protoplasts are induced to fuse and form transient hybridsor “fusants.” During this hybrid state, genetic recombination occurs athigh frequency allowing the genomes to reassort. The final crucial stepis the successful segregation and regeneration of viable cells from thefused protoplasts. Protoplast fusion can be intraspecific,interspecific, and intergeneric and has been applied to both prokaryotesand eukaryotes. In addition, it is possible to fuse more than two cells,thus providing a mechanism for effecting poolwise recombination. Whileno fertility factors, transducing phages or competency development isneeded for protoplast fusion, a method for the formation, fusing, andregeneration of protoplasts is typically optimized for each organism.Protoplast fusion as applied to poolwise recombination is described inmore detail, supra.

One key to SIP is having an assay that can be dependably used toidentify a few mutants out of thousands that have subtle increases inproduct yield. The limiting factor in many assay formats is theuniformity of cell growth. This variation is the source of baselinevariability in subsequent assays. Inoculum size and culture environment(temperature/humidity) are sources of cell growth variation. Automationof all aspects of establishing initial cultures and state-of-the-arttemperature and humidity controlled incubators are useful in reducingvariability.

Mutant cells or spores are separated on solid media to produceindividual sporulating colonies. Using an automated colony picker(Q-bot, Genetix, U.K.), colonies are identified, picked, and 10,000different mutants inoculated into 96 well microtitre dishes containingtwo 3 mm glass balls/well. The Q-bot does not pick an entire colony butrather inserts a pin through the center of the colony and exits with asmall sampling of cells (or mycelia) and spores. The time the pin is inthe colony, the number of dips to inoculate the culture medium, and thetime the pin is in that medium each effect inoculum size, and each canbe controlled and optimized. The uniform process of the Q-bot decreaseshuman handling error and increases the rate of establishing cultures(roughly 10,000/4 hours). These cultures are then shaken in atemperature and humidity controlled incubator. The glass balls act topromote uniform aeration of cells and the dispersal of mycelialfragments similar to the blades of a fermenter. An embodiment of thisprocedure is further illustrated in FIG. 28, including an integratedsystem for the assay.

(a.) Prescreen

The ability to detect a subtle increase in the performance of a mutantover that of a parent strain relies on the sensitivity of the assay. Thechance of finding the organisms having an improvement is increased bythe number of individual mutants that can be screened by the assay. Toincrease the chances of identifying a pool of sufficient size aprescreen that increases the number of mutants processed by 10-fold canbe used. The goal of the primary screen will be to quickly identifymutants having equal or better product titres than the parent strain(s)and to move only these mutants forward to liquid cell culture.

The primary screen is an agar plate screen is analyzed by the Q-botcolony picker. Although assays can be fundamentally different, manyresult, e.g., in the production of colony halos. For example, antibioticproduction is assayed on plates using an overlay of a sensitiveindicator strain, such as B. subtilis. Antibiotic production istypically assayed as a zone of clearing (inhibited growth of theindicator organism) around the producing organism. Similarly, enzymeproduction can be assayed on plates containing the enzyme substrate,with activity being detected as a zone of substrate modification aroundthe producing colony. Product titre is correlated with the ratio of haloarea to colony area.

The Q-bot or other automated system is instructed to only pick colonieshaving a halo ratio in the top 10% of the population i.e. 10,000 mutantsfrom the 100,000 entering the plate prescreen. This increases the numberof improved clones in the secondary assay and eliminates the wastedeffort of screening knock-out and low producers. This improves the “hitrate” of the secondary assay.

IV. Promotion of Genetic Exchange

(1) General

Some methods of the invention effect recombination of cellular DNA bypropagating cells under conditions inducing exchange of DNA betweencells. DNA exchange can be promoted by generally applicable methods suchas electroporation, biolistics, cell fusion, or in some instances, byconjugation, transduction, or agrobacterium mediated transfer andmeiosis. For example, Agrobacterium can transform S. cerevisiae withT-DNA, which is incorporated into the yeast genome by both homologousrecombination and a gap repair mechanism. (Piers et al., Proc. Natl.Acad. Sci. USA 93(4), 1613-8 (1996)).

In some methods, initial diversity between cells (i.e., before genomeexchange) is induced by chemical or radiation-induced mutagenesis of aprogenitor cell type, optionally followed by screening for a desiredphenotype. In other methods, diversity is natural as where cells areobtained from different individuals, strains or species.

In some shuffling methods, induced exchange of DNA is used as the solemeans of effecting recombination in each cycle of recombination. Inother methods, induced exchange is used in combination with naturalsexual recombination of an organism. In other methods, induced exchangeand/or natural sexual recombination are used in combination with theintroduction of a fragment library. Such a fragment library can be awhole genome, a whole chromosome, a group of functionally or geneticallylinked genes, a plasmid, a cosmid, a mitochondrial genome, a viralgenome (replicative and nonreplicative) or specific or random fragmentsof any of these. The DNA can be linked to a vector or can be in freeform. Some vectors contain sequences promoting homologous ornonhomologous recombination with the host genome. Some fragments containdouble stranded breaks such as caused by shearing with glass beads,sonication, or chemical or enzymatic fragmentation, to stimulaterecombination.

In each case, DNA can be exchanged between cells after which it canundergo recombination to form hybrid genomes. Cells bearing hybridgenomes are screened for a desired phenotype, and cells having thisphenotype are isolated. These cells form the starting materials for thenext cycle of recombination in a recursive recombination/selectionscheme.

One means of promoting exchange of DNA between cells is by fusion ofcells, such as by protoplast fusion. A protoplast results from theremoval from a cell of its cell wall, leaving a membrane-bound cell thatdepends on an isotonic or hypertonic medium for maintaining itsintegrity. If the cell wall is partially removed, the resulting cell isstrictly referred to as a spheroplast and if it is completely removed,as a protoplast. However, here the term protoplast includes spheroplastsunless otherwise indicated.

Protoplast fusion is described by Shaffner et al., Proc. Natl. Acad.Sci. USA 77, 2163 (1980) and other exemplary procedures are described byYoakum et al., U.S. Pat. No. 4,608,339, Takahashi et al., U.S. Pat. No.4,677,066 and Sambrooke et al., at Ch. 16. Protoplast fusion has beenreported between strains, species, and genera (e.g., yeast and chickenerythrocyte).

Protoplasts can be prepared for both bacterial and eukaryotic cells,including mammalian cells and plant cells, by several means includingchemical treatment to strip cell walls. For example, cell walls can bestripped by digestion with a cell wall degrading enzyme such as lysozymein a 10-20% sucrose, 50 mM EDTA buffer. Conversion of cells to sphericalprotoplasts can be monitored by phase-contrast microscopy. Protoplastscan also be prepared by propagation of cells in media supplemented withan inhibitor of cell wall synthesis, or use of mutant strains lackingcapacity for cell wall formation. Preferably, eukaryotic cells aresynchronized in G1 phase by arrest with inhibitors such as α-factor, K.lactis killer toxin, leflonamide and adenylate cyclase inhibitors.Optionally, some but not all, protoplasts to be fused can be killedand/or have their DNA fragmented by treatment with ultravioletirradiation, hydroxylamine or cupferon (Reeves et al., FEMS Microbiol.Lett. 99, 193-198 (1992)). In this situation, killed protoplasts arereferred to as donors, and viable protoplasts as acceptors. Using deaddonors cells can be advantageous in subsequently recognizing fused cellswith hybrid genomes, as described below. Further, breaking up DNA indonor cells is advantageous for stimulating recombination with acceptorDNA. Optionally, acceptor and/or fused cells can also be briefly, butnonlethally, exposed to uv irradiation further to stimulaterecombination.

Once formed, protoplasts can be stabilized in a variety of osmolytes andcompounds such as sodium chloride, potassium chloride, sodium phosphate,potassium phosphate, sucrose, sorbitol in the presence of DTT. Thecombination of buffer, pH, reducing agent, and osmotic stabilizer can beoptimized for different cell types. Protoplasts can be induced to fuseby treatment with a chemical such as PEG, calcium chloride or calciumpropionate or electrofusion (Tsoneva, Acta Microbiologica Bulgaria 24,53-59 (1989)). A method of cell fusion employing electric fields hasalso been described. See Chang U.S. Pat. No. 4,970,154. Conditions canbe optimized for different strains.

The fused cells are heterokaryons containing genomes from two componentprotoplasts. Fused cells can be enriched from unfused parental cells bysucrose gradient sedimentation or cell sorting. The two nuclei in theheterokaryons can fuse (karyogamy) and homologous recombination canoccur between the genomes. The chromosomes can also segregateasymmetrically resulting in regenerated protoplasts that have lost orgained whole chromosomes. The frequency of recombination can beincreased by treatment with ultraviolet irradiation or by use of strainsoverexpressing recA or other recombination genes, or the yeast radgenes, and cognate variants thereof in other species, or by theinhibition of gene products of MutS, MutL, or MutD. Overexpression canbe either the result of introduction of exogenous recombination genes orthe result of selecting strains, which as a result of natural variationor induced mutation, overexpress endogenous recombination genes. Thefused protoplasts are propagated under conditions allowing regenerationof cell walls, recombination and segregation of recombinant genomes intoprogeny cells from the heterokaryon and expression of recombinant genes.After, or occasionally before or during, recovery of fused cells, thecells are screened or selected for evolution toward a desired property.

Thereafter a subsequent round of recombination can be performed bypreparing protoplasts from the cells surviving selection/screening in aprevious round. The protoplasts are fused, recombination occurs in fusedprotoplasts, and cells are regenerated from the fused protoplasts.Protoplasts, regenerated or regenerating cells are subject to furtherselection or screening.

Alternatively, a subsequent round of recombination can be performed on asplit pool basis as described above. That is, a first subpopulation ofcells surviving selection/screening from a previous round are used forprotoplast formation. A second subpopulation of cells survivingselection/screening from a previous round are used as a source for DNAlibrary preparation. The DNA library from the second subpopulation ofcells is then transformed into the protoplasts from the firstsubpopulation. The library undergoes recombination with the genomes ofthe protoplasts to form recombinant genomes. Cells are regenerated fromprotoplasts, and selection/screening is applied to regenerating orregenerated cells. In a further variation, a fresh library of nucleicacid fragments is introduced into protoplasts survivingselection/screening from a previous round.

An exemplary format for shuffling using protoplast fusion is shown inFIG. 5. The figure shows the following steps: protoplast formation ofdonor and recipient strains, heterokaryon formation, karyogamy,recombination, and segregation of recombinant genomes into separatecells. Optionally, the recombinant genomes, if having a sexual cycle,can undergo further recombination with each other as a result of meiosisand mating. Cells are then screened or selected for a desired property.Cells surviving selection/screening are then used as the startingmaterials in a further cycle of protoplasting.

2. Selection For Hybrid Strains

The invention provides selection strategies to identify cells formed byfusion of components from parental cells from two or more distinctsubpopulations. Selection for hybrid cells is usually performed beforeselecting or screening for cells that have evolved (as a result ofgenetic exchange) to acquisition of a desired property. A basic premiseof most such selection schemes is that two initial subpopulations havetwo distinct markers. Cells with hybrid genomes can thus be identifiedby selection for both markers.

In one such scheme, at least one subpopulation of cells bears aselective marker attached to its cell membrane. Examples of suitablemembrane markers include biotin, fluorescein and rhodamine. The markerscan be linked to amide or thiol groups or through more specificderivatization chemistries, such as iodo-acetates, iodoacetamides,maleimides. For example, a marker can be attached as follows. Cells orprotoplasts are washed with a buffer (e.g., PBS), which does notinterfere with the chemical coupling of a chemically active ligand whichreacts with amino groups of lysines or N-terminal aminogroups ofmembrane proteins. The ligand is either amine reactive itself (e.g.,isothiocyanates, succinimidyl esters, sulfonyl chlorides) or isactivated by a heterobifunctional linker (e.g. EMCS, SIAB, SPDP, SMB) tobecome amine reactive. The ligand is a molecule which is easily bound byprotein derivatized magnetic beads or other capturing solid supports.For example, the ligand can be succinimidyl activated biotin (Molecularprobes: B-1606, B-2603, S-1515, S-1582). This linker is reacted withaminogroups of proteins residing in and on the surface of a cell. Thecells are then washed to remove excess labelling agent before contactingwith cells from the second subpopulation bearing a second selectivemarker.

The second subpopulation of cells can also bear a membrane marker,albeit a different membrane marker from the first subpopulation.Alternatively, the second subpopulation can bear a genetic marker. Thegenetic marker can confer a selective property such as drug resistanceor a screenable property, such as expression of green fluorescentprotein.

After fusion of first and second subpopulations of cells and recovery,cells are screened or selected for the presence of markers on bothparental subpopulations. For example, fusants are enriched for onepopulation by adsorbtion to specific beads and these are then sorted byFACS for those expressing a marker. Cells surviving both screens forboth markers are those having undergone protoplast fusion, and aretherefore more likely to have recombined genomes. Usually, the markersare screened or selected separately. Membrane-bound markers, such asbiotin, can be screened by affinity enrichment for the cell membranemarker (e.g., by panning fused cells on an affinity matrix). Forexample, for a biotin membrane label, cells can be affinity purifiedusing streptavidin-coated magnetic beads (Dynal). These beads are washedseveral times to remove the non-fused host cells. Alternatively, cellscan be panned against an antibody to the membrane marker. In a furthervariation, if the membrane marker is fluorescent, cells bearing themarker can be identified by FACS. Screens for genetic markers depend onthe nature of the markers, and include capacity to grow on drug-treatedmedia or FACS selection for green fluorescent protein. If first andsecond cell populations have fluorescent markers of differentwavelengths, both markers can be screened simultaneously by FACSsorting.

In a further selection scheme for hybrid cells, first and secondpopulations of cells to be fused express different subunits of aheteromultimeric enzyme. Usually, the heteromultimeric enzyme has twodifferent subunits, but heteromultimeric enzymes having three, four ormore different subunits can be used. If an enzyme has more than twodifferent subunits, each subunit can be expressed in a differentsubpopulation of cells (e.g., three subunits in three subpopulations),or more than one subunit can be expressed in the same subpopulation ofcells (e.g., one subunit in one subpopulation, two subunits in a secondsubpopulation). In the case where more than two subunits are used,selection for the poolwise recombination of more than two protoplastscan be achieved.

Hybrid cells representing a combination of genomes of first, second ormore subpopulation component cells can then be recognized by an assayfor intact enzyme. Such an assay can be a binding assay, but is moretypically a functional assay (e.g., capacity to metabolize a substrateof the enzyme). Enzymatic activity can be detected for example byprocessing of a substrate to a product with a fluorescent or otherwiseeasily detectable emission spectrum. The individual subunits of aheteromultimeric enzyme used in such an assay preferably have no enzymicactivity in dissociated form, or at least have significantly lessactivity in dissociated form than associated form. Preferably, the cellsused for fusion lack an endogenous form of the heteromultimeric enzyme,or at least have significantly less endogenous activity than resultsfrom heteromultimeric enzyme formed by fusion of cells.

Penicillin acylase enzymes, cephalosporin acylase and penicillinacyltransferase are examples of suitable heteromultimeric enzymes. Theseenzymes are encoded by a single gene, which is translated as a proenzymeand cleaved by posttranslational autocatalytic proteolysis to remove aspacer endopeptide and generate two subunits, which associate to formthe active heterodimeric enzyme. Neither subunit is active in theabsence of the other subunit. However, activity can be reconstituted ifthese separated gene portions are expressed in the same cell byco-transformation. Other enzymes that can be used have subunits that areencoded by distinct genes (e.g., faoA and faoB genes encode3-oxoacyl-CoA thiolase of Pseudonmonas fragi (Biochem. J 328, 815-820(1997)).

An exemplary enzyme is penicillin G acylase from Escherichia coli, whichhas two subunits encoded by a single gene. Fragments of the geneencoding the two subunits operably linked to appropriate expressionregulation sequences are transfected into first and secondsubpopulations of cells, which lack endogenous penicillin acylaseactivity. A cell formed by fusion of component cells from the first andsecond subpopulations expresses the two subunits, which assemble to formfunctional enzyme, e.g., penicillin acylase. Fused cells can then beselected on agar plates containing penicillin G, which is degraded bypenicillin acylase.

In another variation, fused cells are identified by complementation ofauxotrophic mutants. Parental subpopulations of cells can be selectedfor known auxotrophic mutations. Alternatively, auxotrophic mutations ina starting population of cells can be generated spontaneously byexposure to a mutagenic agent. Cells with auxotrophic mutations areselected by replica plating on minimal and complete media. Lesionsresulting in auxotrophy are expected to be scattered throughout thegenome, in genes for amino acid, nucleotide, and vitamin biosyntheticpathways. After fusion of parental cells, cells resulting from fusioncan be identified by their capacity to grow on minimal media. Thesecells can then be screened or selected for evolution toward a desiredproperty. Further steps of mutagenesis generating fresh auxotrophicmutations can be incorporated in subsequent cycles of recombination andscreening/selection.

In variations of the above method, de novo generation of auxotrophicmutations in each round of shuffling can be avoided by reusing the sameauxotrophs. For example, auxotrophs can be generated by transposonmutagenesis using a transposon bearing selective marker. Auxotrophs areidentified by a screen such as replica plating. Auxotrophs are pooled,and a generalized transducing phage lysate is prepared by growth ofphage on a population of auxotrophic cells. A separate population ofauxtrophic cells is subjected to genetic exchange, and complementationis used to selected cells that have undergone genetic exchange andrecombination. These cells are then screened or selected for acquisitionof a desired property. Cells surviving screening or selection then haveauxotrophic markers regenerated by introduction of the transducingtransposon library. The newly generated auxotrophic cells can then besubject to further genetic exchange and screening/selection.

In a further variation, auxotrophic mutations are generated byhomologous recombination with a targeting vector comprising a selectivemarker flanked by regions of homology with a biosynthetic region of thegenome of cells to be evolved. Recombination between the vector and thegenome inserts the positive selection marker into the genome causing anauxotrophic mutation. The vector is in linear form before introductionof cells. Optionally, the frequency of introduction of the vector can beincreased by capping its ends with self-complementarity oligonucleotidesannealed in a hair pin formation. Genetic exchange andscreening/selection proceed as described above. In each round, targetingvectors are reintroduced regenerating the same population of auxotrophicmarkers.

In another variation, fused cells are identified by screening for agenomic marker present on one subpopulation of parental cells and anepisomal marker present on a second subpopulation of cells. For example,a first subpopulation of yeast containing mitochondria can be used tocomplement a second subpopulation of yeast having a petite phenotype(i.e., lacking mitochondria).

In a further variation, genetic exchange is performed between twosubpopulations of cells, one of which is dead. Cells are preferablykilled by brief exposure to DNA fragmenting agents such ashydroxylamine, cupferon, or irradiation. Viable cells are then screenedfor a marker present on the dead parental subpopulation.

3. Liposome-mediated Transfers

In the methods noted above, in which nucleic acid fragment libraries areintroduced into protoplasts, the nucleic acids are sometimesencapsulated in liposomes to facilitate uptake by protoplasts.Lipsome-mediated uptake of DNA by protoplasts is described in Redford etal., Mol. Gen. Genet. 184, 567-569 (1981). Liposomes can efficientlydeliver large volumes of DNA to protoplasts (see Deshayes et al., EMBOJ. 4, 2731-2737 (1985)). See also, Philippot and Schuber (eds) (1995)Liposomes as Tools in Basic Research and Industry CRC press, Boca Raton,e.g., Chapter 9, Remy et al. “Gene Transfer with Cationic Amphiphiles.”Further, the DNA can be delivered as linear fragments, which are oftenmore recombinogenic that whole genomes. In some methods, fragments aremutated prior to encapsulation in liposomes. In some methods, fragmentsare combined with RecA and homologs, or nucleases (e.g., restrictionendonucleases) before encapsulation in liposomes to promoterecombination.

4. Shuffling Filamentous Fungi

Filamentous fungi are particularly suited to performing the shufflingmethods described above. Filamentous fungi are divided into four mainclassifications based on their structures for sexual reproduction:Phycomycetes, Ascomycetes, Basidiomycetes and the Fungi Imperfecti.Phycomycetes (e.g., Rhizopus, Mucor) form sexual spores in sporangium.The spores can be uni or multinucleate and often lack septated hyphae(coenocytic). Ascomycetes (e.g., Aspergillus, Neurospora, Penicillum)produce sexual spores in an ascus as a result of meiotic division. Ascitypically contain 4 meiotic products, but some contain 8 as a result ofadditional mitotic division. Basidiomycetes include mushrooms, and smutsand form sexual spores on the surface of a basidium. Inholobasidiomycetes, such as mushrooms, the basidium is undivided. Inhemibasidiomycetes, such as ruts (Uredinales) and smut fungi(Ustilaginales), the basidium is divided. Fungi imperfecti, whichinclude most human pathogens, have no known sexual stage.

Fungi can reproduce by asexual, sexual or parasexual means. Asexualreproduction, involves vegetative growth of mycelia, nuclear divisionand cell division without involvement of gametes and without nuclearfusion. Cell division can occur by sporulation, budding or fragmentationof hyphae.

Sexual reproduction provides a mechanism for shuffling genetic materialbetween cells. A sexual reproductive cycle is characterized by analteration of a haploid phase and a diploid phase. Diploidy occurs whentwo haploid gamete nuclei fuse (karyogamy). The gamete nuclei can comefrom the same parental strains (self-fertile), such as in thehomothallic fungi. In heterothallic fungi, the parental strains comefrom strains of different mating type.

A diploid cell converts to haploidy via meiosis, which essentiallyconsists of two divisions of the nucleus accompanied by one division ofthe chromosomes. The products of one meiosis are a tetrad (4 haploidnuclei). In some cases, a mitotic division occurs after meiosis, givingrise to eight product cells. The arrangement of the resultant cells(usually enclosed in spores) resembles that of the parental strains. Thelength of the haploid and diploid stages differs in various fungi: forexample, the Basidiomycetes and many of the Ascomycetes have a mostlyhapolid life cycle (that is, meiosis occurs immediately afterkaryogamy), whereas others (e.g., Saccharomyces cerevisiae) are diploidfor most of their life cycle (karyogamy occurs soon after meiosis).Sexual reproduction can occur between cells in the same strain (selfing)or between cells from different strains (outcrossing).

Sexual dimorphism (dioecism) is the separate production of male andfemale organs on different mycelia. This is a rare phenomenon among thefungi, although a few examples are known. Heterothallism (one locus-twoalleles) allows for outcrossing between crosscompatable strains whichare self-incompatable. The simplest form is the two allele-one locussystem of mating types/factors, illustrated by the following organisms:

A and a in Neurospora

a and α in Saccharomyces

plus and minus in Schizzosaccharomyces and Zygomycetes

a₁ and a₂ in Ustilago

Multiple-allelomorph heterothallism is exhibited by some of the higherBasidiomycetes (e.g. Gasteromycetes and Hymenomycetes), which areheterothallic and have several mating types determined by multiplealleles. Heterothallism in these organisms is either bipolar with onemating type factor, or tetrapolar with two unlinked factors, A and B.Stable, fertile heterokaryon formation depends on the presence ofdifferent A factors and, in the case of tetrapolar organisms, ofdifferent B factors as well. This system is effective in the promotionof outbreeding and the prevention of self-breeding. The number ofdifferent mating factors may be very large (i.e. thousands) (Kothe, FEMSMicrobiol. Rev. 18, 65-87 (1996)), and non-parental mating factors mayarise by recombination.

Parasexual reproduction provides a further means for shuffling geneticmaterial between cells. This process allows recombination of parentalDNA without involvement of mating types or gametes. Parasexual fusionoccurs by hyphal fusion giving rise to a common cytoplasm containingdifferent nuclei. The two nuclei can divide independently in theresulting heterokaryon but occasionally fuse. Fusion is followed byhaploidization, which can involve loss of chromosomes and mitoticcrossing over between homolgous chromosomes. Protoplast fusion is a formof parasexual reproduction.

Within the above four classes, fungi are also classified by vegetativecompatibility group. Fungi within a vegetative compatibility group canform heterokaryons with each other. Thus, for exchange of geneticmaterial between different strains of fungi, the fungi are usuallyprepared from the same vegetative compatibility group. However, somegenetic exchange can occur between fungi from different incompatibilitygroups as a result of parasexual reproduction (see Timberlake et al.,U.S. Pat. No. 5,605,820). Further, as discussed elsewhere, the naturalvegetative compatibility group of fungi can be expanded as a result ofshuffling.

Several isolates of Aspergillus nidulans, A. flavus, A. fumigatus,Penicillium chrysogenum, P. notatum, Cephalosporium chrysogenum,Neurospora crassa, Aureobasidium pullulans have been karyotyped. Genomesizes generally range between 20 and 50 Mb among the Aspergilli.Differences in karyotypes often exist between similar strains and arealso caused by transformation with exogenous DNA. Filamentous fungalgenes contain introns, usually ˜50-100 bp in size, with similarconsensus 5′ and 3′ splice sequences. Promotion and termination signalsare often cross-recognizable, enabling the expression of a gene/pathwayfrom one fungus (e.g. A. nidulans) in another (e.g. P. chrysogenum).

The major components of the fungal cell wall are chitin (or chitosan),β-glucan, and mannoproteins. Chitin and β-glucan form the scaffolding,mannoproteins are interstitial components which dictate the wall'sporosity, antigenicity and adhesion. Chitin synthetase catalyzes thepolymerization of β-(1,4)-linked N-acetylglucosamine (GIcNAc) residues,forming linear strands running antiparallel; β-(1,3)-glucan synthetasecatalyze the homopolymerization of glucose.

One general goal of shuffling is to evolve fungi to become useful hostsfor genetic engineering, in particular for the shuffling of unrelatedgenes. A. nidulans is generally the fungal organism of choice to serveas a host for such manipulations because of its sexual cycle andwell-established use in classical and molecular genetics. Anothergeneral goal is to improve the capacity of fungi to make specificcompounds (e.g. antibacterials (penicillins, cephalosporins),antifungals (e.g. echinocandins, aureobasidins), and wood-degradingenzymes). There is some overlap between these general goals, and thus,some desired properties are useful for achieving both goals.

One desired property is the introduction of meiotic apparatus into fungipresently lacking a sexual cycle (see Sharon et al., Mol. Gen. Genet.251, 60-68 (1996)). A scheme for introducing a sexual cycle into thefungi P. chrysogenum (a fungus imperfecti) is shown in FIG. 6.Subpopulations of protoplasts are formed from A. nidulans (which has asexual cycle) and P. chrysogenum, which does not. The two strainspreferably bear different markers. The A. nidulans protoplasts arekilled by treatment with uv or hydroxylamine. The two subpopulations arefused to form heterokaryons. In some heterokaryons, nuclei fuse, andsome recombination occurs. Fused cells are cultured under conditions togenerate new cell walls and then to allow sexual recombination to occur.Cells with recombinant genomes are then selected (e.g., by selecting forcomplementation of auxotrophic markers present on the respective parentstrains). Cells with hybrid genomes are more likely to have acquired thegenes necessary for a sexual cycle. Protoplasts of cells can then becrossed with killed protoplasts of a further population of cells knownto have a sexual cycle (the same or different as the previous round) inthe same manner, followed by selection for cells with hybrid genomes.

Another desired property is the production of a mutator strain of fungi.Such a fungus can be produced by shuffling a fungal strain containing amarker gene with one or more mutations that impair or prevent expressionof a functional product. Shufflants are propagated under conditions thatselect for expression of the positive marker (while allowing a smallamount of residual growth without expression). Shufflants growingfastest are selected to form the starting materials for the next roundof shuffling.

Another desired property is to expand the host range of a fungus so itcan form heterokaryons with fungi from other vegetative compatibilitygroups. Incompatability between species results from the interactions ofspecific alleles at different incompatability loci (such as the “het”loci). If two strains undergo hyphal anastomosis, a lethal cytoplasmicincompatability reaction may occur if the strains differ at these loci.Strains must carry identical loci to be entirely compatible. Several ofthese loci have been identified in various species, and theincompatibility effect is somewhat additive (hence, “partialincompatibility” can occur). Some tolerant and het-negative mutants havebeen described for these organisms (e.g. Dales & Croft, J. Gen.Microbiol. 136, 1717-1724 (1990)). Further, a tolerance gene (tol) hasbeen reported, which suppresses mating-type heterokaryonincompatibility. Shuffling is performed between protoplasts of strainsfrom different incompatibility groups. A preferred format uses a liveacceptor strain and a UV-irradiated dead acceptor strain. The UVirradiation serves to introduce mutations into DNA inactivating hetgenes. The two strains should bear different genetic markers.Protoplasts of the strain are fused, cells are regenerated and screenedfor complementation of markers. Subsequent rounds of shuffling andselection can be performed in the same manner by fusing the cellssurviving screening with a protoplasts of a fresh population of donorcells.

Another desired property is the introduction of multiple-allelomorphheterothallism into Ascomycetes and Fungi imperfecti, which do notnormally exhibit this property. This mating system allows outbreedingwithout self-breeding. Such a mating system can be introduced byshuffling Ascomycetes and Fungi imperfecti with DNA from Gasteromycetesor Hymenomycetes, which have such a system.

Another desired property is spontaneous formation of protoplasts tofacilitate use of a fungal strain as a shuffling host. Here, the fungusto be evolved is typically mutagenized. Spores of the fungus to beevolved are briefly treated with a cell-wall degrading agent for a timeinsufficient for complete protoplast formation, and are mixed withprotoplasts from other strain(s) of fungi. Protoplasts formed by fusionof the two different subpopulations are identified by genetic or otherselection/or screening as described above. These protoplasts are used toregenerate mycelia and then spores, which form the starting material forthe next round of shuffling. In the next round, at least some of thesurviving spores are treated with cell-wall removing enzyme but for ashorter time than the previous round. After treatment, the partiallystripped cells are labelled with a first label. These cells are thenmixed with protoplasts, which may derive from other cells survivingselection in a previous round, or from a fresh strain of fungi. Theseprotoplasts are physically labelled with a second label. Afterincubating the cells under conditions for protoplast fusion fusants withboth labels are selected. These fusants are used to generate mycelia andspores for the next round of shuffling, and so forth. Eventually,progeny that spontaneously form protoplasts (i.e., without addition ofcell wall degrading agent) are identified.

Another desired property is the acquisition and/or improvement of genesencoding enzymes in biosynthetic pathways, genes encoding transporterproteins, and genes encoding proteins involved in metabolic fluxcontrol. In this situation, genes of the pathway can be introduced intothe fungus to be evolved either by genetic exchange with another strainof fungus possessing the pathway or by introduction of a fragmentlibrary from an organism possessing the pathway. Genetic material ofthese fungi can then be subjected to further shuffling andscreening/selection by the various procedures discussed in thisapplication. Shufflant strains of fungi are selected/screened forproduction of the compound produced by the metabolic pathway orprecursors thereof.

Another desired property is increasing the stability of fungi to extremeconditions such as heat. In this situation, genes conferring stabilitycan be acquired by exchanging DNA with or transforming DNA from a strainthat already has such properties. Alternatively, the strain to beevolved can be subjected to random mutagenesis. Genetic material of thefungus to be evolved can be shuffled by any of the procedures describedin this application, with shufflants being selected by survivingexposure to extreme conditions.

Another desired property is capacity of a fungus to grow under alterednutritional requirements (e.g., growth on particular carbon or nitrogensources). Altering nutritional requirements is particularly valuable,e.g., for natural isolates of fungi that produce valuable commercialproducts but have esoteric and therefore expensive nutritionalrequirement. The strain to be evolved undergoes genetic exchange and/ortransformation with DNA from a strain that has the desired nutritionalrequirements. The fungus to be evolved can then optionally be subjectedto further shuffling as described in this application and withrecombinant strains being selected for capacity to grow in the desirednutritional circumstances. Optionally, the nutritional circumstances canbe varied in successive rounds of shuffling starting at close to thenatural requirements of the fungus to be evolved and in subsequentrounds approaching the desired nutritional requirements.

Another desired property is acquisition of natural competence in afungus. The procedure for acquisition of natural competence by shufflingis generally described in PCT/US97/04494. The fungus to be evolvedtypically undergoes genetic exchange or transformation with DNA from abacterial strain or fungal strain that already has this property. Cellswith recombinant genomes are then selected by capacity to take up aplasmid bearing a selective marker. Further rounds of recombination andselection can be performed using any of the procedures described above.

Another desired property is reduced or increased secretion of proteasesand DNase. In this situation, the fungus to be evolved can acquire DNAby exchange or transformation from another strain known to have thedesired property. Alternatively, the fungus to be evolved can be subjectto random mutagenesis. The fungus to be evolved is shuffled as above.Before selection/screening isolates, pooled isolates of fungi aretypically lysed to release proteases or DNase to the surrounding media.The presence of such enzymes, or lack thereof, can be assayed bycontacting the media with a fluorescent molecule tethered to a supportvia a peptide or DNA linkage. Cleavage of the linkage releasesdetectable fluorescence to the media.

Another desired property is producing fungi with altered transporters(e.g., MDR). Such altered transporters are useful, for example, in fungithat have been evolved to produce new secondary metabolites, to allowentry of precursors required for synthesis of the new secondarymetabolites into a cell, or to allow efflux of the secondary metabolitefrom the cell. Transporters can be evolved by introduction of a libraryof transporter variants into a fungal cells and allowing the cells torecombine by sexual or parasexual recombination. To evolve a transporterwith capacity to transport a precursor into the cells, cells arepropagated in the present of precursor, and cells are then screened forproduction of metabolite. To evolve a transporter with capacity toexport a metabolite, cells are propagated under conditions supportingproduction of the metabolite, and screened for export of metabolite toculture medium.

A general method of fungal shuffling is shown in FIG. 7. Spores from afrozen stock, a lyophilized stock, or fresh from an agar plate are usedto inoculate suitable liquid medium (1). Spores are germinated resultingin hyphal growth (2). Mycelia are harvested, and washed by filtrationand/or centrifugation. Optionally the sample is pretreated with DTT toenhance protoplast formation (3). Protoplasting is performed in anosmotically stabling medium (e.g., 1 m NaCl/20 mM MgSO4, pH 5.8) by theaddition of cell wall-degrading enzyme (e.g., Novozyme 234) (4). Cellwall degrading enzyme is removed by repeated washing with osmoticallystabilizing solution (5). Protoplasts can be separated from mycelia,debris and spores by filtration through miracloth, and densitycentrifugation (6). Protoplasts are harvested by centrifugation andresuspended to the appropriate concentration. This step may lead to someprotoplast fusion (7). Fusion can be stimulated by addition of PEG(e.g., PEG 3350), and/or repeated centrifugation and resuspension withor without PEG. Electrofusion can also be performed (8). Fusedprotoplasts can optionally be enriched from unfused protoplasts bysucrose gradient sedimentation (or other methods of screening describedabove). Fused protoplasts can optionally be treated with ultravioletirradiation to stimulate recombination (9). Protoplasts are cultured onosmotically stabilized agar plates to regenerate cell walls and formmycelia (10). The mycelia are used to generate spores (11), which areused as the starting material in the next round of shuffling (12).Selection for a desired property can be performed either on regeneratedmycelia or spores derived therefrom.

In an alternative method, protoplasts are formed by inhibition of one ormore enzymes required for cell wall synthesis (see FIG. 8). Theinhibitor should be fungistatic rather than fungicidal under theconditions of use. Examples of inhibitors include antifungal compoundsdescribed by (e.g., Georgopapadakou & Walsh, Antimicrob. Ag. Chemother.40, 279-291 (1996); Lyman & Walsh, Drugs 44, 9-35 (1992)). Otherexamples include chitin synthase inhibitors (polyoxin or nikkomycincompounds) and/or glucan synthase inhibitors (e.g. echinocandins,papulocandins, pneumocandins). Inhibitors should be applied inosmotically stabilized medium. Cells stripped of their cell walls can befused or otherwise employed as donors or hosts in genetictransformation/strain development programs. A possible scheme utilizingthis method reiteratively is outlined in FIG. 8.

In a further variation, protoplasts are prepared using strains of fungi,which are genetically deficient or compromised in their ability tosynthesize intact cell walls (see FIG. 9). Such mutants are generallyreferred to as fragile, osmotic-remedial, or cell wall-less, and areobtainable from strain depositories. Examples of such strains includeNeurospora crassa os mutants (Selitrennikoff, Antimicrob. Agents.Chemother. 23, 757-765 (1983)). Some such mutations aretemperature-sensitive. Temperature-sensitive strains can be propagatedat the permissive temperature for purposes of selection andamplification and at a nonpermissive temperature for purposes ofprotoplast formation and fusion. A temperature sensitive strainNeurospora crassa os strain has been described which propagates asprotoplasts when growth in osmotically stabilizing medium containingsorbose and polyoxin at nonpermissive temperature but generates wholecells on transfer to medium containing sorbitol at a permissivetemperature. See U.S. Pat. No. 4,873,196.

Other suitable strains can be produced by targeted mutagenesis of genesinvolved in chitin synthesis, glucan synthesis and other cellwall-related processes. Examples of such genes include CHT1, CHT2 andCALI (or CSD2) of Saccharomyces cerevisiae and Candida spp.(Georgopapadakou & Walsh 1996); ETGI/FKSI/CNDI/CWH53/PB RI and homologsin S. cerevisiae, Candida albicans, Cryptococcus neoformans, Aspergillusfumigatus, ChvAINdvA Agrobacterium and Rhizobium. Other examples are MA,orlB, orIC, MD, tsE, and bimG of Aspergillus nidulans (Borgia, J.Bacteriol. 174, 377-389 (1992)). Strains of A. nidulans containing OrlA1or tse1 mutations lyse at restrictive temperatures. Lysis of thesestrains may be prevented by osmotic stabilization, and the mutations maybe complemented by the addition of N-acetylglucosimine (GlcNac). BimG11mutations are ts for a type 1 protein phosphatase (germlines of strainscarrying this mutation lack chitin, and condia swell and lyse). Othersuitable genes are chsA, chsB, chsC, chsD and chsE of Aspergillusfumigatus; chs1 and chs2 of Neurospora crassa; Phycomyces blakesleeanusMM and chs1, 2 and 3 of S. cerevisiae. Chs1 is a non-essential repairenzyme; chs2 is involved in septum formation and chs3 is involved incell wall maturation and bud ring formation.

Other useful strains include S. cerevisiae CLY (cell lysis) mutants suchas ts strains (Paravicini et al., Mol. Cell Biol. 12, 4896-4905 (1992)),and the CLY 15 strain which harbors a PKC 1 gene deletion. Other usefulstrains include strain VY 1160 containing a ts mutation in srb (encodingactin) (Schade et al. Acta Histochem. Suppl. 41, 193-200 (1991)), and astrain with an ses mutation which results in increased sensitivity tocell-wall digesting enzymes isolated from snail gut (Metha & Gregory,Appl. Environ. Microbiol. 41, 992-999 (1981)). Useful strains of C.albicans include those with mutations in chs1, chs2, or chs3 (encodingchitin synthetases), such as osmotic remedial conditional lethal mutantsdescribed by Payton & de Tiani, Curr. Genet. 17, 293-296 (1990); C.utilis mutants with increased sensitivity to cell-wall digesting enzymesisolated from snail gut (Metha & Gregory, 1981, supra); and N. crassamutants os-1, os-2, os-3, os-4, os-5, and os-6. See, Selitrennikoff,Antimicrob. Agents Chemother. 23, 757-765 (1983). Such mutants grow anddivide without a cell wall at 37° C., but at 22° C. produce a cell wall.

Targeted mutagenesis can be achieved by transforming cells with apositive-negative selection vector containing homologous regionsflanking a segment to be targeted, a positive selection marker betweenthe homologous regions and a negative selection marker outside thehomologous regions (see Capecchi, U.S. Pat. No. 5,627,059). In avariation, the negative selection marker can be an antisense transcriptof the positive selection marker (see U.S. Pat. No. 5,527,674).

Other suitable cells can be selected by random mutagenesis or shufflingprocedures in combination with selection. For example, a firstsubpopulation of cells are mutagenized, allowed to recover frommutagenesis, subjected to incomplete degradation of cell walls and thencontacted with protoplasts of a second subpopulation of cells. Hybridscells bearing markers from both subpopulations are identified (asdescribed above) and used as the starting materials in a subsequentround of shuffling. This selection scheme selects both for cells withcapacity for spontaneous protoplast formation and for cells withenhanced recombinogenicity.

In a further variation, cells having capacity for spontaneous protoplastformation can be crossed with cells having enhanced recombinogenicityevolved using other methods of the invention. The hybrid cells areparticularly suitable hosts for whole genome shuffling.

Cells with mutations in enzymes involved in cell wall synthesis ormaintenance can undergo fusion simply as a result of propagating thecells in osmotic-protected culture due to spontaneous protoplastformation. If the mutation is conditional, cells are shifted to anonpermissive condition. Protoplast formation and fusion can beaccelerated by addition of promoting agents, such as PEG or an electricfield (See Philipova & Venkov, Yeast 6, 205-212 (1990); Tsoneva et al.,FEMS Microbiol. Lett. 51, 61-65 (1989)).

5. Shuffling Methods in Yeast

Yeasts are subspecies of fungi that grow as single cells. Yeasts areused for the production of fermented beverages and leavening, forproduction of ethanol as a fuel, low molecular weight compounds, and forthe heterologous production of proteins and enzymes (see accompanyinglist of yeast strains and their uses). Commonly used strains of yeastinclude Saccharomyces cerevisiae, Pichia sp., Canidia sp. andSchizosaccharomyces pombe.

Several types of vectors are available for cloning in yeast includingintegrative plasmid (YIp), yeast replicating plasmid (YRp, such as the2μ circle based vectors), yeast episomal plasmid (YEp), yeastcentromeric plasmid (YCp), or yeast artificial chromosome (YAC). Eachvector can carry markers useful to select for the presence of theplasmid such as LUE2, URA3, and H1S3, or the absence of the plasmid suchas URA3 (a gene that is toxic to cells grown in the presence of 5-fluoroorotic acid.

Many yeasts have a sexual cycle and asexual (vegetative) cycles. Thesexual cycle involves the recombination of the whole genome of theorganism each time the cell passes through meiosis. For example, whendiploid cells of S. cerevisiae are exposed to nitrogen and carbonlimiting conditions, diploid cells undergo meiosis to form asci. Eachascus holds four haploid spores, two of mating type “a” and two ofmating type “α.” Upon return to rich medium, haploid spores of oppositemating type mate to form diploid cells once again. Asci of oppositemating type can mate within the ascus, or if the ascus is degraded, forexample with zymolase, the haploid cells can mate with spores from otherasci. This sexual cycle provides a format to shuffle endogenous genomesof yeast and/or exogenous fragment libraries inserted into yeastvectors. This process results in swapping or accumulation of hybridgenes, and for the shuffling of homologous sequences shared by matingcells.

Yeast strains having mutations in several known genes have propertiesuseful for shuffling. These properties include increasing the frequencyof recombination and increasing the frequency of spontaneous mutationswithin a cell. These properties can be the result of mutation of acoding sequence or altered expression (usually overexpression) of awildtype coding sequence. The HO nuclease effects the transposition ofHMLa/α and HMRa/α to the MAT locus resulting in mating type switching.Mutants in the gene encoding this enzyme do not switch their mating typeand can be employed to force crossing between strains of definedgenotype, such as ones that harbor a library or have a desired phenotypeand to prevent in breeding of starter strains. PMS1, MLH1, MSH2, MSH6are involved in mismatch repair. Mutations in these genes all have amutator phenotype (Chambers et al., Mol. Cell. Biol. 16, 6110-6120(1996)). Mutations in TOP3 DNA topoisomerase have a 6-fold enhancementof interchromosomal homologous recombination (Bailis et al., Molecularand Cellular Biology 12, 4988-4993 (1992)). The RAD50-57 genes conferresistance to radiation. Rad3 functions in excision of pyrimidinedimers. RAD52 functions in gene conversion. RAD50, MRE11, XRS2 functionin both homologous recombination and illegitimate recombination. HOP1,RED1 function in early meiotic recombination (Mao-Draayer, Genetics 144,71-86) Mutations in either HOP1 or RED1 reduce double stranded breaks atthe HIS2 recombination hotspot. Strains deficient in these genes areuseful for maintaining stability in hyper recombinogenic constructs suchas tandem expression libraries carried on YACs. Mutations in HPR 1 arehyperrecombinogenic. HDF1 has DNA end binding activity and is involvedin double stranded break repair and V(D)J recombination. Strains bearingthis mutation are useful for transformation with random genomicfragments by either protoplast fusion or electroporation. Kar-1 is adominant mutation that prevents karyogamy. Kar-1 mutants are useful forthe directed transfer of single chromosomes from a donor to a recipientstrain. This technique has been widely used in the transfer of YACsbetween strains, and is also useful in the transfer of evolvedgenes/chromosomes to other organisms (Markie, YAC Protocols, (HumanaPress, Totowa, N.J., 1996). HOT1 is an S. cerevisiae recombinationhotspot within the promoter and enhancer region of the rDNA repeatsequences. This locus induces mitotic recombination at adjacentsequences—presumably due to its high level transcription. Genes and/orpathways inserted under the transcriptional control of this regionundergo increased mitotic recombination. CDC2 encodes polymerase δ andis necessary for mitotic gene conversion. Overexpression of this genecan be used in a shuffler or mutator strain. A temperature sensitivemutation in CDC4 halts the cell cycle at G1 at the restrictivetemperature and could be used to synchronize protoplasts for optimizedfusion and subsequent recombination.

As with filamentous fungi, the general goals of shuffling yeast includeimprovement in yeast as a host organism for genetic manipulation, and asa production apparatus for various compounds. One desired property ineither case is to improve the capacity of yeast to express and secrete aheterologous protein. The following example describes the use ofshuffling to evolve yeast to express and secrete increased amounts ofRNase A.

RNase A catalyzes the cleavage of the P—O_(5 ′) bond of RNA specificallyafter pyrimidine nucleotides. The enzyme is a basic 124 amino acidpolypeptide that has 8 half cystine residues, each required forcatalysis. YEpWL-RNase A is a vector that effects the expression andsecretion of RNaseA from the yeast S. cerevisiae, and yeast harboringthis vector secrete 1-2 mg of recombinant RNase A per liter of culturemedium (delCardayré et al., Protein Engineering 8(3):26, 1-273 (1995)).This overall yield is poor for a protein heterologously expressed inyeast and can be improved at least 10-100 fold by shuffling. Theexpression of RNaseA is easily detected by several plate and microtitreplate assays (delCardayré & Raines, Biochemistry 33, 6031-6037 1994)).Each of the described formats for whole genome shuffling can be used toshuffle a strain of S. cerevisiae harboring YEpWL.RNase A, and theresulting cells can be screened for the increased secretion of RNase Ainto the medium. The new strains are cycled recursively through theshuffling format, until sufficiently high levels of RNase A secretion isobserved. The use of RNase A is particularly useful since it not onlyrequires proper folding and disulfide bond formation but also properglycosylation. Thus numerous components of the expression, folding, andsecretion systems can be optimized. The resulting strain is also evolvedfor improved secretion of other heterologous proteins.

Another goal of shuffling yeast is to increase the tolerance of yeast toethanol. Such is useful both for the commercial production of ethanol,and for the production of more alcoholic beers and wines. The yeaststrain to be shuffled acquires genetic material by exchange ortransformation with other strain(s) of yeast, which may or may not beknow to have superior resistance to ethanol. The strain to be evolved isshuffled and shufflants are selected for capacity to survive exposure toethanol. Increasing concentrations of ethanol can be used in successiverounds of shuffling. The same principles can be used to shuffle bakingyeasts for improved osmotolerance.

Another desired property of shuffling yeast is capacity to grow underdesired nutritional conditions. For example, it is useful to yeast togrow on cheap carbon sources such as methanol, starch, molases,cellulose, cellobiose, or xylose depending on availability. Theprinciples of shuffling and selection are similar to those discussed forfilamentous fungi.

Another desired property is capacity to produce secondary metabolitesnaturally produced by filamentous fungi or bacteria. Examples of suchsecondary metabolites are cyclosporin A, taxol, and cephalosporins. Theyeast to be evolved undergoes genetic exchange or is transformed withDNA from organism(s) that produce the secondary metabolite. For example,fungi producing taxol include Taxomyces andreanae and Pestalotopismicrospora (Stierle et al., Science 260, 214-216 (1993); Strobel et al.,Microbiol. 142, 435-440 (1996)). DNA can also be obtained from treesthat naturally produce taxol, such as Taxus brevifolia. DNA encoding oneenzyme in the taxol pathway, taxadiene synthase, which it is believedcatalyzes the commited step in taxol biosynthesis and may be ratelimiting in overal taxol production, has been cloned (Wildung & Croteau,J. Biol. Chem. 271, 9201-4 (1996). The DNA is then shuffled, andshufflants are screened/selected for production of the secondarymetabolite. For example, taxol production can be monitored usingantibodies to taxol, by mass spectroscopy or uv spectrophotometry.Alternatively, production of intermediates in taxol synthesis or enzymesin the taxol synthetic pathway can be monitored. Concetti & Ripani,Biol. Chem. Hoppe Seyler 375, 419-23 (1994). Other examples of secondarymetabolites are polyols, amino acids, polyketides, non-ribosomalpolypeptides, ergosterol, and the like.

Another desired property is to increase the flocculence of yeast tofacilitate separation in preparation of ethanol. Yeast can be shuffledby any of the procedures noted above with selection for shuffled yeastforming the largest clumps.

Exemplary Procedure for Yeast Protoplasting

Protoplast preparation in yeast is reviewed by Morgan, in Protoplasts(Birkhauser Verlag, Basel, 1983). Fresh cells (˜10⁸) are washed withbuffer, for example 0.1 M potassium phosphate, then resuspended in thissame buffer containing a reducing agent, such as 50 mM DTT, incubatedfor 1 h at 30° C. with gentle agitation, and then washed again withbuffer to remove the reducing agent. These cells are then resuspended inbuffer containing a cell wall degrading enzyme, such as Novozyme 234 (1mg/mL), and any of a variety of osmotic stabilizers, such as sucrose,sorbitol, NaCl, KCl, MgSO₄, MgCl₂, or NH₄Cl at any of a variety ofconcentrations. These suspensions are then incubated at 30° C. withgentle shaking (˜60 rpm) until protoplasts are released. To generateprotoplasts that are more likely to produce productive fusants severalstrategies are possible.

Protoplast formation can be increased if the cell cycle of theprotoplasts have been synchronized to be halted at G1. In the case of S.cerevisiae this can be accomplished by the addition of mating factors,either a or α (Curran & Carter, J. Gen. Microbiol. 129, 1589-1591(1983)). These peptides act as adenylate cyclase inhibitors which bydecreasing the cellular level of cAMP arrest the cell cycle at G1. Inaddition, sex factors have been shown to induce the weakening of thecell wall in preparation for the sexual fusion of a and α cells(Crandall & Brock, Bacteriol. Rev. 32, 139-163 (1968); Osumi et al.,Arch. Microbiol. 97, 27-38 (1974)). Thus in the preparation ofprotoplasts, cells can be treated with mating factors or other knowninhibitors of adenylate cyclase, such as leflunomide or the killer toxinfrom K. lactis, to arrest them at G1 (Sugisaki et al., Nature 304,464-466 (1983)). Then after fusing of the protoplasts (step 2), cAMP canbe added to the regeneration medium to induce S-phase and DNA synthesis.Alternatively, yeast strains having a temperature sensitive mutation inthe CDC4 gene can be used, such that cells could be synchronized andarrested at G1. After fusion cells are returned to the permissivetemperature so that DNA synthesis and growth resumes.

Once suitable protoplasts have been prepared, it is necessary to inducefusion by physical or chemical means. An equal number of protoplasts ofeach cell type is mixed in phosphate buffer (0.2 M, pH 5.8, 2×10⁸cells/mL) containing an osmotic stabilizer, for example 0.8 M NaCl, andPEG 6000 (33% w/v) and then incubated at 30° C. for 5 mm while fusionoccurs. Polyols, or other compounds that bind water, can be employed.The fusants are then washed and resuspended in the osmoticallystabilized buffer lacking PEG, and transferred to osmotically stabilizedregeneration medium on/in which the cells can be selected or screenedfor a desired property.

6. Shuffling Methods Using Artificial Chromosomes

Yeast artificial chromosomes (Yacs) are yeast vectors into which verylarge DNA fragments (e.g., 50-2000 kb) can be cloned (see, e.g., Monaco& Larin, Trends. Biotech. 12(7), 280-286 (1994); Ramsay, Mol.Biotechnol. 1(2), 181-201 1994; Huxley, Genet. Eng. 16, 65-91 (1994);Jakobovits, Curr. Biol. 4(8), 761-3 (1994); Lamb & Gearhart, Curr. Opin.Genet. Dev. 5(3), 342-8 (1995); Montoliu et al., Reprod. Fertil. Dev. 6,577-84 (1994)). These vectors have telomeres (Tel), a centromere (Cen),an autonomously replicating sequence (ARS), and can have genes forpositive (e.g., TRP1) and negative (e.g., URA3) selection. YACs aremaintained, replicated, and segregate as other yeast chromosomes throughboth meiosis and mitosis thereby providing a means to expose cloned DNAto true meiotic recombination.

YACs provide a vehicle for the shuffling of libraries of large DNAfragments in vivo. The substrates for shuffling are typically largefragments from 20 kb to 2 Mb. The fragments can be random fragments orcan be fragments known to encode a desirable property. For example, afragment might include an operon of genes involved in production ofantibiotics. Libraries can also include whole genomes or chromosomes.Viral genomes and some bacterial genomes can be cloned intact into asingle YAC. In some libraries, fragments are obtained from a singleorganism. Other libraries include fragment variants, as where somelibraries are obtained from different individuals or species. Fragmentvariants can also be generated by induced mutation. Typically, geneswithin fragments are expressed from naturally associated regulatorysequences within yeast. However, alternatively, individual genes can belinked to yeast regulatory elements to form an expression cassette, anda concatemer of such cassettes, each containing a different gene, can beinserted into a YAC.

In some instances, fragments are incorporated into the yeast genome, andshuffling is used to evolve improved yeast strains. In other instances,fragments remain as components of YACs throughout the shuffling process,and after acquisition of a desired property, the YACs are transferred toa desired recipient cell.

a. Methods of Evolving Yeast Strains

Fragments are cloned into a YAC vector, and the resulting YAC library istransformed into competent yeast cells. Transformants containing a YACare identified by selecting for a positive selection marker present onthe YAC. The cells are allowed to recover and are then pooled.Thereafter, the cells are induced to sporulate by transferring the cellsfrom rich medium, to nitrogen and carbon limiting medium. In the courseof sporulation, cells undergo meiosis. Spores are then induced to mateby return to rich media. Optionally, asci are lysed o liberate spores,so that the spores can mate with other spores originating from otherasci. Mating results in recombination between YACs bearing differentinserts, and between YACs and natural yeast chromosomes. The latter canbe promoted by irradiating spores with ultra violet light. Recombinationcan give rise to new phenotypes either as a result of genes expressed byfragments on the YACs or as a result of recombination with host genes,or both.

After induction of recombination between YACs and natural yeastchromosomes, YACs are often eliminated by selecting against a negativeselection marker on the YACs. For example, YACs containing the markerURA3 can be selected against by propagation on media containing5-fluro-orotic acid. Any exogenous or altered genetic material thatremains is contained within natural yeast chromosomes. Optionally,further rounds of recombination between natural yeast chromosomes can beperformed after elimination of YACs. Optionally, the same or differentlibrary of YACs can be transformed into the cells, and the above stepsrepeated.

After elimination of YACs, yeast are then screened or selected for adesired property. The property can be a new property conferred bytransferred fragments, such as production of an antibiotic. The propertycan also be an improved property of the yeast such as improved capacityto express or secrete an exogenous gene, improved recombinogenicity,improved stability to temperature or solvents, or other propertyrequired of commercial or research strains of yeast.

Yeast strains surviving selection/screening are then subject to afurther round of recombination. Recombination can be exclusively betweenthe chromosomes of yeast surviving selection/screening. Alternatively, alibrary of fragments can be introduced into the yeast cells andrecombined with endogenous yeast chromosomes as before. This library offragments can be the same or different from the library used in theprevious round of transformation. YACs are eliminated as before,followed by additional rounds of recombination and/or transformationwith further YAC libraries. Recombination is followed by another roundof selection/screening, as above. Further rounds ofrecombination/screening can be performed as needed until a yeast strainhas evolved to acquire the desired property.

An exemplary scheme for evolving yeast by introduction of a YAC libraryis shown in FIG. 10. The first part of the figure shows yeast containingan endogenous diploid genome and a YAC library of fragments representingvariants of a sequence. The library is transformed into the cells toyield 100-1000 colonies per μgDNA. Most transformed yeast cells nowharbor a single YAC as well as endogenous chromosomes. Meiosis isinduced by growth on nitrogen and carbon limiting medium. In the courseof meiosis the YACs recombine with other chromosomes in the same cell.Haploid spores resulting from meiosis mate and regenerated diploidforms. The diploid forms now harbor recombinant chromosomes, parts ofwhich come from endogenous chromosomes and parts from YACs. Optionally,the YACs can now be cured from the cells by selecting against a negativeselection marker present on the YACS. Irrespective whether YACS areselected against, cells are then screened or selected for a desiredproperty. Cells surviving selection/screening are transformed withanother YAC library to start another shuffling cycle.

b. Method of Evolving YACs for Transfer to Recipient Strain

These methods are based in part on the fact that multiple YACs can beharbored in the same yeast cell, and YAC—YAC recombination is known tooccur (Green & Olson, Science 250, 94-98 1990)). Inter-YAC recombinationprovides a format for which families of homologous genes harbored onfragments of >20 kb can be shuffled in vivo.

The starting population of DNA fragments show sequence similarity witheach other but differ as a result of for example, induced, allelic orspecies diversity. Often DNA fragments are known or suspected to encodemultiple genes that function in a common pathway.

The fragments are cloned into a Yac and transformed into yeast,typically with positive selection for transformants. The transformantsare induced to sporulate, as a result of which chromosomes undergomeiosis. The cells are then mated. Most of the resulting diploid cellsnow carry two YACs each having a different insert. These are againinduced to sporulate and mated. The resulting cells harbor YACs ofrecombined sequence. The cells can then be screened or selected for adesired property. Typically, such selection occurs in the yeast strainused for shuffling. However, if fragments being shuffled are notexpressed in yeast, YACs can be isolated and transferred to anappropriate cell type in which they are expressed for screening.Examples of such properties include the synthesis or degradation of adesired compound, increased secretion of a desired gene product, orother detectable phenotype.

Cells surviving selection/screening are subjected to successive cyclesof pooling, sporulation, mating and selection/screening until thedesired phenotype has been observed. Recombination can be achievedsimply by transferring cells from rich medium to carbon and nitrogenlimited medium to induce sporulation, and then returning the spores torich media to induce mating. Asci can be lysed to stimulate mating ofspores originating from different asci.

After YACs have been evolved to encode a desired property they can betransferred to other cell types. Transfer can be by protoplast fusion,or retransformation with isolated DNA. For example, transfer of YACsfrom yeast to mammalian cells is discussed by Monaco & Larin, Trends inBiotechnology 12, 280-286 (1994); Montoliu et al., Reprod. Fertil. Dev.6, 577-84 (1994); Lamb et al., Curr. Opin. Genet. Dev. 5, 342-8 (1995).

An exemplary scheme for shuffling a YAC fragment library in yeast isshown in FIG. 11. A library of YAC fragments representing geneticvariants are transformed into yeast that have diploid endogenouschromosomes. The transformed yeast continue to have diploid endogenouschromosomes, plus a single YAC. The yeast are induced to undergo meiosisand sporulate. The spores contain haploid genomes, some of which containonly endogenous yeast chromosomes, and some of which contain yeastchromosomes plus a YAC. The spores are induced to mate generatingdiploid cells. Some of the diploid cells now contain two YAC bearingdifferent inserts as well as diploid endogenous chromosomes. The cellsare again induced to undergo meiosis and sporulate. In cells bearing twoYACs, recombination occurs between the inserts, and recombinant YACs aresegregated to ascoytes. Some ascoytes thus contain haploid endogenouschromosomes plus a YAC chromosome with a recombinant insert. Theascoytes mature to spores, which can mate again generating diploidcells. Some diploid cells now possess a diploid complement of endogenouschromosomes plus two recombinant YACs. These cells can then be takenthrough further cycles of meiosis, sporulation and mating. In eachcycle, further recombination occurs between YAC inserts and furtherrecombinant forms of inserts are generated. After one or several cyclesof recombination has occurred, cells can be tested for acquisition of adesired property. Further cycles of recombination, followed byselection, can then be performed in similar fashion.

c. Use of YACs to Clone Unlinked Genes

Shuffling of YACs is particularly amenable to transfer of unlinked butfunctionally related genes from one species to another, particularlywhere such genes have not been identified. Such is the case for severalcommercially important natural products, such as taxol. Transfer of thegenes in the metabolic pathway to a different organism is oftendesirable because organisms naturally producing such compounds are notwell suited for mass culturing.

Clusters of such genes can be isolated by cloning a total genomiclibrary of DNA from an organisms producing a useful compound into a YAClibrary. The YAC library is then transformed into yeast. The yeast issporulated and mated such that recombination occurs between YACs and/orbetween YACs and natural yeast chromosomes. Selection/screening is thenperformed for expression of the desired collection of genes. If thegenes encode a biosynthetic pathway, expression can be detected from theappearance of product of the pathway. Production of individual enzymesin the pathway, or intermediates of the final expression product orcapacity of cells to metabolize such intermediates indicates partialacquisition of the synthetic pathway. The original library or adifferent library can be introduced into cells surviving/selectionscreening, and further rounds of recombination and selection/screeningcan be performed until the end product of the desired metabolic pathwayis produced.

7. Conjugation-Mediated Genetic Exchange

Conjugation can be employed in the evolution of cell genomes in severalways. Conjugative transfer of DNA occurs during contact between cells.See Guiney (1993) in: Bacterial Conjugation (Clewell, ed., Plenum Press,New York), pp. 75-104; Reimmann & Haas in Bacterial Conjugation(Clewell, ed., Plenum Press, New York 1993), at pp. 137-188(incorporated by reference in their entirety for all purposes).Conjugation occurs between many types of gram negative bacteria, andsome types of gram positive bacteria. Conjugative transfer is also knownbetween bacteria and plant cells (Agrobacterium tumefaciens) or yeast.As discussed in copending application attorney docket no. 16528J-014612,the genes responsible for conjugative transfer can themselves be evolvedto expand the range of cell types (e.g., from bacteria to mammals)between which such transfer can occur.

Conjugative transfer is effected by an origin of transfer (oriT) andflanking genes (MOB A, B and C), and 15-25 genes, termed tra, encodingthe structures and enzymes necessary for conjugation to occur. Thetransfer origin is defined as the site required in cis for DNA transfer.Tra genes include tra A, B, C, D, E, F, G, H, I, J, K, L, M, N, P, Q, R,S, T, U, V, W, X, Y, Z, vir AB (alleles 1-11), C, D, E, G, IHF, andFinOP. Tra genes can be expressed in cis or trans to oriT. Othercellular enzymes, including those of the RecBCD pathway, RecA, SSBprotein, DNA gyrase, DNA poll, and DNA ligase, are also involved inconjugative transfer. RecE or recF pathways can substitute for RecBCD.

One structural protein encoded by a tra gene is the sex pilus, afilament constructed of an aggregate of a single polypeptide protrudingfrom the cell surface. The sex pilus binds to a polysaccharide onrecipient cells and forms a conjugative bridge through which DNA cantransfer. This process activates a site-specific nuclease encoded by aMOB gene, which specifically cleaves DNA to be transferred at oriT. Thecleaved DNA is then threaded through the conjugation bridge by theaction of other tra enzymes.

Mobilizable vectors can exist in episomal form or integrated into thechromosome. Episomal mobilizable vectors can be used to exchangefragments inserted into the vectors between cells. Integratedmobilizable vectors can be used to mobilize adjacent genes from thechromosome.

a. Use of Integrated Mobilizable Vectors to Promote Exchange of

Genomic DNA

The F plasmid of E. coli integrates into the chromosome at highfrequency and mobilizes genes unidirectional from the site ofintegration (Clewell, 1993, supra; Firth et al., in Escherichia coli andSalmonella Cellular and Molecular Biology 2, 2377-2401 (1996); Frost etal., Microbiol. Rev. 58, 162-210 (1994)). Other mobilizable vectors donot spontaneously integrate into a host chromosome at high efficiencybut can be induced to do by growth under particular conditions (e.g.,treatment with a mutagenic agent, growth at a nonpermissive temperaturefor plasmid replication). See Reimann & Haas in Bacterial Conjugation(ed. Clewell, Plenum Press, NY 1993), Ch. 6. Of particular interest isthe IncP group of conjugal plasmids which are typified by their broadhost range (Clewell, 1993, supra.

Donor “male” bacteria which bear a chromosomal insertion of a conjugalplasmid, such as the E. coli F factor can efficiently donate chromosomalDNA to recipient “female” enteric bacteria which lack F (F−). Conjugaltransfer from donor to recipient is initiated at oriT. Transfer of thenicked single strand to the recipient occurs in a 5′ to 3′ direction bya rolling circle mechanisms which allows mobilization of tandemchromosomal copies. Upon entering the recipient, the donor strand isdiscontinuously replicated. The linear, single-stranded donor DNA strandis a potent substrate for initiation of recA-mediated homologousrecombination within the recipient. Recombination between the donorstrand and recipient chromosomes can result in the inheritance of donortraits. Accordingly, strains which bear a chromosomal copy of F aredesignated Hfr (for high frequency of recombination) (Low, 1996 inEscherichia coli and Salmonella Cellular and Molecular Biology Vol. 2,pp. 2402-2405; Sanderson, in Escherichia coli and Salmonella Cellularand Molecular Biology 2, 2406-2412 (1996)).

The ability of strains with integrated mobilizable vector to transferchromosomal DNA provides a rapid and efficient means of exchanginggenetic material between a population of bacteria thereby allowingcombination of positive mutations and dilution of negative mutations.Such shuffling methods typically start with a population of strains withan integrated mobilizable vector encompassing at least some geneticdiversity. The genetic diversity can be the result of natural variation,exposure to a mutagenic agent or introduction of a fragment library. Thepopulation of cells is cultured without selection to allow geneticexchange, recombination and expression of recombinant genes. The cellsare then screened or selected for a evolution toward a desired property.The population surviving selection/screening can then be subject to afurther round of shuffling by HFR-mediated genetic exchange orotherwise.

The natural efficiency of Hfr and other strains with integrated mobvectors as recipients of conjugal transfer can be improved by severalmeans. The relatively low recipient efficiency of natural HFR strains isattributable to the products of traS and traT genes of F (Clewell, 1993,supra; Firth et al., 1996, supra; Frost et al., 1994, supra; Achtman etal., J. Mol. Biol. 138, 779-795 (1980). These products are localized tothe inner and outer membranes of F+ strains, respectively, where theyserve to inhibit redundant matings between two strains which are bothcapable of donating DNA. The effects of traS and traT, and cognate genesin other conjugal plasmids, can be eliminated by use of knockout cellsincapable of expressing these enzymes or reduced by propagating cells ona carbon-limited source. (Peters et al., J. Bacteriol., 178, 3037-3043(1996)).

In some methods, the starting population of cells has a mobilizablevector integrated at different genomic sites. Directional transfer fromoriT typically results in more frequent inheritance of traits proximalto oriT. This is because mating pairs are fragile and tend to dissociate(particularly when in liquid medium) resulting in the interruption oftransfer. In a population of cells having a mobilizable vectorintegrated at different sites chromosomal exchange occurs in a morerandom fashion. Kits of Hfr strains are available from the E. coli.Genetic Stock Center and the Salmonella Genetic Stock Centre (Frost etal., 1994, supra). Alternatively, a library of strains with oriT atrandom sites and orientations can be produced by insertion mutagenesisusing a transposon which bears oriT. The use of a transposon bearing anoriT [e.g., the Tn5-oriT described by Yakobson E A, et al. J. Bacteriol.1984 October; 160(1): 451-453] provides a quick method of generatingsuch a library. Transfer functions for mobilization from thetransposon-borne oriT sites are provided by a helper vector. It ispossible to generate similar genetic constructs using other sequencesknown to one of skill as well.

In one aspect, a recursive scheme for genomic shuffling using Tn-oriTelements is provided. A prototrophic bacterial strain or set of relatedstrains bearing a conjugal plasmid, such as the F fertility factor or amember of the IncP group of broad host range plasmids is mutagenized andscreened for the desired properties. Individuals with the desiredproperties are mutagenized with a Tn-oriT element and screened foracquisition of an auxotrophy (e.g., by replica-plating to a minimal andcomplete media) resulting from insertion of the Tn-oriT element in anyone of many biosynthetic gene scattered across the genome. The resultingauxotrophs are pooled and allowed to mate under conditions promotingmale-to-male matings, e.g., during growth in close proximity on a filtermembrane. Note that transfer functions are provided by the helperconjugal plasmid present in the original strain set. Recombinanttransconjugants are selected on minimal medium and screened for furtherimprovement.

Optionally, strains bearing integrated mobilizable vectors are defectivein mismatch repair gene(s). Inheritance of donor traits which arise fromsequence heterologies increases in strains lacking the methyl-directedmismatch repair system. Optionally, the gene products which decreaserecombination efficiency can be inhibited by small molecules.

Intergenic congual transfer between species such as E. coli andSalmonella typhimurium, which are 20% divergent at the DNA level, isalso possible if the recipient strain is mutH, mutL or mutS (seeRayssiguier et al., Nature 342, 396-401 (1989)). Such transfer can beused to obtain recombination at several points as shown by the followingexample.

The example uses an S. typhimurium Hfr donor strain having markersthr557 at map position 0, pyrF2690 at 33 min, serA13 at 62 min and hfrK5at 43 min. MutS +/−, F− E. coli recipient strains had markers pyrD68 at21 min aroC355 at 51 min, ilv3164 at 85 min and mutS215 at 59 min. Thetriauxotrophic S. typhimurium Hfr donor and isogenicmutS+/−triauxotrophic E. coli recipient were inoculated into 3 ml of Lbbroth and shaken at 37° C. until fully grown. 100 μl of the donor andeach recipient were mixed in 10 ml fresh LB broth, and then deposited toa sterile Millipore 0.45 μM HA filter using a Nalgene 250 ml reusablefiltration device. The donor and recipients alone were similarly dilutedand deposited to check for reversion. The filters with cells were placedcell-side-up on the surface of an LB agar plate which was incubatedovernight at 37° C. The filters were removed with the aid of a sterileforceps and placed in a sterile 50 ml tube containing 5 ml of minimalsalts broth. Vigorous vortexing was used to wash the cells from thefilters. 100 μl of mating mixtures, as well as donor and recipientcontrols were spread to LB for viable cell counts and minimal glucosesupplemented with either two of the three recipient requirements forsingle recombinant counts, one of the three requirements for doublerecombinant counts, or none of the three requirements for triplerecombinant counts. The plates were incubated for 48 hr at 37° afterwhich colones were counted.

Recombinant CFUs/ Medium Recombinant Total CFUs Supplements GenotypemutS⁺ mutS⁻ mutS⁻/mutS⁺ Aro + Iiv pyr⁺ aro⁻ ilv⁻ — — — Aro + Ura pyr⁻aro⁻ ilv⁺ 1.2 × 10⁻⁸ 2.5 × 10⁻⁶ 208 Ilv + Ura pyr⁻ aro⁺ ilv⁻ 2.7 × 10⁻⁸3.0 × 10⁻⁶ 111 Aro pyr⁺ aro⁻ ilv⁺ — — — Ilv pyr⁺ aro⁺ ilv⁻ — — — Urapyr⁻ aro⁺ ilv⁺ <10⁻⁹ <10⁻⁹ nothing pyr⁺ aro⁺ ilv⁺ Aro = aromatic aminoacids and vitamins Ilv = branched chain amino acids Ura = uracil

The data indicate that recombinants can be generated at reasonablefrequenceis using Hfr matings. Intergeneric recombination is enhanced100-200 fold in a recipient that is defective methyl-directed mismatchrepair.

b. Introduction of Fragments by Conjugation

Mobilizable vectors can also be used to transfer fragment libraries intocells to be evolved. This approach is particularly useful in situationsin which the cells to be evolved cannot be efficiently transformeddirectly with the fragment library but can undergo conjugation withprimary cells that can be transformed with the fragment library.

DNA fragments to be introduced into host cells encompasses diversityrelative to the host cell genome. The diversity can be the result ofnatural diversity or mutagenesis. The DNA fragment library is clonedinto a mobilizable vector having an origin of transfer. Some suchvectors also contain mob genes although alternatively these functionscan also be provided in trans. The vector should be capable of efficientconjugal transfer between primary cells and the intended host cells. Thevector should also confer a selectable phenotype. This phenotype can bethe same as the phenotype being evolved or can be conferred by a marker,such as a drug resistance marker. The vector should preferably allowself-elimination in the intended host cells thereby allowing selectionfor cells in which a cloned fragment has undergone genetic exchange witha host homologous host segment rather than duplication. Such can beachieved by use of vector lacking an origin of replication functional inthe intended host type or inclusion of a negative selection marker inthe vector.

One suitable vector is the broad host range conjugation plasmiddescribed by Simon et al., Bio/Technology 1, 784-791 (1983); TrieuCuotet al., Gene 102, 99-104 (1991); Bierman et al., Gene 116, 43-49 (1992).These plasmids can be transformed into E. coli and then force-mated intobacteria that are difficult or impossible to transform by chemical orelectrical induction of competence. These plasmids contain the origin ofthe IncP plasmid, oriT. Mobilization functions are supplied in trans bychromosomally-integrated copies of the necessary genes. Conjugaltransfer of DNA can in some cases be assisted by treatment of therecipient (if gram-positive) with sub-inhibitory concentrations ofpenicillins (Trieu-Cuot et al., 1993 FEMS Microbiol. Lett. 109, 19-23).

Cells that have undergone allelic exchange with library fragments can bescreened or selected for evolution toward a desired phenotype.Subsequent rounds of recombination can be performed by repeating theconjugal transfer step. the library of fragments can be fresh or can beobtained from some (but not all) of the cells surviving a previous roundof selection/screening. Conjugation-mediated shuffling can be combinedwith other methods of shuffling.

8. Genetic Exchange Promoted by Transducing Phage

Transduction is the transfer, from one cell to another, of nonviralgenetic material within a viral coat (Masters, in Escherichia coli andSalmonella Cellular and Molecular Biology 2, 2421-2442 (1996). Perhapsthe two best examples of generalized transducing phage arebacteriophages P1 and P22 of E. coli and S. typhimurium, respectively.Generalized transducing bacteriophage particles are formed at a lowfrequency during lytic infection when viral-genome-sized,doubled-stranded fragments of host (which serves as donor) chromosomalDNA are packaged into phage heads. Promiscuous high transducing (HT)mutants of bacteriophage P22 which efficiently package DNA with littlesequence specificity have been isolated. Infection of a susceptible hostresults in a lysate in which up to 50% of the phage are transducingparticles. Adsorption of the generalized transducing particle to asusceptible recipient cell results in the injection of the donorchromosomal fragment. RecA-mediated homologous recombination followinginjection of the donor fragment can result in the inheritance of donortraits. Another type of phage which achieves quasi random insertion ofDNA into the host chromosome is Mu. For an overview of Mu biology, see,Groisman (1991) in Methods in Enzymology v. 204. Mu can generate avariety of chromosomal rearrangements including deletions, inversions,duplications and transpositions. In addition, elements which combine thefeatures of P22 and Mu are available, including Mud-P22, which containsthe ends of the Mu genome in place of the P22 att site and int gene.See, Berg, supra.

Generalized transducing phage can be used to exchange genetic materialbetween a population of cells encompassing genetic diversity andsusceptible to infection by the phage. Genetic diversity can be theresult of natural variation between cells, induced mutation of cells orthe introduction of fragment libraries into cells. DNA is then exchangedbetween cells by generalized transduction. If the phage does not causelysis of cells, the entire population of cells can be propagated in thepresence of phage. If the phage results in lytic infection, transductionis performed on a split pool basis. That is, the starting population ofcells is divided into two. One subpopulation is used to preparetransducing phage. The transducing phage are then infected into theother subpopulation. Preferably, infection is performed at highmultiplicity of phage per cell so that few cells remain uninfected.Cells surviving infection are propagated and screened or selected forevolution toward a desired property. The pool of cells survivingscreening/selection can then be shuffled by a further round ofgeneralized transduction or by other shuffling methods.

The efficiency of the above methods can be increased by reducinginfection of cells by infectious (nontransducing phage) and by reducinglysogen formation. The former can be achieved by inclusion of chelatorsof divalent cations, such as citrate and EGTA in culture media. Taildefective transducing phages can be used to allow only a single round ofinfection. Divalent cations are required for phage absorption and theinclusion of chelating agents therefore provides a means of preventingunwanted infection. Integration defective (int⁻) derivatives ofgeneralized transducing phage can be used to prevent lysogen formation.In a further variation, host cells with defects in mismatch repairgene(s) can be used to increase recombination between transduced DNA andgenomic DNA.

9. Use of Locked in Prophages to Facilitate DNA Shuffling

The use of a hybrid, mobile genetic element (locked-in prophages) as ameans to facilitate whole genome shuffling of organisms using phagetransduction as a means to transfer DNA from donor to recipient is apreferred embodiment. One such element (Mud-P22) based on the temperateSalmonella phage P22 has been described for use in genetic and physicalmapping of mutations. See, Youderian et al. (1988) Genetics 118:581-592,and Benson and Goldman (1992) J. Bacteriol. 174(5):1673-1681. IndividualMud-P22 insertions package specific regions of the Salmonella chromosomeinto phage P22 particles. Libraries of random Mud-P22 insertions can bereadily isolated and induced to create pools of phage particlespackaging random chromosomal DNA fragments. These phage particles can beused to infect new cells and transfer the DNA from the host into therecipient in the process of transduction. Alternatively, the packagedchromosomal DNA can be isolated and manipulated further by techniquessuch as DNA shuffling or any other mutagenesis technique prior to beingreintroduced into cells (especially recD cells for linear DNA) bytransformation or electroporation, where they integrate into thechromosome.

Either the intact transducing phage particles or isolated DNA can besubjected to a variety of mutagens prior to reintroduction into cells toenhance the mutation rate. Mutator cell lines such as mutD can also beused for phage growth. Either method can be used recursively in aprocess to create genes or strains with desired properties. E. colicells carrying a cosmid clone of Salmonella LPS genes are infectable byP22 phage. It is possible to develop similar genetic elements usingother combinations of transposable elements and bacteriophages orviruses as well.

P22 is a lambdoid phage that packages its DNA into preassembled phageparticles (heads) by a “headful” mechanism. Packaging of phage DNA isinitiated at a specific site (pac) and proceeds unidirectionally along alinear, double stranded normally concatameric molecule. When the phagehead is full (˜43 kb), the DNA strand is cleaved, and packaging of thenext phage head is initiated. Locked-in or excision-defective P22prophages, however, initiate packaging at their pac site, and thenproceed unidirectionally along the chromosome, packaging successiveheadfuls of chromosomal DNA (rather than phage DNA). When thesetransducing phages infect new Salmonella cells they inject thechromosomal DNA from the original host into the recipient cell, where itcan recombine into the chromosome by homologous recombination creating achimeric chromosome. Upon infection of recipient cells at a highmultiplicity of infection, recombination can also occur between incomingtransducing fragments prior to recombination into the chromosome.

Integration of such locked-in P22 prophages at various sites in thechromosome allows flanking regions to be amplified and packaged intophage particles. The Mud-P22 mobile genetic element contains anexcision-defective P22 prophage flanked by the ends of phage/transposonMu. The entire Mud-P22 element can transpose to virtually any locationin the chromosome or other episome (eg. F′, BAC clone) when the Mu A andB proteins are provided in trans.

A number of embodiments for this type of genetic element are available.In one example, the locked in prophage are used as generalizedtransducing phage to transfer random fragments of a donor chromosomeinto a recipient. The Mud-P22 element acts as a transposon when Mu A andB transposase proteins are provided in trans and integrate copies ofitself at random locations in the chromosome. In this way, a library ofrandom chromosomal Mud-P22 insertions can be generated in a suitablehost. When the Mud-P22 prophages in this library are induced, randomfragments of chromosomal DNA will be packaged into phage particles. Whenthese phages infect recipient cells, the chromosomal DNA is injected andcan recombine into the chromosome of the recipient. These recipientcells are screened for a desired property and cells showing improvementare then propagated. The process can be repeated, since the Mud-P22genetic element is not transferred to the recipient in this process.Infection at a high multiplicity allows for multiple chromosomalfragments to be injected and recombined into the recipient chromosome.

Locked-in prophages can also be used as specialized transducing phage.Individual insertions near a gene of interest can be isolated from arandom insertion library by a variety of methods. Induction of thesespecific prophages results in packaging of flanking chromosomal DNAincluding the gene(s) of interest into phage particles. Infection ofrecipient cells with these phages and recombination of the packaged DNAinto the chromosome creates chimeric genes that can be screened fordesired properties. Infection at a high multiplicity of infection canallow recombination between incoming transducing fragments prior torecombination into the chromosome.

These specialized transducing phage can also be used to isolate largequantities of high quality DNA containing specific genes of interestwithout any prior knowledge of the DNA sequence. Cloning of specificgenes is not required. Insertion of such an element nearby abiosynthetic operon for example allows for large amounts of DNA fromthat operon to be isolated for use in DNA shuffling (in vitro and/or invivo), cloning, sequencing, or other uses as set forth herein. DNAisolated from similar insertions in other organisms containinghomologous operons are optionally mixed for use in family shufflingformats as described herein, in which homologous genes from differentorgansims (or different chromosomal locations within a single species,or both).

Phage isolated from insertions in a variety of strains or organismscontaining homologous operons are optionally mixed and used to coinfectcells at a high MOI allowing for recombination between incomingtransducing fragments prior to recombination into the chromosome.

Locked in prophage are useful for mapping of genes, operons, and/orspecific mutations with either desirable or undesirable phenotypes.Locked-in prophages can also provide a means to separate and mapmultiple mutations in a given host. If one is looking for beneficialmutations outside a gene or operon of interest, then an unmodified geneor operon can be transduced into a mutagenized or shuffled host thenscreened for the presence of desired secondary mutations. Alternatively,the gene/operon of interest can be readily moved from amutagenized/shuffled host into a different background to screen/selectfor modifications in the gene/operon itself.

It is also possible to develop similar genetic elements using othercombinations of transposable elements and bacteriophages or viruses aswell. Similar systems are set up in other organisms, e.g., that do notallow replication of P22 or P1. Broad host range phages and transposableelements are especially useful. Similar genetic elements are derivedfrom other temperate phages that also package by a headful mechanism. Ingeneral, these are the phages that are capable of generalizedtransduction. Viruses infecting eukaryotic cells may be adapted forsimilar purposes. Examples of generalized transducing phages that areuseful are described in: Green et al., “Isolation and preliminarycharacterization of lytic and lysogenic phages with wide host rangewithin the streptomycetes”, J. Gen Microbiol 131(9):2459-2465 (1985);Studdard et al., “Genome structure in Streptomyces spp.: adjacent geneson the S. coelicolor A3(2) linkage map have cotransducible analogs in S.venezuelae”, J. Bacteriol 169(8):3814-3816 (1987); Wang et al., “Highfrequency generalized transduction by miniMu plasmid phage”, Genetics116(2):201-206, (1987); Welker, N. E., “Transduction in Bacillusstearothermophilus”, J. Bacteriol, 176(11):3354-3359, (1988); Darzins etal., “Mini-D3112 bacteriophage transposable elements for geneticanalysis of Pseudomonas aeruginosa, J. Bacteriol 171(7):3909-3916(1989); Hugouvieux-Cotte-Pattat et al., “Expanded linkage map of Erwiniachrysanthemi strain 3937”, Mol Microbiol 3(5):573-581, (1989); Ichige etal., “Establishment of gene transfer systems for and construction of thegenetic map of a marine Vibrio strain”, J. Bacteriol 171(4):1825-1834(1989); Muramatsu et al., “Two generalized transducing phages in Vibrioparahaemolyticus and Vibrio alginolyticus”, Microbiol Immunol35(12):1073-1084 (1991); Regue et al., “A generalized transducingbacteriophage for Serratia marcescens”, Res Microbiol 42(1):23-27,(1991); Kiesel et al., “Phage Acm1-mediated transduction in thefacultatively methanol-utilizing Acetobacter methanolicus MB 58/4”, J.Gen Virol 74(9):1741-1745 (1993); Blahova et al., “Transduction ofimipenem resistance by the phage F-116 from a nosocomial strain ofPseudomonas aeruginosa isolated in Slovakia”, Acta Virol 38(5):247-250(1994); Kidambi et al., “Evidence for phage-mediated gene transfer amongPseudomonas aeruginosa strains on the phylloplane”, Appl EnvironMicrobiol 60:(2)496-500 (1994); Weiss et al., “Isolation andcharacterization of a generalized transducing phage for Xanthomonascampestris pv. campestris”, J. Bacteriol 176(11):3354-3359 (1994);Matsumoto et al., “Clustering of the trp genes in Burkholderia (formerlyPseudomonas) cepacia”, FEMS Microbiol Lett 134(2-3):265-271 (1995);Schicklmaier et al., “Frequency of generalized transducing phages innatura isolates of the Salmonella typhimurium complex”, Appl EnvironMicrobiol 61(4): 61(4):1637-1640 (1995); Humphrey et al., “Purificationand characterization of VSH-1, a generalized transducing bacteriophaseof Serpulina hyodysenteriae”, J Bacteriol 179(2):323-329 (1997); Williet al., “Transduction of antibiotic resistance markers amongActinobacillus actinomycetemcomitans strains by temperate bacteripphagesAa phi 23”, Cell Mol Life Sci 53(11-12):904-910 (1997); Jensen et al.,“Prevalence of broad-host-range lytic bacteriophages of Sphaerotilusnatans, Escherichia coli, and Pseudomonas aeruginosa”, Appl EnvironMicrobiol 64(2):575-580 (1998), and Nedelmann et al., “Generalizedtransduction for genetic linkage analysis and transfer of transposoninsertions in different Staphylococcus epidermidis strains”,Zentiviralalbl Bakteriol 287(1-2):85-92 (1998).

A Mud-P1/Tn-P1 system comparable to Mud-P22 is developed using phage P1.Phage P1 has an advantage of packaging much larger (˜110 kb) fragmentsper headful. Phage P1 is currently used to create bacterial artificialchromosomes or BAC's. P1-based BAC vectors are designed along theseprinciples so that cloned DNA is packaged into phage particles, ratherthan the current system, which requires DNA preparation from single-copyepisomes. This combines the advantages of both systems in having thegenes cloned in a stable single-copy format, whilst allowing foramplification and specific packaging of cloned DNA upon induction of theprophage.

10. Random Placement of Genes or Improved Genes Throughout the Genomefor Optimization of Gene Context

The placement and orientation of genes in a host chromosome (the“context” of the gene in a chromosome) or episome has large effects ongene expression and activity. Random integration of plasmid or otherepisomal sequences into a host chromosome by non-homologousrecombination, followed by selection or screening for the desiredphenotype, is a preferred way of identifing optimal chromosomalpositions for expression of a target. This strategy is illustrated inFIG. 18.

A variety of transposon mediated delivery systems can be employed todeliver genes of interest, either individual genes, genomic libraries,or a library of shuffled gene(s) randomly throughout the genome of ahost. Thus, in one preferred embodiment, the improvement of a cellularfunction is achieved by cloning a gene of interest, for example a geneencoding a desired metabolic pathway, within a transposon deliveryvehicle.

Such transposon vehicles are available for both Gram-negative andGram-positive bacteria. De Lorenzo and Timis (1994) Methods inEnzymology 235:385-404 describe the analysis and construction of stablephenotypes in gram-negative Bacteria with Tn5- and Tn 10-derivedminitransposons. Kleckner et al. (1991) Methods in Enzymology 204,chapter 7 describe uses of transposons such as Tn10, including for usein gram positive bacteria. Petit et al. (1990) Journal of Bacteriology172(12):6736-6740 describe Tn10 derived transposons active in BacillusSubtilis. The transposon delivery vehicle is introduced into a cellpopulation, which is then selected for recombinant cells that haveincorporated the transposon into the genome.

The selection is typically by any of a variety of drug resistant markersalso carried within the transposon. The selected subpopulation isscreened for cells having improved expression of the gene(s) ofinterest. Once cells harboring the genes of interest in the optimallocation are isolated, the genes are amplified from within the genomeusing PCR, shuffled, and cloned back into a similar transposon deliveryvehicle which contains a different selection marker within thetransposon and lacks the transposon integrase gene.

This shuffled library is then transformed back into the strain harboringthe original transposon, and the cells are selected for the presence ofthe new resistance marker and the loss of the previous selection marker.Selected cells are enriched for those that have exchanged by homologousrecombination the original transposon for the new transposon carryingmembers of the shuffled library. The surviving cells are then screenedfor further improvements in the expression of the desired phenotype. Thegenes from the improved cells are then amplified by the PCR and shuffledagain. This process is carried out recursively, oscillating each cyclebetween the different selection markers. Once the gene(s) of interestare optimized to a desired level, the fragment can be amplified andagain randomly distributed throughout the genome as described above toidentify the optimal location of the improved genes.

Alternatively, the gene(s) conferring a desired property may not beknown. In this case the DNA fragments cloned within the transposondelivery vehicle could be a library of genomic fragments originatingfrom a population of cells derived from one or more strains having thedesired property(ies). The library is delivered to a population of cellsderived from one or more strains having or lacking the desiredproperty(ies) and cells incorporating the transposon are selected. Thesurviving cells are then screened for acquisition or improvement of thedesired property. The fragments contained within the surviving cells areamplified by PCR and then cloned as a pool into a similar transposondelivery vector harboring a different selection marker from the firstdelivery vector. This library is then delivered to the pool of survivingcells, and the population having acquired the new selective marker isselected. The selected cells are then screened for further acquisitionor improvement of the desired property. In this way the differentpossible combinations of genes conferring or improving a desiredphenotype are explored in a combinatorial fashion. This process iscarried out repetitively with each new cycle employing an additionalselection marker.

Alternatively, the amplified fragments from each improved cell areshuffled independently. The shuffled libraries are then cloned back intoa transposon delivery vehicle similar to the original vector butcontaining a different selection marker and lacking the transposasegene. Selection is then for acquisition of the new marker and loss ofthe previous marker. Selected cells are enriched for those incorporatingthe shuffled variants of the amplified genes by homologousrecombination. This process is carried out recursively, oscillating eachcycle between the two selective markers.

11. Improvement of Overexpressed Genes for a Desired Phenotype

The improvement of a cellular property or phenotype is often enhanced byincreasing the copy number or expression of gene(s) participating in theexpression of that property. Genes that have such an effect on a desiredproperty can also be improved by DNA shuffling to have a similar effect.A genomic DNA library is cloned into an overexpression vector andtransformed into a target cell population such that the genomicfragments are highly expressed in cells selected for the presence of theoverexpression vector. The selected cells are then screened forimprovement of a desired property. The overexpression vector from theimproved cells are isolated and the cloned genomic fragments shuffled.The genomic fragment carried in the vector from each improved isolate isshuffled independently or with identified homologous genes (familyshuffling). The shuffled libraries are then delivered back to apopulation of cells and the selected transformants rescreened forfurther improvements in the desired property. This shuffling/screeningprocess is cycled recursively until the desired property has beenoptimized to the desired level.

As stated above, gene dosage can greatly enhance a desired cellularproperty. One method of increasing gene copy number of unknown genes isusing a method of random amplification (see also, Mavingui et. al.(1997) Nature Biotech, 15, 564). In this method, a genomic library iscloned into a suicide vector containing a selective marker that also athigher dosage provides an enhanced phenotype. An example of such amarker is the kanamycin resistance gene. At successively higher copynumber, resistance to successively higher levels of kanamycin isachieved. The genomic library is delivered to a target cell by any of avariety of methods including transformation, transduction, conjugation,etc. Cells that have incorporated the vector into the chromosome byhomologous recombination between the vector and chromosomal copies ofthe cloned genes can be selected by requiring expression of theselection marker under conditions where the vector does not replicate.This recombination event results in the duplication of the cloned DNAfragment in the host chromosome with a copy of the vector and selectionmarker separating the two copies. The population of surviving cells arescreened for improvement of a desired cellular property resulting formthe gene duplication event. Further gene duplication events resulting inadditional copies of the original cloned DNA fragments can be generatedby further propagating the cells under successively more stringentselective conditions i.e. increased concentrations of kanamycin. In thiscase selection requires increased copies of the selective marker, butincreased copies of the desired gene fragment is also concomitant.Surviving cells are further screened for an improvement in the desiredphenotype. The resulting population of cells likely resulted in theamplification of different genes since often many genes effect a givenphenotype. To generate a library of the possible combinations of thesegenes, the original selected library showing phenotypic improvements arerecombined, using the methods described herein, e.g., protoplast fusion,split pool transduction, transformation, conjugation, etc.

The recombined cells are selected for increased expression of theselective marker. Survivors are enriched for cells having incorporatedadditional copies of the vector sequence by homologous recombination,and these cells will be enriched for those having combined duplicationsof different genes. In other words, the duplication from one cell ofenhanced phenotype becomes combined with the duplication of another cellof enhanced phenotype. These survivors are screened for furtherimprovements in the desired phenotype. This procedure is repeatedrecursively until the desired level of phenotypic expression isachieved.

Alternatively, genes that have been identified or are suspected as beingbeneficial in increased copy number are cloned in tandem intoappropriate plasmid vectors. These vectors are then transformed andpropagated in an appropriate host organism. Plasmid-plasmidrecombination between the cloned gene fragments result in furtherduplication of the genes. Resoultion of the plasmid doublet can resultin the uneven distribution of the gene copies, with some plasmids havingadditional gene copies and others having fewer gene copies. Cellscarrying this distribution of plasmids are then screened for animprovement in the phenotype effected by the gene duplications.

In summary, a method of selecting for increased copy number of a nucleicacid sequence by the above procedure is provided. In the method, agenomic library in a suicide vector comprising a dose-sensitiveselectable marker is provided, as noted above. The genomic library istransduced into a population of target cells. The target cells areselected in a population of target cells for increasing doses of theselectable marker under conditions in which the suicide vector does notreplicate episomally. A plurality of target cells are selected for thedesired phenotype, recombined and reselected. The process is recursivelyrepeated, if desired, until the desired phenotype is obtained.

12. Strategies for Improving Genomic Shuffling via Transformation ofLinear DNA Fragments

Wild-type members of the Enterobacteriaceae (e.g. Escherichia coli) aretypically resistant to genetic exchange following transformation oflinear DNA molecules. This is due, at least in part, to the ExonucleaseV (Exo V) activity of the RecBCD holoenzyme which rapidly degradeslinear DNA molecules following transformation. Production of Exo V hasbeen traced to the recD gene, which encodes the D subunit of theholoenzyme. As demonstrated by Russel et al. (1989) Journal ofBacteriology 2609-2613, homologous recombination between a transformedlinear donor DNA molecule and the chromosome of recipient is readilydetected in a strains bearing a loss of function mutation in recDmutant. The use of recD strains provides a simple means for genomicshuffling of the Enterobacteriaceae. For example, a bacterial strain orset of related strains bearing a recD null mutation (e.g., the E. colirecD1903::mini-Tet allele) is mutagenized and screened for the desiredproperties. In a split-pool fashion, Chromosomal DNA prepared on onealiquot could be used to transform (e.g., via electroporation orchemically induce competence) the second aliquot. The reslutingtransformants are then screened for improvement.

The RecBCD holoezyme plays an important role in initiation ofRecA-dependent homologous recombination. Upon recognizing a dsDNA end,the RecBCD enzyme unwinds and degrades the DNA asymmetrically in a 5′ to3′ direction until it encounters a chi (or “X”)-site (consensus5′-GCTGGTGG-3′) which attenuates the nuclease activity. This results inthe generation of ssDNA terminating near the c site with 3′-ssDNA tailthat is preferred RecA loading and subsequent invasion of dsDNA forhomologous recombination. Accordingly, preprocessing of transformingfragments with 5′ to 3′ specific ssDNA Exonuclease, such as Lamda (λ)exonuclease (available, e.g., from Boeringer Mannheim) prior totransformation may serve to stimulate homologous recombination recDstrain by providing ssDNA invasive end for RecA loading and subsequentstand invasion.

The addition of DNA sequence encoding chi-sites (consensus5′-GCTGGTGG-3′) to DNA fragments can serve to both attenuate ExonucleaseV activity and stimulate homologous recombination, thereby obviating theneed for a recD mutation (see also, Kowalczykowski, et al. (1994)“Biochemistry of homologous recombination in Escherichia coli,”Microbiol. Rev. 358:401-465 and Jessen, et al. (1998) “Modification ofbacterial artificial chromosomes through Chi-stimulated homologousrecombination and its application in zebrafish transgenesis.” Proc.Natl. Acad. Sci. 95:5121-5126).

Chi-sites are optionally included in linkers ligated to the ends oftransforming fragments or incorporated into the external primers used togenerate DNA fragments to be transformed. The use ofrecombination-stimulatory sequences such as chi is a generally usefulapproach for evolution of a broad range of cell types by fragmenttransformation.

Methods to inhibit or mutate analogs of Exo V or other nucleases (suchas, Exonucleases I (endA1), III (nth), IV (nfo), VII, and VIII of E.coli) is similarly useful. Inhibition or elimination of nucleases, ormodification of ends of transforming DNA fragments to render themresistant to exonuclease activity has applications in evolution of abroad range of cell types.

13. Shuffling to optimize unknown interactions

Many observed traits are the result of complex interactions of multiplegenes or gene products. Most such interactions are stilluncharacterized. Accordingly, it is often unclear which genes need tooptimized to achieve a desired trait, even if some of the genescontributing to the trait are known.

This lack of characterization is not an issue during DNA shuffling,which produces solutions that optimize whatever is selected for. Analternative approach, which has the potential to solve not only thisproblem, but also anticipated future rate limiting factors, iscomplementation by overexpression of unknown genomic sequences.

A library of genomic DNA is first made a described, supra. This istransformed into the cell to be optimized and transformants are screenedfor increases in a desired property. Genomic fragments which result inan improved property are evolved by DNA shuffling to further increasetheir beneficial effect. This approach requires no sequence information,nor any knowledge or assumptions about the nature of protein or pathwayinteractions, or even of what steps are rate-limiting; it relies only ondetection of the desired phenotype. This sort of random cloning andsubsequent evolution by DNA shuffling of positively interacting genomicsequences is extremely powerful and generic. A variety of sources ofgenomic DNA are used, from isogenic strains to more distantly relatedspecies with potentially desirable properties. In addition, thetechnique is applicable to any cell for which the molecular biologybasics of transformation and cloning vectors are available, and for anyproperty which can be assayed (preferably in a high-throughput format).

14. Homologous Recombination within the Chromosome

Homologous recombination within the chromosome is used to circumvent thelimitations of plasmid based evolution and size restrictions. Thestrategy is similar to that described above for shuffling genes withintheir chromosomal context, except that no in vitro shuffling occurs.Instead, the parent strain is treated with mutagens such a ultravioletlight or nitrosoguanidine, and improved mutants are selected. Theimproved mutants are pooled and split. Half of the pool is used togenerate random genomic fragments for cloning into a homologousrecombination vector. Additional genomic fragments are optionallyderived from related species with desirable properties. The clonedgenomic fragments are homologously recombined into the genomes of theremaining half of the mutant pool, and variants with improved propertiesare selected. These are subjected to a further round of mutagenesis,selection and recombination. Again this process is entirely generic forthe improvement of any whole cell biocatalyst for which a recombinationvector and an assay can be developed.

V. Methods for Recursive Sequence Recombination

Some formats and examples for recursive sequence recombination,sometimes referred to as DNA shuffling or molecular breeding, have beendescribed by the present inventors and co-workers in copendingapplication Ser. No. 08/621,859, now U.S. Pat. No. 6,117,679, filed Mar.25, 1996, PCT/US95/02126 filed Feb. 17, 1995 (published as WO 95/22625);Stemmer, Science 270, 1510 (1995); Stemmer et al., Gene, 164, 49-53(1995); Stemmer, Bio/Technology, 13, 549-553 (1995); Stemmer, Proc.Natl. Acad. Sci. USA 91, 10747-10751 (1994); Stemmer, Nature 370,389-391 (1994); Crameri et al., Nature Medicine, 2(1):1-3, (1996), andCrameri et al., Nature Biotechnology 14, 315-319 (1996) (each of whichis incorporated by reference in its entirety for all purposes).

As shown in FIGS. 16 and 17, DNA Shuffling provides most rapidtechnology for evolution of complex new functions. As shown in FIG. 16,panel (A), recombination in DNA shuffling achieves accumulation ofmultiple beneficial mutations in a few cycles. In contrast, because ofthe high frequency of deleterious mutations relative to beneficial ones,iterative point mutation must build beneficial mutations one at a time,and consequently requires many cycles to reach the same point. As shownin FIG. 16 panel B, rather than a simple linear sequence of mutationaccumulation, DNA shuffling is a parallel process where multipleproblems may be solved independently, and then combined.

(1) In Vitro Formats

One format for shuffling in vitro is illustrated in FIG. 1. The initialsubstrates for recombination are a pool of related sequences. The X's inthe FIG. 1, panel A, show where the sequences diverge. The sequences canbe DNA or RNA and can be of various lengths depending on the size of thegene or DNA fragment to be recombined or reassembled. Preferably thesequences are from 50 bp to 50 kb.

The pool of related substrates are converted into overlapping fragments,e.g., from about 5 bp to 5 kb or more, as shown in FIG. 1, panel B.Often, the size of the fragments is from about 10 bp to 1000 bp, andsometimes the size of the DNA fragments is from about 100 bp to 500 bp.The conversion can be effected by a number of different methods, such asDNaseI or RNase digestion, random shearing or partial restriction enzymedigestion. Alternatively, the conversion of substrates to fragments canbe effected by incomplete PCR amplification of substrates or PCR primedfrom a single primer. Alternatively, appropriate single-strandedfragments can be generated on a nucleic acid synthesizer. Theconcentration of nucleic acid fragments of a particular length andsequence is often less than 0.1% or 1% by weight of the total nucleicacid. The number of different specific nucleic acid fragments in themixture is usually at least about 100, 500 or 1000.

The mixed population of nucleic acid fragments are converted to at leastpartially single-stranded form. Conversion can be effected by heating toabout 80° C. to 100° C., more preferably from 90° C. to 96° C., to formsingle-stranded nucleic acid fragments and then reannealing. Conversioncan also be effected by treatment with single-stranded DNA bindingprotein or recA protein. Single-stranded nucleic acid fragments havingregions of sequence identity with other single-stranded nucleic acidfragments can then be reannealed by cooling to 20° C. to 75° C., andpreferably from 40° C. to 65° C. Renaturation can be accelerated by theaddition of polyethylene glycol (PEG), other volume-excluding reagentsor salt. The salt concentration is preferably from 0 mM to 200 mM, morepreferably the salt concentration is from 10 mM to 100 mM. The salt maybe KCl or NaCl. The concentration of PEG is preferably from 0% to 20%,more preferably from 5% to 10%. The fragments that reanneal can be fromdifferent substrates as shown in FIG. 1, panel C. The annealed nucleicacid fragments are incubated in the presence of a nucleic acidpolymerase, such as Taq or Klenow, or proofreading polymerases, such aspfu or pwo, and dNTP's (i.e. dATP, dCTP, dGTP and dTTP). If regions ofsequence identity are large, Taq polymerase can be used with anannealing temperature of between 45-65° C. If the areas of identity aresmall, Klenow polymerase can be used with an annealing temperature ofbetween 20-30° C. (Stemmer, Proc. Natl. Acad. Sci. USA (1994), supra).The polymerase can be added to the random nucleic acid fragments priorto annealing, simultaneously with annealing or after annealing.

The process of denaturation, renaturation and incubation in the presenceof polymerase of overlapping fragments to generate a collection ofpolynucleotides containing different permutations of fragments issometimes referred to as shuffling of the nucleic acid in vitro. Thiscycle is repeated for a desired number of times. Preferably the cycle isrepeated from 2 to 100 times, more preferably the sequence is repeatedfrom 10 to 40 times. The resulting nucleic acids are a family ofdouble-stranded polynucleotides of from about 50 bp to about 100 kb,preferably from 500 bp to 50 kb, as shown in FIG. 1, panel D. Thepopulation represents variants of the starting substrates showingsubstantial sequence identity thereto but also diverging at severalpositions. The population has many more members than the startingsubstrates. The population of fragments resulting from shuffling is usedto transform host cells, optionally after cloning into a vector.

In a variation of in vitro shuffling, subsequences of recombinationsubstrates can be generated by amplifying the full-length sequencesunder conditions which produce a substantial fraction, typically atleast 20 percent or more, of incompletely extended amplificationproducts. The amplification products, including the incompletelyextended amplification products are denatured and subjected to at leastone additional cycle of reannealing and amplification. This variation,in which at least one cycle of reannealing and amplification provides asubstantial fraction of incompletely extended products, is termed“stuttering.” In the subsequent amplification round, the incompletelyextended products reanneal to and prime extension on differentsequence-related template species.

In a further variation, a mixture of fragments is spiked with one ormore oligonucleotides. The oligonucleotides can be designed to includeprecharacterized mutations of a wildtype sequence, or sites of naturalvariations between individuals or species. The oligonucleotides alsoinclude sufficient sequence or structural homology flanking suchmutations or variations to allow annealing with the wildtype fragments.Some oligonucleotides may be random sequences. Annealing temperaturescan be adjusted depending on the length of homology.

In a further variation, recombination occurs in at least one cycle bytemplate switching, such as when a DNA fragment derived from onetemplate primes on the homologous position of a related but differenttemplate. Template switching can be induced by addition of recA, rad51,rad55, rad57 or other polymerases (e.g., viral polymerases, reversetranscriptase) to the amplification mixture. Template switching can alsobe increased by increasing the DNA template concentration.

In a further variation, at least one cycle of amplification can beconducted using a collection of overlapping single-stranded DNAfragments of related sequence, and different lengths. Fragments can beprepared using a single stranded DNA phage, such as M13. Each fragmentcan hybridize to and prime polynucleotide chain extension of a secondfragment from the collection, thus forming sequence-recombinedpolynucleotides. In a further variation, ssDNA fragments of variablelength can be generated from a single primer by Vent or other DNApolymerase on a first DNA template. The single stranded DNA fragmentsare used as primers for a second, Kunkel-type template, consisting of auracil-containing circular ssDNA. This results in multiple substitutionsof the first template into the second. See Levichkin et al., Mol.Biology 29, 572-577 (1995).

(2) In Vivo Formats

(a) Plasmid-Plasmid Recombination

The initial substrates for recombination are a collection ofpolynucleotides comprising variant forms of a gene. The variant formsoften show substantial sequence identity to each other sufficient toallow homologous recombination between substrates. The diversity betweenthe polynucleotides can be natural (e.g., allelic or species variants),induced (e.g., error-prone PCR), or the result of in vitrorecombination. Diversity can also result from resynthesizing genesencoding natural proteins with alternative and/or mixed codon usage.There should be at least sufficient diversity between substrates thatrecombination can generate more diverse products than there are startingmaterials. There must be at least two substrates differing in at leasttwo positions. However, commonly a library of substrates of 10³-10⁸members is employed. The degree of diversity depends on the length ofthe substrate being recombined and the extent of the functional changeto be evolved. Diversity at between 0.1-50% of positions is typical. Thediverse substrates are incorporated into plasmids. The plasmids areoften standard cloning vectors, e.g., bacterial multicopy plasmids.However, in some methods to be described below, the plasmids includemobilization functions. The substrates can be incorporated into the sameor different plasmids. Often at least two different types of plasmidhaving different types of selection marker are used to allow selectionfor cells containing at least two types of vector. Also, where differenttypes of plasmid are employed, the different plasmids can come from twodistinct incompatibility groups to allow stable co-existence of twodifferent plasmids within the cell. Nevertheless, plasmids from the sameincompatibility group can still co-exist within the same cell forsufficient time to allow homologous recombination to occur.

Plasmids containing diverse substrates are initially introduced intoprocaryotic or eukaryotic cells by any transfection methods (e.g.,chemical transformation, natural competence, electroporation, viraltransduction or biolistics). Often, the plasmids are present at or nearsaturating concentration (with respect to maximum transfection capacity)to increase the probability of more than one plasmid entering the samecell. The plasmids containing the various substrates can be transfectedsimultaneously or in multiple rounds. For example, in the latterapproach cells can be transfected with a first aliquot of plasmid,transfectants selected and propagated, and then infected with a secondaliquot of plasmid.

Having introduced the plasmids into cells, recombination betweensubstrates to generate recombinant genes occurs within cells containingmultiple different plasmids merely by propagating in the cells. However,cells that receive only one plasmid are unable to participate inrecombination and the potential contribution of substrates on suchplasmids to evolution is not fully exploited (although these plasmidsmay contribute to some extent if they are propagated in mutator cells orotherwise accumulate point mutations (i.e., by ultraviolet radiationtreatment). The rate of evolution can be increased by allowing allsubstrates to participate in recombination. Such can be achieved bysubjecting transfected cells to electroporation. The conditions forelectroporation are the same as those conventionally used forintroducing exogenous DNA into cells (e.g., 1,000-2,500 volts, 400 μFand a 1-2 mM gap). Under these conditions, plasmids are exchangedbetween cells allowing all substrates to participate in recombination.In addition the products of recombination can undergo further rounds ofrecombination with each other or with the original substrate. The rateof evolution can also be increased by use of conjugative transfer.Conjugative transfer systems are known in many bacteria (E. coli, P.aeruginosa, S. pneumoniae, and H. influenzae) and can also be used totransfer DNA between bacteria and yeast or between bacteria andmammalian cells.

To exploit conjugative transfer, substrates are cloned into plasmidshaving MOB genes, and tra genes are also provided in cis or in trans tothe MOB genes. The effect of conjugative transfer is very similar toelectroporation in that it allows plasmids to move between cells andallows recombination between any substrate and the products of previousrecombination to occur merely by propagating the culture. The details ofhow conjugative transfer is exploited in these vectors are discussed inmore detail below. The rate of evolution can also be increased by fusingprotoplasts of cells to induce exchange of plasmids or chromosomes.Fusion can be induced by chemical agents, such as PEG, or viruses orviral proteins, such as influenza virus hemagglutinin, HSV-1 gB and gD.The rate of evolution can also be increased by use of mutator host cells(e.g., Mut L, S, D, T, H and Ataxia telangiectasia human cell lines).

The time for which cells are propagated and recombination is allowed tooccur, of course, varies with the cell type but is generally notcritical, because even a small degree of recombination can substantiallyincrease diversity relative to the starting materials. Cells bearingplasmids containing recombined genes are subject to screening orselection for a desired function. For example, if the substrate beingevolved contains a drug resistance gene, one selects for drugresistance. Cells surviving screening or selection can be subjected toone or more rounds of screening/selection followed by recombination orcan be subjected directly to an additional round of recombination.

The next round of recombination can be achieved by several differentformats independently of the previous round. For example, a furtherround of recombination can be effected simply by resuming theelectroporation or conjugation-mediated intercellular transfer ofplasmids described above. Alternatively, a fresh substrate orsubstrates, the same or different from previous substrates, can betransfected into cells surviving selection/screening. Optionally, thenew substrates are included in plasmid vectors bearing a differentselective marker and/or from a different incompatibility group than theoriginal plasmids. As a further alternative, cells survivingselection/screening can be subdivided into two subpopulations, andplasmid DNA from one subpopulation transfected into the other, where thesubstrates from the plasmids from the two subpopulations undergo afurther round of recombination. In either of the latter two options, therate of evolution can be increased by employing DNA extraction,electroporation, conjugation or mutator cells, as described above. In astill further variation, DNA from cells surviving screening/selectioncan be extracted and subjected to in vitro DNA shuffling.

After the second round of recombination, a second round ofscreening/selection is performed, preferably under conditions ofincreased stringency. If desired, further rounds of recombination andselection/screening can be performed using the same strategy as for thesecond round. With successive rounds of recombination andselection/screening, the surviving recombined substrates evolve towardacquisition of a desired phenotype. Typically, in this and other methodsof recursive recombination, the final product of recombination that hasacquired the desired phenotype differs from starting substrates at0.1%-25% of positions and has evolved at a rate orders of magnitude inexcess (e.g., by at least 10-fold, 100-fold, 1000-fold, or 10,000 fold)of the rate of naturally acquired mutation of about 1 mutation per 10⁻⁹positions per generation (see Anderson & Hughes, Proc. Natl. Acad. Sci.USA 93, 906-907 (1996)).

(b) Virus-Plasmid Recombination

The strategy used for plasmid-plasmid recombination can also be used forvirus-plasmid recombination; usually, phage-plasmid recombination.However, some additional comments particular to the use of viruses areappropriate. The initial substrates for recombination are cloned intoboth plasmid and viral vectors. It is usually not critical whichsubstrate(s) are inserted into the viral vector and which into theplasmid, although usually the viral vector should contain differentsubstrate(s) from the plasmid. As before, the plasmid (and the virus)typically contains a selective marker. The plasmid and viral vectors canboth be introduced into cells by transfection as described above.However, a more efficient procedure is to transform the cells withplasmid, select transformants and infect the transformants with a virus.Because the efficiency of infection of many viruses approaches 100% ofcells, most cells transformed and infected by this route contain both aplasmid and virus bearing different substrates.

Homologous recombination occurs between plasmid and virus generatingboth recombined plasmids and recombined virus. For some viruses, such asfilamentous phage, in which intracellular DNA exists in bothdouble-stranded and single-stranded forms, both can participate inrecombination. Provided that the virus is not one that rapidly killscells, recombination can be augmented by use of electroporation orconjugation to transfer plasmids between cells. Recombination can alsobe augmented for some types of virus by allowing the progeny virus fromone cell to reinfect other cells. For some types of virus, virusinfected-cells show resistance to superinfection. However, suchresistance can be overcome by infecting at high multiplicity and/orusing mutant strains of the virus in which resistance to superinfectionis reduced.

The result of infecting plasmid-containing cells with virus depends onthe nature of the virus. Some viruses, such as filamentous phage, stablyexist with a plasmid in the cell and also extrude progeny phage from thecell. Other viruses, such as lambda having a cosmid genome, stably existin a cell like plasmids without producing progeny virions. Otherviruses, such as the T-phage and lytic lambda, undergo recombinationwith the plasmid but ultimately kill the host cell and destroy plasmidDNA. For viruses that infect cells without killing the host, cellscontaining recombinant plasmids and virus can be screened/selected usingthe same approach as for plasmid-plasmid recombination. Progeny virusextruded by cells surviving selection/screening can also be collectedand used as substrates in subsequent rounds of recombination. Forviruses that kill their host cells, recombinant genes resulting fromrecombination reside only in the progeny virus. If the screening orselective assay requires expression of recombinant genes in a cell, therecombinant genes should be transferred from the progeny virus toanother vector, e.g., a plasmid vector, and retransfected into cellsbefore selection/screening is performed.

For filamentous phage, the products of recombination are present in bothcells surviving recombination and in phage extruded from these cells.The dual source of recombinant products provides some additional optionsrelative to the plasmid-plasmid recombination. For example, DNA can beisolated from phage particles for use in a round of in vitrorecombination. Alternatively, the progeny phage can be used to transfector infect cells surviving a previous round of screening/selection, orfresh cells transfected with fresh substrates for recombination.

(c) Virus-Virus Recombination

The principles described for plasmid-plasmid and plasmid-viralrecombination can be applied to virus-virus recombination with a fewmodifications. The initial substrates for recombination are cloned intoa viral vector. Usually, the same vector is used for all substrates.Preferably, the virus is one that, naturally or as a result of mutation,does not kill cells. After insertion, some viral genomes can be packagedin vitro. The packaged viruses are used to infect cells at highmultiplicity such that there is a high probability that a cell receivesmultiple viruses bearing different substrates.

After the initial round of infection, subsequent steps depend on thenature of infection as discussed in the previous section. For example,if the viruses have phagemid genomes such as lambda cosmids or M13, F1or Fd phagemids, the phagemids behave as plasmids within the cell andundergo recombination simply by propagating the cells. Recombination canbe augmented by electroporation of cells. Following selection/screening,cosmids containing recombinant genes can be recovered from survivingcells (e.g., by heat induction of a cos⁻ lysogenic host cell),repackaged in vitro, and used to infect fresh cells at high multiplicityfor a further round of recombination.

If the viruses are filamentous phage, recombination of replicating formDNA occurs by propagating the culture of infected cells.Selection/screening identifies colonies of cells containing viralvectors having recombinant genes with improved properties, together withphage extruded from such cells. Subsequent options are essentially thesame as for plasmid-viral recombination.

(d) Chromosome-Plasmid Recombination

This format can be used to evolve both the chromosomal and plasmid-bornesubstrates. The format is particularly useful in situations in whichmany chromosomal genes contribute to a phenotype or one does not knowthe exact location of the chromosomal gene(s) to be evolved. The initialsubstrates for recombination are cloned into a plasmid vector. If thechromosomal gene(s) to be evolved are known, the substrates constitute afamily of sequences showing a high degree of sequence identity but somedivergence from the chromosomal gene. If the chromosomal genes to beevolved have not been located, the initial substrates usually constitutea library of DNA segments of which only a small number show sequenceidentity to the gene or gene(s) to be evolved. Divergence betweenplasmid-borne substrate and the chromosomal gene(s) can be induced bymutagenesis or by obtaining the plasmid-borne substrates from adifferent species than that of the cells bearing the chromosome.

The plasmids bearing substrates for recombination are transfected intocells having chromosomal gene(s) to be evolved. Evolution can occursimply by propagating the culture, and can be accelerated bytransferring plasmids between cells by conjugation, electroporation orprotoplast fusion. Evolution can be further accelerated by use ofmutator host cells or by seeding a culture of nonmutator host cellsbeing evolved with mutator host cells and inducing intercellulartransfer of plasmids by electroporation, conjugation or protoplastfusion. Preferably, mutator host cells used for seeding contain anegative selection marker to facilitate isolation of a pure culture ofthe nonmutator cells being evolved. Selection/screening identifies cellsbearing chromosomes and/or plasmids that have evolved toward acquisitionof a desired function.

Subsequent rounds of recombination and selection/screening proceed insimilar fashion to those described for plasmid-plasmid recombination.For example, further recombination can be effected by propagating cellssurviving recombination in combination with electroporation, conjugativetransfer of plasmids, or protoplast fusion. Alternatively, plasmidsbearing additional substrates for recombination can be introduced intothe surviving cells. Preferably, such plasmids are from a differentincompatibility group and bear a different selective marker than theoriginal plasmids to allow selection for cells containing at least twodifferent plasmids. As a further alternative, plasmid and/or chromosomalDNA can be isolated from a subpopulation of surviving cells andtransfected into a second subpopulation. Chromosomal DNA can be clonedinto a plasmid vector before transfection.

(e) Virus-Chromosome Recombination

As in the other methods described above, the virus is usually one thatdoes not kill the cells, and is often a phage or phagemid. The procedureis substantially the same as for plasmid-chromosome recombination.Substrates for recombination are cloned into the vector. Vectorsincluding the substrates can then be transfected into cells or in vitropackaged and introduced into cells by infection. Viral genomes recombinewith host chromosomes merely by propagating a culture. Evolution can beaccelerated by allowing intercellular transfer of viral genomes byelectroporation, or reinfection of cells by progeny virions.Screening/selection identifies cells having chromosomes and/or viralgenomes that have evolved toward acquisition of a desired function.

There are several options for subsequent rounds of recombination. Forexample, viral genomes can be transferred between cells survivingselection/recombination by electroporation. Alternatively, virusesextruded from cells surviving selection/screening can be pooled and usedto superinfect the cells at high multiplicity. Alternatively, freshsubstrates for recombination can be introduced into the cells, either onplasmid or viral vectors.

(f) Poolwise Whole Genome Recombination

Asexual evolution is a slow and inefficient process. Populations move asindividuals rather than as a group. A diverse population is generated bymutagenesis of a single parent, resulting in a distribution of fit andunfit individuals. In the absence of a sexual cycle, each piece ofgenetic information for the surviving population remains in theindividual mutants. Selection of the fittest results in many fitindividuals being discarded, along with the genetically usefulinformation they carry. Asexual evolution proceeds one genetic event ata time, and is thus limited by the intrinsic value of a single geneticevent. Sexual evolution moves more quickly and efficiently. Matingwithin a population consolidates genetic information within thepopulation and results in useful information being combined together.The combining of useful genetic information results in progeny that aremuch more fit than their parents. Sexual evolution thus proceeds muchfaster by multiple genetic events. These differences are furtherillustrated in FIG. 17. In contrast to sexual evolution, DNA shufflingis the recursive mutagenesis, recombination, and selection of DNAsequences (see also, FIG. 25.).

Sexual recombination in nature effects pairwise recombination andresults in progeny that are genetic hybrids of two parents. In contrast,DNA shuffling in vitro effects poolwise recombination, in which progenyare hybrids of multiple parental molecules. This is because DNAshuffling effects many individual pairwise recombination events witheach thermal cycle. After many cycles the result is a repetitivelyinbred population, with the “progeny” being the F_(X) (for X cycles ofreassembly) of the original parental molecules. These progeny arepotentially descendants of many or all of the original parents. Thegraph shown in FIG. 25 shows a plot of the potential number of mutationsan individual can accumulate by sequential, pairwise and poolwiserecombination.

Poolwise recombination is an important feature to DNA shuffling in thatit provides a means of generating a greater proportion of the possiblecombinations of mutations from a single “breeding” experiment. In thisway, the “genetic potential” of a population can be readily assessed byscreening the progeny of a single DNA shuffling experiment.

For example, if a population consists of 10 single mutant parents, thereare 2¹⁰=1024 possible combinations of those mutations ranging fromprogeny having 0-10 mutations. Of these 1024, only 56 will result from asingle pairwise cross (FIG. 14) (i.e those having 0, 1, and 2mutations). In nature the multiparent combinations will eventually ariseafter multiple random sexual matings, assuming no selection is impartedto remove some mutations from the population. In this way, sex effectsthe consolidation and sampling of all useful mutant combinationspossible within a population. For the purposes of directed evolution,having the greatest number of mutant combinations entering a screen orselection is desirable so that the best progeny (i.e., according to theselection criteria used in the selection screen) is identified in theshortest possible time.

One challenge to in vivo and whole genome shuffling is devising methodsfor effecting poolwise recombination or multiple repetitive pairwiserecombination events. In crosses with a single pairwise cross per cyclebefore screening, the ability to screen the “genetic potential” of thestarting population is limited. For this reason, the rate of in vivo andwhole genome shuffling mediated cellular evolution would be facilitatedby effecting poolwise recombination. Two strategies for poolwiserecombination are described below (protoplast fusion and transduction).

(i.) Protoplast Fusion

Protoplast fusion (discussed supra) mediated whole genome shuffling(WGS) is one format that can directly effect poolwise recombination.Whole gene shuffling is the recursive recombination of whole genomes, inthe form of one or more nucleic acid molecule(s) (fragments,chromosomes, episomes, etc), from a population of organisms, resultingin the production of new organisms having distributed geneticinformation from at least two of the starting population of organisms.The process of protoplast fusion is further illustrated in FIG. 26.

Progeny resulting from the fusion of multiple parent protoplasts havebeen observed (Hopwood & Wright, 1978), however, these progeny are rare(10⁻⁴-10⁻⁶). The low frequency is attributed to the distribution offusants arising from two, three, four, etc parents and the likelihood ofthe multiple recombination events (6 crossovers for a four parent cross)that would have to occur for multiparent progeny to arise. Thus, it isuseful to enrich for the multiparent progeny. This can be accomplished,e.g., by repetitive fusion or enrichment for multiply fused protoplasts.The process of poolwise fusion and recombination is further illustratedin FIG. 27.

(ii.) Repetitive Fusion

Protoplasts of identified parental cells are prepared, fused andregenerated. Protoplasts of the regenerated progeny are then, withoutscreening or enrichment, formed, fused and regenerated. This can becarried out for two, three, or more cycles before screening to increasethe representation of multiparent progeny. The number of possiblemutations/progeny doubles for each cycle. For example, if one crossproduces predominantly progeny with 0, 1, and 2 mutations, a breeding ofthis population with itself will produce progeny with 0, 1, 2, 3, and 4mutations (FIG. 15), the third cross up to eight, etc. Therepresentation of the multiparent progeny from these subsequent crosseswill not be as high as the single and double parent progeny, but it willbe detectable and much higher than from a single cross. The repetitivefusion prior to screening is analogous to many sexual crosses within apopulation, and the individual thermal cycles of in vitro DNA shufflingdescribed supra. A factor effecting the value of this approach is thestarting size of the parental population. As the population grows, itbecomes more likely that a multiparent fusion will arise from repetitivefusions. For example, if 4 parents are fused twice, the 4 parent progenywill make up approximately 0.2% of the total progeny. This is sufficientto find in a population of 3000 (95% confidence), but betterrepresentation is preferable. If ten parents are fused twice >20% of theprogeny will be four parent offspring.

(iii.) Enrichment for Multiply Fused Protoplasts

After the fusion of a population of protoplasts, the fusants aretypically diluted into hypotonic medium, to dilute out the fusing agent(e.g., 50% PEG). The fused cells can be grown for a short period toregenerate cell walls or separated directly and are then separated onthe basis of size. This is carried out, e.g., by cell sorting, usinglight dispersion as an estimate of size, to isolate the largest fusants.Alternatively the fusants can be sorted by FACS on the basis of DNAcontent. The large fusants or those containing more DNA result from thefusion of multiple parents and are more likely to segregate tomultiparent progeny. The enriched fusants are regenerated and screeneddirectly or the progeny are fused recursively as above to further enrichthe population for diverse mutant combinations.

(iv.) Transduction

Transduction can theoretically effect poolwise recombination, if thetransducing phage particles contain predominantly host genomic DNArather than phage DNA. If phage DNA is overly represented, then mostcells will receive at least one undesired phage genome. Phage particlesgenerated from locked-in-prophage (supra) are useful for this purpose. Apopulation of cells is infected with an appropriate transducing phage,and the lysate is collected and used to infect the same startingpopulation. A high multiplicity of infection is employed to delivermultiple genomic fragments to each infected cell, thereby increasing thechance of producing recombinants containing mutations from more than twoparent genomes. The resulting transductants are recovered underconditions where phage can not propagate e.g., in the presence ofcitrate. This population is then screened directly or infected againwith phage, with the resulting transducing particles being used totransduce the first progeny. This would mimic recursive protoplastfusion, multiple sexual recombination, and in vitro DNA shuffling.

(g) Methods for Whole Genome Shuffling by Blind Family Shuffling ofParsed Genomes and Recursive Cycles of Forced Integration and Excisionby Homologous Recombination, and Screening for Improved Phenotypes.

In vitro methods have been developed to shuffle single genes andoperons, as set forth, e.g., herein. “Family” shuffling of homologousgenes within species and from different species is also an effectivemethods for accelerating molecular evolution. This section describesadditional methods for extending these methods such that they can beapplied to whole genomes.

In some cases, the genes that encode rate limiting steps in abiochemical process, or that contribute to a phenotype of interest areknown. This method can be used to target family shuffled libraries tosuch loci, generating libraries of organisms with high quality familyshuffled libraries of alleles at the locus of interest. An example ofsuch a gene would be the evolution of a host chaperonin to moreefficiently chaperone the folding of an overexpressed protein in E.coli.

The goals of this process are to shuffle homologous genes from two ormore species and to then integrate the shuffled genes into thechromosome of a target organism. Integration of multiple shuffled genesat multiple loci can be achieved using recursive cycles of integration(generating duplications), excision (leaving the improved allele in thechromosome) and transfer of additional evolved genes by seriallyapplying the same procedure.

In the first step, genes to be shuffled into suitable bacterial vectorsare subcloned. These vectors can be plasmids, cosmids, BACS or the like.Thus, fragments from 100 bp to 100 kb can be handled. Homologousfragments are then “family shuffled” together (i.e. homologous fragmentsfrom different species or chromosomal locations are homologouslyrecombined). As a simple case, homologs from two species (say, E. coliand Salmonella) are cloned, family shuffled in vitro and cloned into anallele replacement vector (e.g., a vector with a positively selectablemarker, a negatively selectable marker and conditionally active originof replication). The basic strategy for whole genome family shuffling ofparsed (subcloned) genomes is additionally set forth in FIG. 22.

The vectors are transduced into E. coli and selected, e.g., for drugresistance. Most drug resistant vectors occur only by homologousrecombination between a family shuffled insert and a chromosomal copy ofthe cloned insert. Colonies with improved phenotype are screened (e.g.,by mass spectroscopy for enzyme activity or small molecule production,or a chromogenic screen, or the like, depending on the phenotype to beassayed). Negative selection (i.e. sac selection) is imposed to forceexcision of tandem duplication. Roughly half of the colonies shouldretain the improved phenotype. Importantly, this process regenerates a‘clean’ chromosome in which the wild type locus is replaced with afamily shuffled fragment that encodes a beneficial allele. Since thechromosome is “clean” (i.e., has no vector sequences), other improvedalleles can also be moved into this point on the chromosome byhomologous recombination.

In subsequent rounds, independently identified improved alleles areoptionally moved into the improved strain (e.g., by P1 transduction ofthe drug marked tandem duplication above). Transductants are screenedfor further improvement in phenotype by virtue of receiving thetransduced tandem duplication, which itself contains the family shuffledgenetic material. Negative selection is again imposed and the process ofshuffling the improved strain is recursively repeated as desired.

Although this process was described with reference to targeting a geneor genes of interest, it can be used “blindly,” making no assumptionsabout which locus is to be targeted. This procedure is set forth in FIG.23. For example, the whole genome of an organism of interest is clonedinto manageable fragments (e.g., 10 kb for plasmid-based methods).Homologous fragments are then isolated from related species.

For E. coli., cloning the genome in 10 kb fragments requires about 300clones. The homologous fragments are isolated, e.g., from Salmonella.This gives roughly three hundred pairs of homologous fragments. Eachpair is family shuffled and the shuffled fragments are cloned into anallele replacement vector. The inserts are integrated into the E. coligenome as described above. A global screen is made to identify variantswith an improved phenotype. This serves as the basis collection ofimprovements that are to be shuffled to produce a desired strain. Theshuffling of these independently identified variants into one superstrain is done as described above.

(h) Methods for High Throughput Family Shuffling of Genes

Family shuffling has been shown to be an efficient method for creatinghigh quality libraries of genetic variants. Given a cloned gene from onespecies, it is of interest to quickly and rapidly isolate homologs fromother species, and this process can be rate limiting. For example, ifone wants to perform family shuffling on an entire genome, one may needto construct hundreds to thousands of individual family shuffledlibraries.

In this embodiment, a gene of interest is optionally cloned into avector in which ssDNA can be made. An example of such a vector is aphagemid vector with an M13 origin of replication. Genomic DNA or cDNAfrom a species of interest is isolated, denatured, annealed to thephagemid, and then enzymatically manipulated to clone it. The cloned DNAis then used to family shuffle with the original gene of interest. PCRbased formats are also available. These formats require no intermediatecloning steps, and are, therefore, of particular interest for highthroughput applications.

Shuffling the E. coli chaperonin gene DnaJ with other homologs isdescribed below as an example. The example can be generalized to anyother gene, including eukaryotic genes such as plant or animal genes(including mammalian genes), by following the format described. FIG. 24provides a schematic outline of the steps to high throughput familyshuffling.

As a first step, the E. coli DnaJ gene is cloned into an M13 phagemidvector. ssDNA is then produced, preferably in a dut(−) ung(−) strain sothat Kunkel site directed mutagenesis protocols can be applied. GenomicDNA is then isolated from a non- E. coil source, such as Salmonella andYersinia Pestis. The bacterial genomic DNAs are denatured and reannealedto the phagemid ssDNA (e.g., about 1 microgram of ssDNA). Thereannealled product is treated with an enzyme such as Mung Bean nucleasethat degrades ssDNA as an exonuclease but not as an endonuclease (thenuclease does not degrade mismatched DNA that is embedded in a largerannealed fragment). The standard Kunkel site directed mutagenesisprotocol is used to extend the fragment and the target cells aretransformed with the resulting mutagenized DNA.

In a first variation on the above, the procedure is adapted to thesituation where the target gene or genes of interest are unknown. Inthis variation, the whole genome of the organism of interest is clonedin fragments (e.g., of about 10 kb each) into a phagemid. Singlestranded phagemid DNA is then produced. Genomic DNA from the relatedspecies is denatured and annealed to the phagemids. Mung bean nucleaseis used to trim away unhybridized DNA ends. Polymerase plus ligase isused to fill in the resulting gapped circles. These clones aretransformed into a mismatch repair deficient strain. When the mismatchedmolecules are replicated in the bacteria, most colonies contain both theE. coli and the homologous fragment. The two homologous genes are thenisolated from the colonies (e.g., either by standard plasmidpurification or colony PCR) and shuffled.

Another approach to generating chimeras that requires no in vitroshuffling is simply to clone the Salmonella genome into an allelereplacement vector, transform E. coli, and select for chromosomalintegrants. Homologous recombination between Salmonella genes and E.coli homologs generate shuffled chimeras. A global screen is done toscreen for improved phenotypes. If colonies with improved phenotypes areobtained, it is verified that the improvement is due to allelereplacement by P1 transduction into a fresh strain and counterscreeningfor improved phenotype. A collection of such improved alleles can thenbe combined into one strain using the methods for whole genome shufflingby blind family shuffling of parsed genomes as set forth herein.Additionally, once these loci are identified, it is likely that furtherrounds of shuffling and screening will yield further improvements. Thiscould be done by cloning the chimeric gene and then using the methodsdescribed in this disclosure to breed the gene with homologs from manydifferent strains of bacteria.

In general, the transformants contain clones of the homologue of thetarget gene (e.g., E. coli DnaJ in the example above). Mismatch repairin vivo results in a decrease in diversity of the gene. There are atleast two solutions to this. First, transduction can be performed into amismatch repair strain. Alternatively or in addition, the M13 templateDNA can be selectively degraded, leaving the cloned homologue. This canbe done using methods similar to the standard Eckstein site directedmutagenesis technique (General texts which describe general molecularbiological techniques useful herein, including mutagenesis, includeSambrook et al., Molecular Cloning—A Laboratory Manual (2nd Ed.), Vol.1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989(“Sambrook”) and Current Protocols in Molecular Biology, F. M. Ausubelet al., eds., Current Protocols, a joint venture between GreenePublishing Associates, Inc. and John Wiley & Sons, Inc., (supplementedthrough 1998) (“Ausubel”)).

This method relies on incorporation of alpha thiol modified dNTP'sduring synthesis of the new strand followed by selective degradation ofthe template and resynthesis of the template strand. In one embodiment,the template strand is grown in a dut(−) ung(−) strain so that uracil isincorporated into the phagemid DNA. After extension as noted above (andbefore transformation) the DNA is treated with uracil glycosylate and anapurinic site endonuclease such as Endo III or Endo IV. The treated DNAis then treated with a processive exonuclease that resects from theresulting gaps while leaving the other strand intact (as in Ecksteinmutagenesis). The DNA is polymerized and ligated. Target cells are thentransformed. This process enriches for clones encoding the homologuewhich is not derived from the target (i.e., in the example above, thenon- E. coli. homologue).

An analogous procedure is optionally performed in a PCR format. Asapplied to the DnaJ illustration above, DnaJ DNA is amplified by PCRwith primers that build 30-mer priming sites on each end. The PCR isdenatured and annealed with an excess of Salmonella genomic DNA. TheSalmonella DnaJ gene hybribidizes with the E. coli homologue. Aftertreatment with Mung Bean nuclease, the resulting mismatched hybrid isPCR amplified with the flanking 30-mer primers. This PCR product can beused directly for family shuffling.

As genomics provides an increasing amount of sequence information, it isincreasingly possible to directly PCR amplify homologs with designedprimers. For example, given the sequence of the E. coli genome and of arelated genome (i.e. Salmonella), each genome can be PCR amplified withdesigned primers in, e.g., 5 kb fragments. The homologous fragments canbe put together in a pairwise fashion for shuffling. For genomeshuffling, the shuffled products are cloned into the allele replacementvector and bred into the genome as described supra.

Hyper-Recombinogenic RecA Clones

The invention further provides hyper-recombinogenic RecA proteins (see,the examples below). Examples of such proteins are from clones 2, 4, 5,6 and 13 shown in FIG. 13. It is fully expected that one of skill canmake a variety of related recombinogenic proteins given the disclosedsequences.

First, clones comprising the sequences in FIGS. 12 and 13 are optionallyused as the starting point for any of the shuffling methods herein,providing a starting point for mutation and recombination to improve theclones which are shown.

Second, standard molecular biological techniques can be used to makenucleic acids which comprise the given nucleic acids, e.g., by cloningthe nucleic acids into any known vector. Examples of appropriate cloningand sequencing techniques, and instructions sufficient to direct personsof skill through many cloning exercises are found in Berger and Kimmel,Guide to Molecular Cloning Techniques, Methods in Enzymology volume 152Academic Press, Inc., San Diego, Calif. (Berger); Sambrook et al. (1989)Molecular Cloning—A Laboratory Manual (2nd ed.) Vol. 1-3, Cold SpringHarbor Laboratory, Cold Spring Harbor Press, NY, (Sambrook); and CurrentProtocols in Molecular Biology, F. M. Ausubel et al., eds., CurrentProtocols, a joint venture between Greene Publishing Associates, Inc.and John Wiley & Sons, Inc., (1994 Supplement) (Ausubel). Productinformation from manufacturers of biological reagents and experimentalequipment also provide information useful in known biological methods.Such manufacturers include the SIGMA chemical company (Saint Louis,Mo.), R&D systems (Minneapolis, Minn.), Pharmacia LKB Biotechnology(Piscataway, N.J.), CLONTECH Laboratories, Inc. (Palo Alto, Calif.),Chem Genes Corp., Aldrich Chemical Company (Milwaukee, Wis.), GlenResearch, Inc., GIBCO BRL Life Technologies, Inc. (Gaithersberg, Md.),Fluka Chemica-Biochemika Analytika (Fluka Chemie AG, Buchs,Switzerland), Invitrogen, San Diego, Calif., and Applied Biosystems(Foster City, Calif.), as well as many other commercial sources known toone of skill.

Third, it will be appreciated that conservative substitutions of thegiven sequences can be used to produce nucleic acids which encodehyperrecombinogenic clones. “Conservatively modified variations” of aparticular nucleic acid sequence refers to those nucleic acids whichencode identical or essentially identical amino acid sequences, or wherethe nucleic acid does not encode an amino acid sequence, to essentiallyidentical sequences. Because of the degeneracy of the genetic code, alarge number of functionally identical nucleic acids encode any givenpolypeptide. For instance, the codons CGU, CGC, CGA, CGG, AGA, and AGGall encode the amino acid arginine. Thus, at every position where anarginine is specified by a codon, the codon can be altered to any of thecorresponding codons described without altering the encoded polypeptide.Such nucleic acid variations are “silent variations,” which are onespecies of “conservatively modified variations.” Every nucleic acidsequence herein which encodes a polypeptide also describes everypossible silent variation. One of skill will recognize that each codonin a nucleic acid (except AUG, which is ordinarily the only codon formethionine) can be modified to yield a functionally identical moleculeby standard techniques. Accordingly, each “silent variation” of anucleic acid which encodes a polypeptide is implicit in any describedsequence. Furthermore, one of skill will recognize that individualsubstitutions, deletions or additions which alter, add or delete asingle amino acid or a small percentage of amino acids (typically lessthan 5%, more typically less than 1%) in an encoded sequence are“conservatively modified variations” where the alterations result in thesubstitution of an amino acid with a chemically similar amino acid.Conservative substitution tables providing functionally similar aminoacids are well known in the art. The following six groups each containamino acids that are conservative substitutions for one another: 1)Alanine (A), Serine (S), Threonine (T); 2) Aspartic acid (D), Glutamicacid (E); 3) Asparagine (N), Glutamine (Q); 4) Arginine (R), Lysine (K);5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V); and 6)Phenylalanine (F), Tyrosine (Y), Tryptophan (W). See also, Creighton(1984) Proteins W. H. Freeman and Company. Finally, the addition ofsequences which do not alter the activity of a nucleic acid molecule,such as a non-functional sequence is a conservative modification of thebasic nucleic acid.

One of skill will appreciate that many conservative variations of thenucleic acid constructs disclosed yield a functionally identicalconstruct. For example, due to the degeneracy of the genetic code,“silent substitutions” (i.e., substitutions of a nucleic acid sequencewhich do not result in an alteration in an encoded polypeptide) are animplied feature of every nucleic acid sequence which encodes an aminoacid. Similarly, “conservative amino acid substitutions,” in one or afew amino acids in an amino acid sequence of a packaging or packageableconstruct are substituted with different amino acids with highly similarproperties, are also readily identified as being highly similar to adisclosed construct. Such conservatively substituted variations of eachexplicitly disclosed sequence are a feature of the present invention.

Fourth, nucleic acids which hybridize under stringent conditions to thenucleic acids in the figures are a feature of the invention. “Stringenthybridization wash conditions” in the context of nucleic acidhybridization experiments such as Southern and northern hybridizationsare sequence dependent, and are different under different environmentalparameters. An extensive guide to the hybridization of nucleic acids isfound in Tijssen (1993) Laboratory Techniques in Biochemistry andMolecular Biology—Hybridization with Nucleic Acid Probes part I chapter2 “overview of principles of hybridization and the strategy of nucleicacid probe assays”, Elsevier, N.Y. Generally, highly stringenthybridization and wash conditions are selected to be about 5° C. lowerthan the thermal melting point (T_(m)) for the specific sequence at adefined ionic strength and ph. The T_(m) is the temperature (underdefined ionic strength and pH) at which 50% of the target sequencehybridizes to a perfectly matched probe. Very stringent conditions areselected to be equal to the T_(m) for a particular probe. In general, asignal to noise ratio of 2× (or higher) than that observed for anunrelated probe in the particular hybridization assay indicatesdetection of a specific hybridization.

Nucleic acids which do not hybridize to each other under stringentconditions are still substantially identical if the polypeptides whichthey encode are substantially identical. This occurs, e.g., when a copyof a nucleic acid is created using the maximum codon degeneracypermitted by the genetic code.

Finally, preferred nucleic acids encode hyper-recombinogenic RecAproteins which are at least one order of magnitude (10 times) as activeas a wild-type RecA protein.

EXAMPLES

The following examples are offered to illustrate, but not to limit thepresent invention. Variations upon the exact procedures set forth willbe apparent to one of skill upon review of the present disclosure.

Example 1

Evolving Hyper-Recombinogenic RecA

RecA protein is implicated in most E. coli homologous recombinationpathways. Most mutations in recA inhibit recombination, but some havebeen reported to increase recombination (Kowalczykowski et al.,Microbiol. Rev., 58, 401-465 (1994)). The following example describesevolution of RecA to acquire hyper-recombinogenic activity useful in invivo shuffling formats.

Hyperrecombinogenic RecA was selected using a modification of a systemdeveloped by Shen et al., Genetics 112, 441-457 (1986); Shen et al.,Mol. Gen. Genet. 218, 358-360 (1989)) to measure the effect of substratelength and homology on recombination frequency. Shen & Huang's systemused plasmids and bacteriophages with small (31-430 bp) regions ofhomology at which the two could recombine. In a restrictive host, onlyphage that had incorporated the plasmid sequence were able to formplaques.

For shuffling of recA, endogenous recA and mutS were deleted from hoststrain MC1061. In this strain, no recombination was seen between plasmidand phage. E. coli recA was then cloned into two of the recombinationvectors (Bp221 and πMT631c18). Plasmids containing cloned RecA were ableto recombine with homologous phage:λV3 (430 bp identity with Bp221),λV13(430 bp stretch of 89% identity with Bp221) and λlink H (31bp identitywith πMt631c18, except for 1 mismatch at position 18).

The cloned RecA was then shuffled in vitro using the standardDNase-treatment followed by PCR-based reassembly. Shuffled plasmids weretransformed into the nonrecombining host strain. These cells were grownup overnight, infected with phage λVc, λV13 or λlink H, and plated ontoNZCYM plates in the presence of a 10-fold excess of MC1061 lackingplasmid. The more efficiently a recA allele promotes recombinationbetween plasmid and phage, the more highly the allele is represented inthe bacteriophage DNA. Consequently, harvesting all the phage from theplates and recovering the recA genes selects for the most recombinogenicrecA alleles.

Recombination frequencies for wild type and a pool ofhyperrecombinogenic RecA after 3 rounds of shuffling were as follows:

Cross Wild Type Hyper Recom BP221 × V3 6.5 × 10⁻⁴ 3.3 × 10⁻² BP221 × V132.2 × 10⁻⁵ 1.0 × 10⁻³ πMT631c18 × link H 8.7 × 10⁻⁶ 4.7 × 10⁻⁵

These results indicate a 50-fold increase in recombination for the 430bp substrate, and a 5-fold increase for the 31 bp substrate.

The recombination frequency between BP221 and V3 for five individualclonal isolates are shown below, and the DNA and protein sequences andalignments thereof are included in FIGS. 12 and 13.

Wildtype: 1.6×10⁻⁴

Clone 2: 9.8×10⁻³ (61×increase)

Clone 4: 9.9×10⁻³ (62×increase)

Clone 5: 6.2×10⁻³ (39×increase)

Clone 6: 8.5×10⁻³ (53×increase)

Clone 13: 0.019(116×increase)

Clones 2, 4, 5, 6 and 13 can be used as the substrates in subsequentrounds of shuffling, if further improvement in recA is desired. Not allof the variations from the wildtype recA sequence necessarily contributeto the hyperrecombinogenic phenotype. Silent variations can beeliminated by backcrossing. Alternatively, variants of recAincorporating individual points of variation from wildtype at codons 5,18, 156, 190, 236, 268, 271, 283, 304, 312, 317, 345 and 353 can betested for activity.

Example 2

Whole Organism Evolution for Hyper-Recombination

The possibility of selection for an E. coli strain with an increasedlevel of recombination was indicated from phenotypes of wild-type,ΔrecA, mutS and ΔrecA mutS strains following exposure to mitomycin C, aninter-strand cross-linking agent of DNA.

Exposure of E. coli to mitomycin C causes inter-strand cross-linking ofDNA thereby blocking DNA replication. Repair of the inter-strand DNAcross links in E. coli occurs via a RecA-dependent recombinationalrepair pathway (Friedberg et al., in DNA Repair and Mutagenesis (1995)pp. 191-232). Processing of cross-links during repair results inoccasional double-strand DNA breaks, which too are repaired by aRecA-dependent recombinational route. Accordingly, recA⁻ strains aresignificantly more sensitive than wildtype strains to mitomycin Cexposure. In fact, mitomycin C is used in simple disk-sensitivity assaysto differentiate between RecA⁺ and RecA⁻ strains.

In addition to its recombinogenic properties, mitomycin C is a mutagen.Exposure to DNA damaging agents, such as mitomycin C, typically resultsin the induction of the E. coli SOS regulon which includes productsinvolved in error-prone repair of DNA damage (Friedberg et al., 1995,supra, at pp. 465-522).

Following phage P1-mediated generalized transduction of theΔ(recA-srl)::Tn10 allele (a nonfunctional allele) into wild-type andmutS E. coli, tetracycline-resistant transductants were screened for arecA-phenotype using the mitomycin C-sensitivity assay. It was observedin LB overlays with a ¼ inch filter disk saturated with 10 μg ofmitomycin C following 48 hours at 37° C., growth of the wild-type andmutS strains was inhibited within a region with a radius of about 10 mmfrom the center of the disk. DNA cross-linking at high levels ofmitomycin C saturates recombinational repair resulting in lethalblockage of DNA replication. Both strains gave rise to occasional colonyforming units within the zone of inhibition, although, the frequency ofcolonies was ˜10-20-fold higher in the mutS strain. This is presumablydue to the increased rate of spontaneous mutation of mutS backgrounds. Aside-by-side comparison demonstrated that the ΔrecA and ΔrecA mutSstrains were significantly more sensitive to mitomycin C with growthinhibited in a region extending about 15 mm from the center of the disk.However, in contrast to the recA⁺ strains, no Mit^(r) individuals wereseen within the region of growth inhibition-not even in the mutSbackground. The appearance of Mit^(r) individuals in recA⁺ backgrounds,but not in ΔrecA backgrounds indicates the Mit^(r) is dependent upon afunctional RecA protein and suggests that Mit^(r) may result from anincreased capacity for recombinational repair of mitomycin C-induceddamage.

Mutations which lead to increased capacity for RecA-mediatedrecombinational repair may be diverse, unexpected, unlinked, andpotentially synergistic. A recursive protocol alternating selection forMit^(r) and chromosomal shuffling evolves individual cells with adramatically increased capacity for recombination.

The recursive protocol is as follows. Following exposure of a mutSstrain to mitomycin C, Mit^(r) individuals are pooled and cross-bread[e.g., via Hfr-mediated chromosomal shuffling or split-pool generalizedtransduction, or protoplast fusion). Alleles which result in Mit^(r) andpresumably result in an increased capacity for recombinational repairare shuffled among the population in the absence of mismatch repair. Inaddition, error-prone repair following exposure to mitomycin C canintroduce new mutations for the next round of shuffling. The process isrepeated using increasingly more stringent exposures to mitomycin C. Anumber of parallel selections in the first round as a means ofgenerating a variety of alleles. Optionally, recombinogencity ofisolates can be monitored for hyper-recombination using aplasmid×plasmid assay or a chromosome×chromosome assay (e.g., that ofKonrad, J. Bacteriol. 130, 167-172 (1977)).

Example 3

Whole Genome Shuffling of Streptomyces Coelicolor to Improve theProduction of γ-actinorhodin.

To improve the production of the secondary metabolite γ-actinorhodinfrom S. coelicolor, the entire genome of this organism is shuffledeither alone or with its close relative S. lividans. In the firstprocedure described below, genetic diversity arises from randommutations generated by chemical or physical means. In the secondprocedure, genetic diversity arises from the natural diversity existingbetween the genomes of S. coelicolor and S. lividans.

Spore suspensions of S. coelicolor are resuspended in sterile water andsubjected to U.V. mutagenesis such that 1% of the spores survive (˜600“energy” units using a Stratalinker, Stratagene), and the resultingmutants are “grown out” on sporulation agar. Individual spores representuninucleate cells harboring different mutations within their genome.Spores are collected, washed, and plated on solid medium, preferably soyagar, R5, or other rich medium that results in sporulating colonies.Colonies are then imaged and picked randomly using an automated colonypicker, for example the Q-bot (Genetix). Alternatively coloniesproducing larger or darker halos of blue pigment are picked in additionor preferentially.

The colonies are inoculated into 96 well microtitre plates containing⅓×YEME medium (170 μl/well). Two sterile 3 mm glass beads are added toeach well, and the plates are shaken at 150-250 rpm at 30° C. in ahumidified incubator. The plates are incubated up to 7 days and the cellsupernatents are assayed for γ-actinorhodin production.

To assay, 50 μL of supernatant is added to 100 μL of distilled water ina 96 well polypropylene microtitre plate, and the plate is centrifugedat 4000 rpm to pellet the mycelia. 50 μL of the cleared supernatant isthen removed and added to a flat bottom polystyrene 96 well microtitreplate containing 150 μL 1M KOH in each well. The resulting plates arethen read in a microtitre plate reader measuring the absorbance at 654nm of the individual samples as a measure of the content γ-actinorhodin.

Mycelia from cultures producing γ-actinorhodin at levels significantlyhigher than that of wildtype S. coelicolor are then isolated. These arepropagated on solid sporulation medium, and spore preparations of eachimproved mutant are made. From these preparations protoplasts of each ofthe improved mutants are generated, pooled together, and fused (asdescribed in Genetic Manipulation of Streptomyces—A laboratory Manual,Hopwood, D. A., et al.). The fused protoplasts are regenerated andallowed to sporulate. Spores are collected and either plated on solidmedium for further picking and screening, or, to increase therepresentation of multiparent progeny, are used to generate protoplastsand fused again (or several times as described previously for methods toeffect poolwise recombination) before further picking and screening.

Further improved mutants result from the combination of two or moremutations that have additive or synergistic effects on g-actinorhodinproduction. Further improved mutants can be again mated by protoplastpoolwise fusion, or they can be exposed to random mutagenesis to createa new population of cells to be screened and mated for furtherimprovements.

As an alternative to random mutagenesis a source of genetic diversity,natural diversity can be employed. In this case, protoplasts generatedfrom wildtype S. coelicolor and S. lividans are fused together. Sporesfrom the regenerated progeny of this mating are then either repetitivelyfused and regenerated to create additional diversity, or they areseparated on solid medium, picked, and screened for enhanced productionof g-actinorhodin. As before, the improved subpopulation are matedtogether to identify further improved family shuffled organisms.

Example 4

Whole Genome Shuffling of Rhodococcus for Two-Phase Reaction Catalysis

This example provides and example of how to apply the techniquesdescribed herein to technologies that allow the generic improvement ofbiotransformations catalyzed by whole cells. Rhodococcus was selected asan initial target because it is both representative of systems in whichmolecular biology is rudimentary (as is common in whole cell catalystswhich are generally selected by screening environmental isolates), andbecause it is an organism that can catalyze two-phase reactions.

The goal of whole genome shuffling of Rhodococcus is to obtain anincrease in flux through any chosen pathway. The substrate specificityof the pathway can be altered to accept molecules which are notcurrently substrates. Each of these features can be selected for duringwhole genome shuffling.

During whole genome shuffling, libraries of shuffled enzymes andpathways are made and transformed into Rhodococcus and screened,preferably by high-throughput assays for improvements in the targetphenotype, e.g., by mass spectroscopy for measuring the product.

As noted above, the chromosomal context of genes can have dramaticeffects on their activities. Cloning of the target genes onto a smallplasmid in Rhodococcus can dramatically reduce the overall pathwayactivity (by a factor of 5- to 10-fold or more). Thus, the startingpoint for DNA shuffling of a pathway (on a plasmid) can be 10-fold lowerthan the activity of wild-type strain. By contrast, integration of thegenes into random sites in the Rhodococcus chromosome can result in asignificant (5- to 10-fold) increase in activity. A similar phenomenonwas observed in the recent directed evolution in E coli of an arsenateresistance operon (originally from Staphylococcus aureus) by DNAshuffling. Shuffling of this plasmid produced sequence changes that ledto efficient integration of the operon into the E coli chromosome. Ofthe total 50-fold increase in arsenate resistance obtained by directedevolution of the three gene pathway, approximately 10-fold resulted fromthis integration into the chromosome. The position within the chromosomeis also likely to be important: for example sequences close to thereplication origin have an effectively higher gene dosage and thereforegreater expression level.

In order to fully exploit unpredictable chromosomal position effects,and to incorporate them into a directed evolution strategy whichutilizes multiple cycles of mutation, recombination and selection, genesare manipulated in vitro and then transferred to an optimal chromosomalposition. Recombination between plasmid and chromosome occurs in twodifferent ways. Integration takes place at a position where there issignificant sequence homology between plasmid and chromosome, i.e., byhomologous recombination. Integration also takes place where there is noapparent sequence identity, i.e., by non-homologous recombination. Thesetwo recombination mechanisms are effected by different cellularmachineries and have different potential applications in directedevolution.

To combine the increase in activity that resulted from gene duplicationand chromosomal integration of the target pathway with the powerfultechnique of DNA shuffling, libraries of shuffled genes are made invitro, and integrated into the chromosome in place of the wild-typegenes by homologous recombination. Recombinants are then be screened forincreased activity. This process is optionally made recursive asdiscussed herein. The best Rhodococcus variants are pooled, and the pooldivided in two. Genes are cloned out of the pool by PCR, shuffledtogether and re-integrated into the chromosomes of the other half of thepool by homologous recombination. Recombinants are once again bescreened, the best taken and pooled and the process optionally repeated.

Sometimes there are complex interactions between enzymes catalyzingsuccessive reactions in a pathway. Sometimes the presence of one enzymecan adversely affect the activities of others in the pathway. This canbe the result of protein-protein interactions, or inhibition of oneenzyme by the product of another, or an imbalance of primary orsecondary metabolism.

This problem is overcome by DNA shuffling, which produces solutions inthe target gene cluster that bring about improvements in whatever traitis screened. An alternative approach, which can solve not only thisproblem, but also anticipated future rate limiting steps such as supplyof reducing power and substrate transportation, is complementation byoverexpression of other as yet unknown genomic sequences.

A library of Rhodococcus genomic DNA in a multicopy Rhodococcus vectorsuch as pRC1 is first made. This is transformed into Rhodococcus andtransformants are screened for increases in the desired phenotype.Genomic fragments which result in increased pathway activity are evolvedby DNA shuffling to further increase their beneficial effect on aselected property. This approach requires no sequence information, norany knowledge or assumptions about the nature of protein or pathwayinteractions, or even of the rate-limiting step; it relies only ondetection of the desired phenotype. This sort of random cloning andsubsequent evolution by DNA shuffling of positively interacting genomicsequences is extremely powerful and generic. A variety of sources ofgenomic DNA are used, from isogenic strains to more distantly relatedspecies with potentially desirable properties. In addition, thetechnique is, in principle, applicable to any microorganism for whichthe molecular biology basics of transformation and cloning vectors areavailable, and for any property which can be assayed, preferably in ahigh-throughput format.

Homologous recombination within the chromosome is used to circumvent thelimitations of plasmid-evolution and size restrictions, and isoptionally used to alter central metabolism. The strategy is similar tothat described above for shuffling genes within their chromosomalcontext, except that no in vitro shuffling occurs. Instead, the parentstrain is treated with mutagens such as ultraviolet light ornitrosoguanidine, and improved mutants are selected. The improvedmutants are pooled and split. Half of the pool is used to generaterandom genomic fragments for cloning into a homologous recombinationvector. Additional genomic fragments are derived from related specieswith desirable properties (in this case higher metabolic rates and theability to grow on cheaper carbon sources). The cloned genomic fragmentsare homologous recombined into the genomes of the remaining half of themutant pool, and variants with improved phenotypes are selected. Theseare subjected to a further round of mutagenesis, selection andrecombination. Again this process is entirely generic for theimprovement of any whole cell biocatalyst for which a recombinationvector and an assay can be developed.

Efficient homologous recombination is important for the recursivity ofthe chromosomal evolution strategies outlined above. Non-homologousrecombination results in a futile integration (upon selection) followedby excision (following counterselection) of the entire plasmid.Alternatively, if no counter-selection were used, there is integrationof more and more copies of plasmid/genomic sequences which is bothunstable and also requires an additional selectable marker for eachcycle. Furthermore, additional non-homologous recombination will occurat random positions and may or may not lead to good expression of theintegrated sequence.

Example 5

Increasing the Rate of Homologous Recombination in Rhodococcus

A genetic approach is used to increase the rate of homologousrecombination in Rhodococcus. Both targeted and non-targeted strategiesto evolve increases in homologous recombination are used. RhodococcusrecA is evolved by DNA shuffling to increase its ability to promotehomologous recombination within the chromosome. The recA gene was chosenbecause there are variants of recA known to result in increased rates ofhomologous recombination in E coli. as discussed above.

The recA gene from Rhodococcus is DNA shuffled and cloned into a plasmidthat carries a selectable marker and a disrupted copy of the Rhodococcushomolog of the S cerevisiae URA3 gene (a gene which also conferssensitivity to the uracil precursor analogue 5-fluoroorotic acid).Homologous integration of the plasmid into the chromosome disrupts thehost uracil synthesis pathway leading to a strain that carries theselectable marker and is also resistant to 5-fluoroorotic acid. Theshuffled recA genes is integrated, and can be amplified from thechromosome, shuffled again and cloned back into theintegration-selection vector. At each cycle, the recA genes promotingthe greatest degree of homologous recombination are those that are thebest represented as integrants in the genome. Thus a Rhodococcus recAwith enhanced homologous recombination-promoting activity is evolved.

Many other genes are involved in several different homologousrecombination pathways, and mutations in some of these proteins may alsolead to cells with an increased level of homologous recombination. Forexample mutations in E coli DNA polymerase III have recently been shownto increase RecA-independent homologous recombination. Resistance to DNAcross-linking agents such as nitrous acid, mitomycin and ultraviolet aredependent on homologous recombination. Thus, increases in the activityof this pathway result in increased resistance to these agents.Rhodococcus cells are mutagenized and selected for increased toleranceto DNA cross-linking agents. These mutants are tested for the rate atwhich a plasmid will integrate homologous into the chromosome. Genomiclibraries are prepared from these mutants, combined as described above,and used to evolve a strain with even higher levels of homologousrecombination.

The foregoing description of the preferred embodiments of the presentinvention has been presented for purposes of illustration anddescription. They are not intended to be exhaustive or to limit theinvention to the precise form disclosed, and many modifications andvariations are possible in light of the above teaching. Suchmodifications and variations which may be apparent to a person skilledin the art are intended to be within the scope of this invention. Allpatent documents and publications cited above are incorporated byreference in their entirety for all purposes to the same extent as ifeach item were so individually denoted.

14 1 1485 DNA Escherichia coli 1 gggattttgg tcatgagatt atcaaaaagcggccgcggcc taagaggcca gagaagcctg 60 tcggcacggt ctggtttgct tttgccactgcccgcggtga aggcattacc cggcgggatg 120 cttcagcggc gaccgtgatg cggtgcgtcgtcaggctact gcgtatgcat tgcagacctt 180 gtggcaacaa tttctacaaa acacttgatactgtatgagc atacagtata attgcttcaa 240 cagaacatat tgactatccg gtattacccggcatgacagg agtaaaaatg gctatcgacg 300 aaaacaaaca gaaagcgttg gcggcagcactgggccagat tgagaaacaa tttggtaaag 360 gctccatcat gcgcctgggt gaagaccgttccatggatgt ggaaaccatc tctaccggtt 420 cgctttcact ggatatcgcg cttggggcaggtggtctgcc gatgggccgt atcgtcgaaa 480 tctacggacc ggaatcttcc ggtaaaaccacgctgacgct gcaggtgatc gccgcagcgc 540 agcgtgaagg taaaacctgt gcgtttatcgatgctgaaca cgcgctggac ccaatctacg 600 cacgtaaact gggcgtcgat atcgacaacctgctgtgctc ccagccggac accggcgagc 660 aggcactgga aatctgtgac gccctggcgcgttctggcgc agtagacgtt atcgtcgttg 720 actccgtggc ggcactgacg ccgaaagcggaaatcgaagg cgaaatcggc gactctcaca 780 tgggccttgc ggcacgtatg atgagccaggcgatgcgtaa gctggcgggt aacctgaagc 840 agtccaacac gctgctgatc ttcatcaaccagatccgtat gaaaattggt gtgatgttcg 900 gtaacccgga aaccaccacc ggtggtaacgcgctgaaatt ctacgcctct gttcgtctcg 960 acatccgtcg tatcggcgcg gtgaaagagggcgaaaacgt ggtgggtagc gaaacccgcg 1020 tgaaagtggt gaagaacaaa atcgctgcgccgtttaaaca ggctgaattc cagatcctct 1080 acggcgaagg tatcaacttc tacggcgaactggttgacct gggcgtaaaa gagaagctga 1140 tcgagaaagc aggcgcgtgg tacagctacaaaggtgagaa gatcggtcag ggtaaagcga 1200 atgcgactgc ctggctgaaa gataacccggaaaccgcgaa agagatcgag aagaaagtac 1260 gtgagttgct gctgagcaac ccgaactcaacgccggattt ctctgtagat gatagcgaag 1320 gcgtagcaga aactaacgaa gatttttaatcgtcttgttt gatacacaag ggtcgcatct 1380 gcggcccttt tgctttttta agttgtaaggatatgccatg acagaatcaa catcccgtcg 1440 gcctggtagg ccattttttg gatcttcacctagatccttt taaat 1485 2 1382 DNA Escherichia coli 2 tgttggcacggtctggcttg cttttgccac tgcccgcggt gaaggcatta cccggcggga 60 atgcttcaacggcgaccgtg atgcggtgcg tcgtcaggct actgcgtatg cattgcagac 120 cttgtggcaacaatttctac gaaacacctg atactgtatg agcatacagt ataattgctt 180 caacagaacatattgactat ccggtattac ccggcatgac aggagtgaaa atggctattg 240 acgaaaacaaacagaaagcg ttggcgacag cactgggcca gattgagaaa caatttggta 300 aaggctccatcatgcgcctg ggtgaagacc gttccatgga tgtggaaacc atctctaccg 360 gttcgctttcactggatatc gcgcttgggg caggtggtct gccgatgggc cgtatcgtcg 420 aaatctacggaccggaatct tccggtaaaa ccacactgac gctgcaggtg atcgccgcag 480 cgcagcgtgaaggtaaaacc tgtgcgttta tcgatgccga acacgcgctg gacccaatct 540 acgcacgcaaactgggcgtc gatatcgaca acctgctgtg ctcccagccg gacaccggcg 600 agcaggcactggaaatctgt gacgccctgg cgcgttctgg cgcagtagac gttatcgtcg 660 ttgactccgtggcggcactg acgccgaaag cggaaatcga aggcgaaatc ggcgactctc 720 acatgggccttgcggcacgt atgatgagcc aggcgatgcg caagctggcg ggtaacctga 780 agcagtccaacacgctgctg atcttcatta accagatccg tatgaaaatt ggtgtgatgt 840 tcggtaacccggaaaccact accggtggta acgcgctgaa attctacgcc tccgttcgtc 900 tcgacatccgtcgtatcggc gcggtgaaag agggcgaaaa cgtggtgggt agcgaaaccc 960 gcgtgaaagtggtgaagaac aaaatcgctg cgccgtttaa acaggctgaa ttccaggtcc 1020 tctacggcgaaggtatcaac ttctacggcg aactggttga cctgggcgta aaagagaagc 1080 tgatcgagaaagcaggcgcg tggtacagct acaaaggaga gaagattggt cagggtaaag 1140 cgaacgcgactgcctggctg aaagataatc cggaaaccgc gaaagagatt gagaagaaag 1200 tacgtgagttgctgctgagc aacccgaact caacgccgga tttctctgga gatgatagcg 1260 aaggcgtagcagaaactaac gaagattttt aatcgtcttg tttgatacac aagggtcgca 1320 tctgcgacccttttgctttt ttaagttgta aggatatgcc atgacagaat caacatcccg 1380 tc 1382 31430 DNA Escherichia coli 3 agaggccaga gaagcctgtc ggcacggtct ggtttgcctttgccactgcc cgcggtgaag 60 gcattactcg gcgggaatgc ttcagtggcg accgtgatgcggtgcgtcgt caggctactg 120 cgtatgcatt gcagaccttg tggcaacaat ttctacaaaacacctgatac tgtatgagca 180 tacagtataa ttgcttcaac agaacatatt gactatccggtattacccgg catgacagga 240 gtaaacatgg ctatcgacga aaacaaacag aaagcgttagcggcagcact gggccagatt 300 gagaaacaat ttggtaaagg ctccatcatg cgcctgggtgaagaccgttc catggatgtg 360 gaaaccatct ccaccggttc gctttcactg gatatcgcacttggggcagg tggtctgccg 420 atgggccgta tcgtcgaaat ctacggaccg gaatcttccggtaaaaccac gctgacgctg 480 caggtgatcg ccgcagcgca gcgtgaaggt aaaacctgtgcgtttatcga tgctgaacac 540 gcgctggacc caatctacgc acgtaaactg ggcgtcgatatcgacaacct gctgtgctcc 600 cagcccgaca ccggcgagca ggcactggaa atctgtgacgccctggcgcg ttctggcgcg 660 gtagacgtta tcgtcgttga ctccgtggcg gcactgacgccgaaagcgga aatcgaaggc 720 gaaatcggcg actctcacat gggccttgcg gcacgtatgatgagccaggc gatgcgtaag 780 ctggcgggta acctgaagca gtccaacacg ctgctgatcttcatcaacca gatccgtatg 840 aaaattggtg tgatgttcgg taacccggaa accactaccggtggtaacgc gctgaaattc 900 tacgcctctg ttcgtctcga catccgtcgt atcggcgcggtgaaagaggg cgaaaacgtg 960 gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaatcgctgcgcc gtttaaacag 1020 gctgaattcc aaatcctcta cggcgaaggt atcaacttctacggcgaact ggttgacctg 1080 ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggtacagctacaa aggtgagaag 1140 atcggtcagg gtaaagcgaa tgcgactgcc tggctgaaagataacccgga aaccgcgaaa 1200 gagatcgaga agaaagtacg tgagttgctg ctgagtaacccgaactcaac gccggatttc 1260 tctgtagatg atagcgaagg cgtagcagga actaacgaagatttttaatc gtcttgtttg 1320 atacacaagg gtcgcatctg cggccctttt gcttttttaagttgtaggga tatgccatga 1380 cagaatcaac atcccgtcgg cctggtaggc cattttttggatcttcacct 1430 4 1380 DNA Escherichia coli 4 cggcagggtc tggtttgcttttgccactgc ccgcggtgaa ggcattatcc ggcgggaatg 60 cttcagcggc ggccgtgatgcggtgcgtcg tcaggctact gcgtatgcat tgcagacctt 120 gtggcaacaa tttctacaaaacacctgata ctgtatgagc atacagtata attgcttcga 180 cagaacatat tgactatccggtattacccg gcatgacagg agtaaaaatg gctatcgacg 240 agaacaaaca gaaagcgttggcggcagcac tgggccagat tgagaaacaa tttggtaaag 300 gctccatcat gcgcctgggtgaagaccgtt ccatggatgt ggaaaccatc tctaccggtt 360 cgctttcact ggatatcgcgcttggggcag gtggtctgcc gatgggccgt atcgtcgaaa 420 tctacggacc ggaatcttccggtaaaacca cactgacgct gcaggtgatc gccgcagcgc 480 agcgtgaagg taaaacctgttgcgtttatc gatgctgaac acgcgctaga cccaatctac 540 gcacgtaaac tgggcgtcgatatcgacaac ctgctgtgct cccagccgga caccggcgag 600 caggcactgg aaatctgtgacgccctggcg cgttctggcg cagtagacgt tatcgtcgtt 660 gactccgtag cggcactgacgccgaaagcg gaaatcgaag gcgaaatcgg cgactctcac 720 atgggccttg cggcacgtatgatgagccag gcgatgcgta agctggcggg taacctgaag 780 ttgtccaaca cgctgctgatctttatcaac cagatccgta tgaaaattgg cgtgatgttc 840 ggtaacccgg aaaccaccaccggtggtaac gcgctgaaat tctacgcctc tgttcgtctc 900 gacatccgtc gtatcggtgcggtgaaagag ggcgaaaacg tggtgggtag cgaaacccgc 960 gtgaaagtgg tgaagaacaaaatcgctgcg ccgtttaaac aggctgaatt ccagatcctc 1020 tacggcgaag gtatcaacttctacggcgaa ctggttgacc tgggcgtaaa agagaagctg 1080 atcgagaaag caggcgcgtggtacagctac aaaggtgaga agatcggtca gggtaaagcg 1140 aatgcggctg cctggctgaaaggtaacccg gaaaccgcga aagagatcga gaagaaagta 1200 cgtgagttgc tgctgagcaacccgaactca acgccggatt tctctagaga tgatagcgaa 1260 ggcgtagcag aaactaacgaagatttttaa tcgtcttgtt taatacacga gggtcgcatc 1320 tgcggccctt ttgcttttttaagttgtaag gatatgccat gacagaatca acatccagtc 1380 5 1343 DNA Escherichiacoli 5 agaggccaga gaagccagtt ggcacggtct ggtttgcttt tgccactgcc cggggtgagg60 gcattacccg gcgggaatgc ttcagcggcg accgtgatgc ggtgcgtcgt caggctactg 120cgtatgcact gcagaccttg tggcaacaat ttctacaaaa cacctgttac tgtatgagca 180tgcagtataa ttgcttcaac agaacatatt gactatccgg tattacccgg catgacagga 240gtaaaaatgg ctattgacga aaacaaacag aaagcgttgg cggcagcact gggccagatt 300gagaaacaat ttggtaaagg ctccatcatg cgcctgggtg aagaccgttc catggatgtg 360gaaaccatct ctactggttc gctttcactg gatatcgcgc ttggggcagg tggtctgccg 420atgggccgta tcgtcgaaat ctatggaccg gaatcttccg gtaaaaccac actgacgctg 480caggtgatcg ccgcagcgca gcgtgagggt aaaacctgtg cgtttatcga tgctgaacac 540gcgctggacc caatctacgc acgtaaactg ggcgtcgata tcgacaacct gctgtgctcc 600cagccggaca ccggcgagca ggcactggaa atctgtgacg ccctggcgcg ttctggcgct 660gtagacgtta tcgtcgttga ctccgtggcg gcactgtcgc cgaaagcgga aatcgaaggc 720gaaatcggcg actctcacat gggccttgcg gcacgtatga tgagccaggc aatgcgtaag 780ctggcgggta acctgaagca gtccaacacg ctgctgatct tcatcaacca gatccgtatg 840aaaattggtg tgatgttcgg taacccggaa accaccaccg gtggtaacgc gctgaaattc 900tacgcctctg ttcgtctcga catccgtcgt atcggcgcag tgaaagaggg cgaaaacgtg 960gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaa tcgctgcgcc gtttaaacag 1020gctgaattcc agatcctcta cggcgaaggt atcaacttct acggcgaact ggttgatctg 1080ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggt acagctacaa aggtgagaag 1140gttggtcagg gtaaagcgaa tgcgactgcc tggctgaaag ataacccgga aaccgcgaaa 1200gagatcgaga agaaagtacg tgagttgctg ctgagcaacc cgaactcaac gccggatttc 1260tctgtagatg atagcgaagg cgtagcagaa actaacgaag atttttaatc stcttgtttg 1320atacacaagg gtcgcatctg cgg 1343 6 1379 DNA Escherichia coli 6 gaggccagagaagcctgtcg gcttggtctg gtttgctttt accattgccc gcggtgaagg 60 cattacccggcgggaatgct tcagcggcga ccgtgatgcg gtgcgtcgtc aggctactgt 120 gtatgcactgcagaccttgt ggcaacgatt tctacaaaac actcgatacc gtatgagcac 180 acagtataatcgcttcgaca gaacttattg actatccggt attacccggc atgacaggag 240 taaaaatggctattgacgaa aacaaacaga aagcgttggc ggcagcactg ggccagattg 300 agaaacagtttggtaaaggc tccatcatgc gcctggggga agaccgttcc atggatgtgg 360 aaaccatctctaccggttcg ctttcactgg atatcgcgct tggggcaggt ggtctgccga 420 tgggccgtatcgtcgaaatc tacggaccgg aatcttccgg taaaaccacg ctgacgctgc 480 aggtgatcgccgcagcgcag cgtgaaggta aaacctgtgc gtttatcgat gctgaacacg 540 cgctggacccgatctacgca cgtaaactgg gcgtcgatat cgacaacctg ctgtgctccc 600 agccggacaccggcgagcag gcactggaaa tctgtgacgc cctggcgcgc tctggcgcag 660 tggacgttatcgtcgttgac tccgtggcgg cactgacgcc gaaagcggaa atcgaaggcg 720 aaatcggcgactctcacatg ggccttgcag cacgtatgat gagccaggcg atgcgtaagc 780 tggcgggtaacctgaagcag tccaacacgc tgctgatctt catcaaccag atccgtatga 840 aaattggtgtgatgttcggt aacccggaaa ccactaccgg tggtaacgcg ctgaaattct 900 acgcctctgttcgtctcgac atccgtcgta tcggcacggt gaaagagggc gaaaacgtgg 960 tgggtagcgaaacccgcgtg aaagtggtga agaacaaaat cgctgcgccg tttaaacagg 1020 ctgaattccaaatcctctac gacgaaggta tcaacttcta cggcgaactg gttgacatgg 1080 gcgtaaaagagaagctgatc gagaaagcag gcgcgtggta cagctacaaa ggtgagaagg 1140 ccggtcagggtaaagcgaat gcgactgcct ggctgaaaga taacccggaa accgcgaaag 1200 agatcgagaagaaagtacgt gagttgctgc tgagcaaccc gaactcaacg ccggatttct 1260 ctgtagatgatagcgaaggc gtagcagaaa ctaacgaaga tttttaatcg tcttgtttga 1320 tacacaagggtcgcatctgc ggcccttttg cttttttaag ttgtaaggat atgccatga 1379 7 358 PRTEscherichia coli 7 Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Thr Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysIle 290 295 300 Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Val Asp AspSer Glu Gly Val Ala 340 345 350 Glu Thr Asn Glu Asp Phe 355 8 358 PRTEscherichia coli 8 Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Thr Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Thr Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Val Leu Tyr Gly Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysIle 290 295 300 Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Gly Asp AspSer Glu Gly Val Ala 340 345 350 Glu Thr Asn Glu Asp Phe 355 9 358 PRTEscherichia coli 9 Met Thr Gly Val Asn Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Thr Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysIle 290 295 300 Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Val Asp AspSer Glu Gly Val Ala 340 345 350 Gly Thr Asn Glu Asp Phe 355 10 358 PRTEscherichia coli 10 Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Thr Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Leu Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysIle 290 295 300 Gly Gln Gly Lys Ala Asn Ala Ala Ala Trp Leu Lys Gly AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Arg Asp AspSer Glu Gly Val Ala 340 345 350 Glu Thr Asn Glu Asp Phe 355 11 358 PRTEscherichia coli 11 Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Ser Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Ala Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Gly Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Leu Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysVal 290 295 300 Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Val Asp AspSer Glu Gly Val Ala 340 345 350 Glu Thr Asn Glu Asp Phe 355 12 358 PRTEscherichia coli 12 Met Thr Gly Val Lys Met Ala Ile Asp Glu Asn Lys GlnLys Ala Leu 1 5 10 15 Ala Ala Ala Leu Gly Gln Ile Glu Lys Gln Phe GlyLys Gly Ser Ile 20 25 30 Met Arg Leu Gly Glu Asp Arg Ser Met Asp Val GluThr Ile Ser Thr 35 40 45 Gly Ser Leu Ser Leu Asp Ile Ala Leu Gly Ala GlyGly Leu Pro Met 50 55 60 Gly Arg Ile Val Glu Ile Tyr Gly Pro Glu Ser SerGly Lys Thr Thr 65 70 75 80 Leu Thr Leu Gln Val Ile Ala Ala Ala Gln ArgGlu Gly Lys Thr Cys 85 90 95 Ala Phe Ile Asp Ala Glu His Ala Leu Asp ProIle Tyr Ala Arg Lys 100 105 110 Leu Gly Val Asp Ile Asp Asn Leu Leu CysSer Gln Pro Asp Thr Gly 115 120 125 Glu Gln Ala Leu Glu Ile Cys Asp AlaLeu Ala Arg Ser Gly Ala Val 130 135 140 Asp Val Ile Val Val Asp Ser ValAla Ala Leu Thr Pro Lys Ala Glu 145 150 155 160 Ile Glu Gly Glu Ile GlyAsp Ser His Met Gly Leu Ala Ala Arg Met 165 170 175 Met Ser Gln Ala MetArg Lys Leu Ala Gly Asn Leu Lys Gln Ser Asn 180 185 190 Thr Leu Leu IlePhe Ile Asn Gln Ile Arg Met Lys Ile Gly Val Met 195 200 205 Phe Gly AsnPro Glu Thr Thr Thr Gly Gly Asn Ala Leu Lys Phe Tyr 210 215 220 Ala SerVal Arg Leu Asp Ile Arg Arg Ile Gly Thr Val Lys Glu Gly 225 230 235 240Glu Asn Val Val Gly Ser Glu Thr Arg Val Lys Val Val Lys Asn Lys 245 250255 Ile Ala Ala Pro Phe Lys Gln Ala Glu Phe Gln Ile Leu Tyr Asp Glu 260265 270 Gly Ile Asn Phe Tyr Gly Glu Leu Val Asp Met Gly Val Lys Glu Lys275 280 285 Leu Ile Glu Lys Ala Gly Ala Trp Tyr Ser Tyr Lys Gly Glu LysAla 290 295 300 Gly Gln Gly Lys Ala Asn Ala Thr Ala Trp Leu Lys Asp AsnPro Glu 305 310 315 320 Thr Ala Lys Glu Ile Glu Lys Lys Val Arg Glu LeuLeu Leu Ser Asn 325 330 335 Pro Asn Ser Thr Pro Asp Phe Ser Val Asp AspSer Glu Gly Val Ala 340 345 350 Glu Thr Asn Glu Asp Phe 355 13 1398 DNAArtificial Sequence Description of Artificial Sequence consensus e. colisequence 13 agaggccaga gaagcctgtc ggcacggtct ggtttgcttt tgccactgcccgcggtgaag 60 gcattacccg gcgggaatgc ttcagcggcg accgtgatgc ggtgcgtcgtcaggctactg 120 cgtatgcatt gcagaccttg tggcaacaat ttctacaaaa cacctgatactgtatgagca 180 tacagtataa ttgcttcaac agaacatatt gactatccgg tattacccggcatgacagga 240 gtaaaaatgg ctattgacga aaacaaacag aaagcgttgg cggcagcactgggccagatt 300 gagaaacaat ttggtaaagg ctccatcatg cgcctgggtg aagaccgttccatggatgtg 360 gaaaccatct ctaccggttc gctttcactg gatatcgcgc ttggggcaggtggtctgccg 420 atgggccgta tcgtcgaaat ctacggaccg gaatcttccg gtaaaaccacgctgacgctg 480 caggtgatcg ccgcagcgca gcgtgaaggt aaaacctgtg cgtttatcgatgctgaacac 540 gcgctggacc caatctacgc acgtaaactg ggcgtcgata tcgacaacctgctgtgctcc 600 cagccggaca ccggcgagca ggcactggaa atctgtgacg ccctggcgcgttctggcgca 660 gtagacgtta tcgtcgttga ctccgtggcg gcactgacgc cgaaagcggaaatcgaaggc 720 gaaatcggcg actctcacat gggccttgcg gcacgtatga tgagccaggcgatgcgtaag 780 ctggcgggta acctgaagca gtccaacacg ctgctgatct tcatcaaccagatccgtatg 840 aaaattggtg tgatgttcgg taacccggaa accactaccg gtggtaacgcgctgaaattc 900 tacgcctctg ttcgtctcga catccgtcgt atcggcgcgg tgaaagagggcgaaaacgtg 960 gtgggtagcg aaacccgcgt gaaagtggtg aagaacaaaa tcgctgcgccgtttaaacag 1020 gctgaattcc agatcctcta cggcgaaggt atcaacttct acggcgaactggttgacctg 1080 ggcgtaaaag agaagctgat cgagaaagca ggcgcgtggt acagctacaaaggtgagaag 1140 atcggtcagg gtaaagcgaa tgcgactgcc tggctgaaag ataacccggaaaccgcgaaa 1200 gagatcgaga agaaagtacg tgagttgctg ctgagcaacc cgaactcaacgccggatttc 1260 tctgtagatg atagcgaagg cgtagcagaa actaacgaag atttttaatcgtcttgtttg 1320 atacacaagg gtcgcatctg cggccctttt gcttttttaa gttgtaaggatatgccatga 1380 cagaatcaac atcccgtc 1398 14 358 PRT Artificial SequenceDescription of Artificial Sequence consensus e. coli sequence 14 Met ThrGly Val Lys Met Ala Ile Asp Glu Asn Lys Gln Lys Ala Leu 1 5 10 15 AlaAla Ala Leu Gly Gln Ile Glu Lys Gln Phe Gly Lys Gly Ser Ile 20 25 30 MetArg Leu Gly Glu Asp Arg Ser Met Asp Val Glu Thr Ile Ser Thr 35 40 45 GlySer Leu Ser Leu Asp Ile Ala Leu Gly Ala Gly Gly Leu Pro Met 50 55 60 GlyArg Ile Val Glu Ile Tyr Gly Pro Glu Ser Ser Gly Lys Thr Thr 65 70 75 80Leu Thr Leu Gln Val Ile Ala Ala Ala Gln Arg Glu Gly Lys Thr Cys 85 90 95Ala Phe Ile Asp Ala Glu His Ala Leu Asp Pro Ile Tyr Ala Arg Lys 100 105110 Leu Gly Val Asp Ile Asp Asn Leu Leu Cys Ser Gln Pro Asp Thr Gly 115120 125 Glu Gln Ala Leu Glu Ile Cys Asp Ala Leu Ala Arg Ser Gly Ala Val130 135 140 Asp Val Ile Val Val Asp Ser Val Ala Ala Leu Thr Pro Lys AlaGlu 145 150 155 160 Ile Glu Gly Glu Ile Gly Asp Ser His Met Gly Leu AlaAla Arg Met 165 170 175 Met Ser Gln Ala Met Arg Lys Leu Ala Gly Asn LeuLys Gln Ser Asn 180 185 190 Thr Leu Leu Ile Phe Ile Asn Gln Ile Arg MetLys Ile Gly Val Met 195 200 205 Phe Gly Asn Pro Glu Thr Thr Thr Gly GlyAsn Ala Leu Lys Phe Tyr 210 215 220 Ala Ser Val Arg Leu Asp Ile Arg ArgIle Gly Ala Val Lys Glu Gly 225 230 235 240 Glu Asn Val Val Gly Ser GluThr Arg Val Lys Val Val Lys Asn Lys 245 250 255 Ile Ala Ala Pro Phe LysGln Ala Glu Phe Gln Ile Leu Tyr Gly Glu 260 265 270 Gly Ile Asn Phe TyrGly Glu Leu Val Asp Leu Gly Val Lys Glu Lys 275 280 285 Leu Ile Glu LysAla Gly Ala Trp Tyr Ser Tyr Lys Gly Glu Lys Ile 290 295 300 Gly Gln GlyLys Ala Asn Ala Thr Ala Trp Leu Lys Asp Asn Pro Glu 305 310 315 320 ThrAla Lys Glu Ile Glu Lys Lys Val Arg Glu Leu Leu Leu Ser Asn 325 330 335Pro Asn Ser Thr Pro Asp Phe Ser Val Asp Asp Ser Glu Gly Val Ala 340 345350 Glu Thr Asn Glu Asp Phe 355

What is claimed is:
 1. A method of evolving a cell to acquire a desiredfunction, comprising: (1) introducing a library of DNA fragments into aplurality of cells, whereby at least one of the fragments undergoesrecombination with a segment in the genome or an episome of the cells toproduce modified cells; (2) screening the modified cells for modifiedcells that have evolved toward acquisition of the desired function; (3)recombining DNA from the modified cells that have evolved toward thedesired function with a further library of DNA fragments, at least oneof which undergoes recombination with a segment in the genome or theepisome of the modified cells to produce further modified cells, orrecombining DNA between the modified cells that have evolved toward thedesired function to produce further modified cells; (4) screening thefurther modified cells for further modified cells that have furtherevolved toward acquisition of the desired function; (5) repeating (3)and (4) as required until the further modified cells have acquired thedesired function.
 2. The method of claim 1, wherein the library is alibrary of locked in prophage.
 3. The method of claim 1, wherein thestep of recombining DNA between the modified cells is performed byprotoplast fusing the modified cells and allowing fused cells torecombine.
 4. The method of claim 1, wherein the step of recombining DNAbetween the modified cells is performed by protoplast fusing themodified cells and allowing fused cells to recombine, the method furthercomprising enriching the resulting fused cell population for fused cellscomprising more than two cell genomes.
 5. The method of claim 1, whereinthe library of DNA fragments is a substantially complete genomic libraryfrom at least one heterologous cell type.
 6. The method of claim 1,wherein the library of fragments comprises natural variants of a genefrom different individuals.
 7. The method of claim 1, further comprisingsubdividing the modified cells into first and second pools, isolatingthe further library of DNA fragments from the second pool andintroducing the further library of DNA fragments into the first pool. 8.The method of claim 1, wherein the library of DNA fragments arecomponents of viruses and the introducing occurs by infection of thecells with the viruses.
 9. The method of claim 1, wherein the library ofDNA fragments is cloned into a suicide vector incapable of permanentepisomal existence in the cells.
 10. The method of claim 9, wherein thesuicide vector further comprises a selective marker.
 11. The method ofclaim 1, further comprising coating the library or further library ofDNA fragments with recA protein to stimulate recombination with thesegment of the genome.
 12. The method of claim 1, further comprisingdenaturing the library of fragments to produce single-stranded DNA,reannealling the single-stranded DNA to produce duplexes some of whichcontain mismatches at points of variation in the fragments, andselecting duplexes containing mismatches by affinity chromatography toimmobilized MutS.
 13. The method of claim 1, further comprisingfragmenting the library of fragments to produce subfragments beforedenaturation, and reassembling duplexes of subfragments containingmismatches into reassembled fragments.
 14. The method of claim 13,wherein the average diversity between reassembled fragments is at leastfive times greater than the average diversity between fragments.
 15. Themethod of claim 1, wherein the desired function is secretion of aprotein, and the plurality of cells further comprises a constructencoding the protein.
 16. The method of claim 15, wherein the protein isinactive unless secreted, and the modified or further modified cellshaving evolved toward acquisition of the desired function are screenedby propagating the cells and recovering surviving cells.
 17. The methodof claim 16, wherein the protein is β-lactamase or alkaline phosphatase,and the modified or further modified cells having evolved towardacquisition of the desired function are screened by monitoringmetabolism of a chromogenic substrate of the alkaline phosphatase, or bymonitoring resistance to a β-lactamase antibiotic.
 18. The method ofclaim 17, wherein the protein is an antibody and the plurality of cellsis E. coli.
 19. The method of claim 18, wherein the construct furtherencodes a marker which is expressed with the protein as a fusionprotein, and the screening comprises propagating the modified or furthermodified cells and identifying cells secreting the fusion protein byFACS sorting.
 20. The method of claim 19, wherein the marker protein islinked to a phospholipid anchoring domain that anchors the markerprotein to the cell surface after secretion from the cell.
 21. Themethod of claim 19, wherein the cells are contained in agar drops whichconfine secreted protein in proximity with the cell secreting theprotein.
 22. The method of claim 15, wherein at least one fragment inthe library encodes a signal sequence, and the at least one fragment isincorporated into a construct operably linked to a sequence encoding aprotein to be secreted from the cells.
 23. The method of claim 12,wherein at least one fragment in the library encodes a signal processingenzyme and the cells contain a construct encoding a protein to besecreted operably linked to a signal sequence.
 24. The method of claim12, wherein at least one fragment in the library encodes a gene selectedfrom the group consisting of SecA, SecB, SecE, SecD and SecF genes. 25.The method of claim 1, wherein the desired function is enhancedrecombination.
 26. The method of claim 1, wherein the library offragments comprises a cluster of genes collectively conferringrecombination capacity.
 27. The method of claim 1, wherein the libraryof DNA fragments comprises at least one gene, which at least one gene isselected from the group consisting of recA, recBCD, recBC, recE, recF,recG, recO, recQ, recR, recT, ruvA, ruvB, sbcB, ssb, topA, gyrA and B,lig, polA, uvrD, E, recL, mutU and helD.
 28. The method of claim 27,wherein the plurality of cells further comprises a gene encoding amarker whose expression is prevented by a mutation removable byrecombination, and the modified or further modified cells are screenedby their expression of the marker resulting from removal of the mutationby recombination.
 29. The method of claim 27, wherein in the screeningsteps, the modified or further modified cells are exposed to a mutagenand modified or further modified cells having evolved toward acquisitionof the desired function are selected by their survival of the exposure,survival being conferred by the cells' enhanced recombinational capacityto remove damage induced by the mutagen.
 30. The method of claim 27,wherein the mutagen is radiation.
 31. The method of claim 30, whereinenhanced recombination is conferred by increased genomic copy number ofthe modified or further modified cells.
 32. The method of claim 22,wherein at least one gene is selected from a replication or cellseptation gene.
 33. The method of claim 32, wherein the modified orfurther modified cells having evolved toward acquisition of the desiredfunction are selected by their capacity for syncytium formation or cellfusion.
 34. The method of claim 1, wherein the plurality of cells areplant cells and the desired property is improved resistance to achemical or microbe, and in the screening the steps, the modified orfurther modified cells are exposed to the chemical or microbe andmodified or further modified cells having evolved toward the acquisitionof the desired function are selected by their capacity to survive theexposure.
 35. The method of claim 34, wherein the microorganism is avirus, bacterium, or fungus.
 36. The method of claim 35, wherein thechemical is a viricide, fungicide, insecticide, bactericide orherbicide.
 37. The method of claim 36, wherein the chemical is BT-toxin.38. The method of claim 36, wherein the chemical is glyphosate oratrazine.
 39. The method of claim 36, further comprising propagating aplant cell having acquired the desired function to produce a transgenicplant.
 40. The method of claim 1, wherein the plurality of cells areembryonic cells of an animal, and the method further comprisespropagating the transformed cells to transgenic animal.
 41. The methodof claim 40, wherein the modified cells are screened as components ofthe transgenic animals.
 42. The method of claim 41, further comprisingobtaining embryonic cells from the transgenic animals having modifiedcells evolved toward acquisition of the property and transforming thecells with the further library.
 43. The method of claim 40, furthercomprising isolating DNA from transgenic animals that have evolvedtoward acquisition of the property and introducing the DNA into freshembryonic cells.
 44. The method of claim 40, wherein the animal is afish.
 45. The method of claim 40, wherein at least one of the fragmentsencodes a growth hormone and the desired property is increased size ofthe animal.
 46. The method of claim 1, wherein the library of DNAfragments comprises a library of natural variants from differentspecies.
 47. The method of claim 1, wherein the library of DNA fragmentscomprises one or more shuffled nucleic acid.
 48. The method of claim 47,wherein the shuffled library is produced by in vitro or in vivoshuffling.
 49. The method of claim 1, wherein the further modified cellsof step (3) are recombined with at least one additional library of DNAfragments, at least one of which undergoes recombination with a segmentin the genome or the episome of the further modified cells to produceadditionally modified cells, or recombining DNA between the furthermodified cells that have evolved toward the desired function to produceadditionally modified cells, prior to performing the screening of step(4).